Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Trinity Capital Inc. Interim / Quarterly Report 2021

Aug 5, 2021

32127_10-q_2021-08-05_28db663f-56da-4128-bc0a-cb439a933b3c.zip

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

10-Q 1 tcpp-20210630x10q.htm 10-Q Enhanced HTML document created with Toppan Merrill Bridge 9.11.0.85 Created on: 8/5/2021 08:30:24 PM (UTC) HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2021

OR

◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-56139

TRINITY CAPITAL INC.

(Exact name of registrant as specified in its charter)

Maryland 35-2670395
(State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)
1 N. 1 st Street 3 rd Floor Phoenix, Arizona 85004
(Address of principal executive offices) (Zip Code)

(480) 374-5350

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share TRIN Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ◻ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Act). Yes ◻ No ⌧

As of August 4, 2021, the registrant had 26,554,664 shares of common stock ($0.001 par value per share) outstanding.

Table of Contents

TRINITY CAPITAL INC.

FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2021

TABLE OF CONTENTS

PAGE NO.
PART I FINANCIAL INFORMATION 3
Item 1. Consolidated Financial Statements 3
Consolidated Statements of Assets and Liabilities as of June 30, 2021 (unaudited) and December 31, 2020 3
Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2021 and 2020 (unaudited) 4
Consolidated Statements of Changes in Net Assets for the Three and Six Months Ended June 30, 2021 and 2020 (unaudited) 5
Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2021 and 2020 (unaudited) 7
Consolidated Schedule of Investments as of June 30, 2021 (unaudited) 9
Consolidated Schedule of Investments as of December 31, 2020 24
Notes to Consolidated Financial Statements (unaudited) 39
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 70
Item 3. Quantitative and Qualitative Disclosures About Market Risk 87
Item 4. Controls and Procedures 88
PART II OTHER INFORMATION 90
Item 1. Legal Proceedings 90
Item 1A. Risk Factors 90
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 91
Item 3. Defaults Upon Senior Securities 92
Item 4. Mine Safety Disclosures 92
Item 5. Other Information 92
Item 6. Exhibits 93
SIGNATURES 94

2

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

TRINITY CAPITAL INC.

Consolidated Statements of Assets and Liabilities

(In thousands, except share and per share data)

June 30, December 31,
2021 2020
(Unaudited)
ASSETS
Investments at fair value:
Control investments (cost of $62,363 and $57,072, respectively) $ 41,938 $ 48,730
Affiliate investments (cost of $13,001 and $20,653, respectively) 11,795 27,650
Non-control / Non-affiliate investments (cost of $499,191 and $420,611, respectively) 543,963 417,271
Total investments (cost of $574,555 and $498,336, respectively) 597,696 493,651
Cash and cash equivalents 19,124 44,656
Restricted cash 15,341 16,445
Interest receivable 4,065 3,468
Prepaid expenses 1,298 744
Other assets 3,923 744
Total assets $ 641,447 $ 559,708
LIABILITIES
Credit Facility, net of $1,053 and $2,107, respectively, of unamortized deferred financing costs $ 68,947 $ 132,893
2025 Notes, net of $4,168, and $4,697, respectively, of unamortized deferred financing costs 120,832 120,303
Convertible Notes, net of $2,786, and $3,448, respectively, of unamortized deferred financing costs and discount 47,214 46,552
Distribution payable 7,682 4,947
Security deposits 8,812 7,874
Accounts payable, accrued expenses and other liabilities 8,240 8,391
Total liabilities 261,727 320,960
Commitments and contingencies (Note 6)
NET ASSETS
Common stock, $0.001 par value per share (200,000,000 authorized, 26,491,274 and 18,321,274 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively) 26 18
Paid-in capital in excess of par 369,379 263,366
Distributable earnings/(accumulated loss) 10,315 (24,636)
Total net assets 379,720 238,748
Total liabilities and net assets $ 641,447 $ 559,708
NET ASSET VALUE PER SHARE $ 14.33 $ 13.03

See accompanying notes to consolidated financial statements.

3

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
INVESTMENT INCOME:
Interest income:
Control investments $ 1,266 $ 832 $ 2,572 $ 1,627
Affiliate investments 443 604 882 733
Non-Control / Non-Affiliate investments 16,405 12,004 31,004 21,894
Total interest income 18,114 13,440 34,458 24,254
Fee income:
Non-Control / Non-Affiliate investments 1,362 407 2,337 1,841
Total fee income 1,362 407 2,337 1,841
Total investment income 19,476 13,847 36,795 26,095
EXPENSES:
Interest expense and other debt financing costs 4,425 4,281 9,041 8,539
Compensation and benefits 3,370 1,690 7,366 3,079
Professional fees 570 700 1,216 1,180
General and administrative 1,031 415 1,838 827
Total expenses 9,396 7,086 19,461 13,625
NET INVESTMENT INCOME 10,080 6,761 17,334 12,470
NET REALIZED GAIN/(LOSS) FROM INVESTMENTS:
Control investments
Affiliate investments 1,491
Non-Control / Non-Affiliate investments 504 (2,002) 4,590 (2,884)
Net realized gain/(loss) from investments 1,995 (2,002) 4,590 (2,884)
NET CHANGE IN UNREALIZED APPRECIATION/(DEPRECIATION) FROM INVESTMENTS:
Control investments (4,530) 1,342 (12,084) (8,234)
Affiliate investments (1,892) (969) (8,204) (2,136)
Non-Control / Non-Affiliate investments 19,052 1,750 48,394 (11,799)
Net change in unrealized appreciation/(depreciation) from investments 12,630 2,123 28,106 (22,169)
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS BEFORE FORMATION COSTS 24,705 6,882 50,030 (12,583)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds (15,586)
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $ 24,705 $ 6,882 $ 50,030 $ (28,169)
NET INVESTMENT INCOME PER SHARE - BASIC AND DILUTED $ 0.38 $ 0.37 $ 0.69 $ 0.69
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS PER SHARE - BASIC AND DILUTED $ 0.93 $ 0.38 $ 2.00 $ (1.57)
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC AND DILUTED 26,478,747 18,074,929 25,024,925 17,959,728

See accompanying notes to consolidated financial statements.

4

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statements of Changes in Net Assets

(In thousands, except share and per share data)

(Unaudited)

Three Months Ended June 30, 2021:

Distributable
Earnings /
Common Stock Paid In Capital (Accumulated Total
Shares Par Value in Excess of Par Loss) Net Assets
Balance as of March 31, 2021 26,415,275 $ 26 $ 368,245 $ (6,708) $ 361,563
Issuance of common stock pursuant to distribution reinvestment plan 75,999 1,134 1,134
Distributions to stockholders (7,682) (7,682)
Net increase/(decrease) in net assets resulting from operations:
Net investment income 10,080 10,080
Net realized gain/(loss) from investments 1,995 1,995
Net unrealized appreciation/(depreciation) from investments 12,630 12,630
Balance as of June 30, 2021 26,491,274 $ 26 $ 369,379 $ 10,315 $ 379,720

Three Month Ended June 30, 2020:

Distributable
Paid In Capital Earnings /
Common Stock in Excess of (Accumulated Total
Shares Par Value Par Value Loss) Net Assets
Balance as of March 31, 2020 18,049,860 $ 18 $ 260,120 $ (35,575) $ 224,563
Issuance of common stock, net of issuance costs 81 81
Issuance of common stock pursuant to distribution reinvestment plan 87,740 1,091 1,091
Distributions to stockholders (3,971) (3,971)
Net increase/(decrease) in net assets resulting from operations:
Net investment income/(loss) 6,761 6,761
Net realized gain/(loss) from investments (2,002) (2,002)
Net unrealized appreciation/(depreciation) from investments 2,123 2,123
Balance as of June 30, 2020 18,137,600 $ 18 $ 261,292 $ (32,664) $ 228,646

5

Table of Contents

Six Months Ended June 30, 2021:

Distributable
Paid In Capital Earnings /
Common Stock in Excess of (Accumulated Total
Shares Par Value Par Value Loss) Net Assets
Balance as of December 31, 2020 18,321,274 $ 18 $ 263,366 $ (24,636) $ 238,748
Impact of adoption of ASU 2020-06 (462) (462)
Issuance of common stock in initial public offering, net of issuance costs 8,006,291 8 104,200 104,208
Issuance of common stock pursuant to distribution reinvestment plan 163,709 2,275 2,275
Distributions to stockholders (15,079) (15,079)
Net increase/(decrease) in net assets resulting from operations:
Net investment income/(loss) 17,334 17,334
Net realized gain/(loss) from investments 4,590 4,590
Net unrealized appreciation/(depreciation) from investments 28,106 28,106
Balance as of June 30, 2021 26,491,274 $ 26 $ 369,379 $ 10,315 $ 379,720

Six Months Ended June 30, 2020:

Distributable
Paid In Capital Earnings /
Common Stock in Excess of (Accumulated Total
Shares Par Value Par Value Loss) Net Assets
Balance as of December 31, 2019 10 $ $ $ (524) $ (524)
Issuance of shares related to Formation Transaction (1) 9,716,517 10 145,738 145,748
Issuance of common stock, net of issuance costs 8,333,333 8 114,463 114,471
Issuance of common stock pursuant to distribution reinvestment plan 87,740 1,091 1,091
Distributions to stockholders (3,971) (3,971)
Net increase/(decrease) in net assets resulting from operations:
Net investment income/(loss) 12,470 12,470
Net realized gain/(loss) from investments (2,884) (2,884)
Net unrealized appreciation/(depreciation) from investments (22,169) (22,169)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds (15,586) (15,586)
Balance as of June 30, 2020 18,137,600 $ 18 $ 261,292 $ (32,664) $ 228,646

(1) See “Note 1 - Organization and Basis of Presentation”

See accompanying notes to consolidated financial statements.

6

Table of Contents

TRINITY CAPITAL INC.

Consolidated Statement of Cash Flows

(In thousands)

(Unaudited)

Six Months Ended
June 30, 2021 June 30, 2020
Cash flows provided by/(used in) operating activities:
Net increase/(decrease) in net assets resulting from operations $ 50,030 $ (28,169)
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by/(used in) operating activities:
Purchase of investments, net of deferred fees (208,232) (101,503)
Proceeds from sales and paydowns of investments 146,879 79,731
Net change in unrealized appreciation/(depreciation) from investments, net of third party participation (27,823) 22,168
Net realized gain/(loss) from investments (4,590) 2,884
Accretion of original issue discounts and end of term payments on investments (10,279) (5,049)
Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds 15,586
Amortization of deferred financing costs 1,837 1,416
Change in operating assets and liabilities
(Increase)/Decrease in interest receivable (597) (2,069)
(Increase)/Decrease in prepaid expenses (554) (118)
(Increase)/Decrease in other assets (2,357) (419)
Increase/(Decrease) in security deposits 938 1,810
Increase/(Decrease) in accounts payable, accrued expenses and other liabilities (151) 2,643
Increase/(Decrease) in due to related party (1,059)
Net cash provided by/(used in) operating activities (54,899) (12,148)
Cash flows provided by/(used in) investing activities:
Formation Transactions of Legacy Funds, net of cash acquired (1) (89,515)
Acquisition of Trinity Capital Holdings (2,211)
Acquisition of fixed assets (822) (34)
Net cash provided by/(used in) investing activities (822) (91,760)
Cash flows provided by/(used in) financing activities
Issuance of common stock 112,088 125,000
Common stock issuance costs (7,880) (10,529)
Cash distributions paid (10,069) (2,880)
Proceeds from issuance of 2025 Notes 125,000
Financing costs paid related to 2025 Notes (54) (5,542)
Proceeds under Credit Facility 25,000
Repayments under Credit Facility (90,000) (85,000)
Financing costs paid related to credit facility (3,740)
Net cash provided by/(used in) financing activities 29,085 142,309
Net increase/(decrease) in cash, cash equivalents and restricted cash (26,636) 38,401
Cash, cash equivalents and restricted cash at beginning of period 61,101
Cash, cash equivalents and restricted cash at end of period $ 34,465 $ 38,401
For the Six Months Ended
June 30, 2021 June 30, 2020
Supplemental and non-cash investing and financing activities:
Cash paid for interest $ 6,829 $ 6,455
Shares issued to Trinity Capital Holdings (1) $ $ 8,000
Assumption of severance liability (1) $ $ 3,508
Shares issued to the Legacy Investors as part of the Formation Transactions (1) $ $ 137,748
Accrued but unpaid distributions $ 7,682 $
Value of shares issued in connection with the distribution reinvestment plan $ 2,275 $ 1,091

7

Table of Contents

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the Consolidated Statements of Assets and Liabilities that sum to the total of the same such amounts on the Consolidated Statement of Cash Flows:

June 30, June 30
2021 2020
Cash and cash equivalents $ 19,124 $ 21,849
Restricted cash 15,341 16,552
Total cash, cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows $ 34,465 $ 38,401

(1) See “Note 1 - Organization and Basis of Presentation”

See accompanying notes to consolidated financial statements.

8

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities
Administrative and Support and Waste Management and Remediation (2)
SeaOn Environmental, LLC Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 9.0%; EOT 12.0% $ 1,636 $ 1,951 $ 1,947
Sub-total: Administrative and Support and Waste Management and Remediation (0.5%)* $ 1,636 $ 1,951 $ 1,947
Agriculture, Forestry, Fishing and Hunting (2)
Bowery Farming, Inc. Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 8.5%; EOT 8.5% $ 1,899 $ 2,198 $ 2,136
Equipment Financing January 16, 2020 February 1, 2023 Fixed interest rate 8.7%; EOT 8.5% 1,904 2,157 2,162
Equipment Financing January 16, 2020 May 1, 2023 Fixed interest rate 8.7%; EOT 8.5% 2,451 2,719 2,793
Equipment Financing December 22, 2020 January 1, 2024 Fixed interest rate 7.5%; EOT 8.5% 8,449 8,636 9,518
Total Bowery Farming, Inc. 14,703 15,710 16,609
Robotany, Inc. Equipment Financing January 16, 2020 January 1, 2024 Fixed interest rate 7.6%; EOT 22.0% $ 1,456 $ 1,624 $ 1,612
Sub-total: Agriculture, Forestry, Fishing and Hunting (4.8%)* $ 16,159 $ 17,334 $ 18,221
Construction (2)
Dandelion Energy, Inc. Equipment Financing March 17, 2020 April 1, 2024 Fixed interest rate 9.0%; EOT 12.5% $ 397 $ 419 $ 422
Equipment Financing October 27, 2020 November 1, 2024 Fixed interest rate 9.2%; EOT 12.5% 485 506 506
Equipment Financing (14) November 19, 2020 December 1, 2024 Fixed interest rate 9.1%; EOT 12.5% 485 508 509
Equipment Financing December 29, 2020 January 1, 2025 Fixed interest rate 9.2%; EOT 12.5% 702 724 725
Equipment Financing (14) March 25, 2021 April 1, 2025 Fixed interest rate 9.1%; EOT 12.5% 1,073 1,096 1,101
Total Dandelion Energy, Inc. 3,142 3,253 3,263
Project Frog, Inc. (19) Secured Loan April 30, 2020 May 1, 2023 Fixed interest rate 12.0% $ 4,128 $ 4,071 $ 3,763
Sub-total: Construction (1.9%)* $ 7,270 $ 7,324 $ 7,026
Educational Services (2)
Medical Sales Training Holding Company Secured Loan March 18, 2021 April 1, 2025 Variable interest rate PRIME + 8.8% or Floor rate 12.0%; EOT 12.5% (11) $ 6,000 $ 5,959 $ 5,998
Yellowbrick Learning, Inc. Secured Loan February 1, 2021 September 1, 2025 Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 5.0% (11) $ 7,500 $ 7,514 $ 7,581
Sub-total: Educational Services (3.6%)* $ 13,500 $ 13,473 $ 13,579

9

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities, Continued
Finance and Insurance (2)
DailyPay, Inc. Secured Loan September 30, 2020 November 1, 2024 Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% (11) $ 20,000 $ 20,055 $ 20,294
Secured Loan December 30, 2020 January 1, 2025 Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% (11) 5,000 5,006 5,046
Total DailyPay, Inc. 25,000 25,061 25,340
Petal Card, Inc. Secured Loan January 16, 2020 December 1, 2023 Fixed interest rate 11.0%; EOT 3.0% $ 10,000 $ 10,078 $ 10,004
Secured Loan (16) January 28, 2021 January 1, 2024 Variable interest rate PRIME + 7.3% or Floor rate 11.5% (11) 3,052 4,973 5,229
13,052 15,051 15,233
Sub-total: Finance and Insurance (10.7%)* $ 38,052 $ 40,112 $ 40,573
Health Care and Social Assistance (2)
Lark Technologies, Inc. Secured Loan September 30, 2020 April 1, 2025 Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% (11) $ 5,000 $ 4,871 $ 4,932
Secured Loan June 30, 2021 January 1, 2026 Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% (11) 5,000 4,743 4,742
Total Lark Technologies, Inc. 10,000 9,614 9,674
WorkWell Prevention & Care Inc. Secured Loan January 16, 2020 March 1, 2024 Fixed interest rate 8.0%; EOT 10.0% $ 3,370 $ 3,632 $ 3,597
Secured Loan January 16, 2020 March 1, 2024 Fixed interest rate 8.0% 700 726 692
Total WorkWell Prevention & Care Inc. (19) 4,070 4,358 4,289
Sub-total: Health Care and Social Assistance (3.7%)* $ 14,070 $ 13,972 $ 13,963
Information (2)
Firefly Systems, Inc. Equipment Financing January 29, 2020 February 1, 2023 Fixed interest rate 9.0%; EOT 10.0% $ 3,065 $ 3,370 $ 3,336
Equipment Financing August 28, 2020 September 1, 2023 Fixed interest rate 9.0%; EOT 10.0% 2,663 2,852 2,842
Equipment Financing September 18, 2020 October 1, 2023 Fixed interest rate 9.0%; EOT 10.0% 323 344 342
Total Firefly Systems, Inc. 6,051 6,566 6,520
Gobiquity, Inc. Equipment Financing January 16, 2020 April 1, 2022 Fixed interest rate 7.5%; EOT 20.0% $ 181 $ 301 $ 296
Rigetti & Co, Inc. Secured Loan March 10, 2021 April 1, 2025 Variable interest rate PRIME + 7.5% or Floor rate 11.0%; EOT 2.8% (11) $ 12,000 $ 11,784 $ 11,888
Secured Loan May 18, 2021 June 1, 2025 Variable interest rate PRIME + 7.5% or Floor rate 11.0%; EOT 2.8% (11) 8,000 7,822 7,822
Total Rigetti & Co, Inc. 20,000 19,606 19,710
Smule, Inc. Secured Loan July 1, 2020 January 1, 2022 Fixed interest rate 0.0% (17) $ 69 $ 69 $ 69
Whip Networks, Inc. Secured Loan June 14, 2021 July 1, 2025 Variable interest rate PRIME + 7.8% or Floor rate 11.0%; EOT 3.5% (11) $ 5,000 $ 4,953 $ 4,953
Sub-total: Information (8.3%)* $ 31,301 $ 31,495 $ 31,548

10

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities, Continued
Manufacturing (2)
Circle Media Labs, Inc. Secured Loan May 5, 2021 June 1, 2025 Variable interest rate PRIME + 6.8% or Floor rate 12.0%; EOT 5.0% (11) $ 5,000 $ 4,948 $ 4,948
Daring Foods, Inc. Equipment Financing April 8, 2021 May 1, 2024 Fixed interest rate 9.5%; EOT 8.0% $ 475 $ 473 $ 473
Footprint International Holding, Inc. Equipment Financing February 14, 2020 March 1, 2024 Fixed interest rate 10.3%; EOT 8.0% $ 12,744 $ 13,475 $ 13,549
Secured Loan June 22, 2020 July 1, 2024 Fixed interest rate 12.0%; EOT 9.0% 7,000 7,214 7,273
Total Footprint International Holding, Inc. 19,744 20,689 20,822
Happiest Baby, Inc. Equipment Financing January 16, 2020 September 1, 2022 Fixed interest rate 8.4%; EOT 9.5% $ 660 $ 795 $ 775
Equipment Financing January 16, 2020 November 1, 2022 Fixed interest rate 8.6%; EOT 9.5% 556 653 654
Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 8.6%; EOT 9.5% 550 628 633
Equipment Financing February 7, 2020 June 1, 2023 Fixed interest rate 8.2%; EOT 9.5% 729 802 802
Equipment Financing September 16, 2020 January 1, 2024 Fixed interest rate 7.8%; EOT 9.5% 1,061 1,114 1,118
Equipment Financing January 22, 2021 May 1, 2025 Fixed interest rate 8.4%; EOT 9.5% 886 909 912
Total Happiest Baby, Inc. 4,442 4,901 4,894
Health-Ade, LLC Equipment Financing January 16, 2020 February 1, 2022 Fixed interest rate 9.4%; EOT 15.0% $ 750 $ 1,329 $ 1,311
Equipment Financing January 16, 2020 April 1, 2022 Fixed interest rate 8.6%; EOT 15.0% 480 762 753
Equipment Financing January 16, 2020 July 1, 2022 Fixed interest rate 9.1%; EOT 15.0% 1,333 1,895 1,879
Total Health-Ade, LLC 2,563 3,986 3,943
Mainspring Energy, Inc. Secured Loan January 16, 2020 August 1, 2023 Fixed interest rate 11.0%; EOT 3.8% $ 7,166 $ 7,392 $ 7,424
Secured Loan November 20, 2020 December 1, 2024 Fixed interest rate 11.0%; EOT 3.8% 5,500 5,348 5,483
Total Mainspring Energy, Inc. 12,666 12,740 12,907
Miyoko's Kitchen Equipment Financing February 19, 2020 September 1, 2022 Fixed interest rate 8.8%; EOT 9.0% $ 415 $ 470 $ 470
Equipment Financing August 27, 2020 March 1, 2023 Fixed interest rate 8.9%; EOT 9.0% 682 731 732
Equipment Financing February 5, 2021 September 1, 2023 Fixed interest rate 8.5%; EOT 9.0% 573 590 591
Equipment Financing June 25, 2021 December 1, 2023 Fixed interest rate 8.9%; EOT 9.0% 598 598 598
Total Miyoko's Kitchen 2,268 2,389 2,391
Molekule, Inc. Equipment Financing June 19, 2020 January 1, 2024 Fixed interest rate 8.8%; EOT 10.0% $ 2,149 $ 2,264 $ 2,275
Equipment Financing September 29, 2020 April 1, 2024 Fixed interest rate 9.0%; EOT 10.0% 468 490 492
Equipment Financing December 18, 2020 July 1, 2024 Fixed interest rate 8.8%; EOT 10.0% 766 790 792
Total Molekule, Inc. 3,383 3,544 3,559
Quip NYC, Inc. Secured Loan March 9, 2021 April 1, 2026 Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% (11) $ 17,500 $ 17,193 $ 17,350
Store Intelligence, Inc. (19) Secured Loan May 2, 2020 June 1, 2024 Fixed interest rate 12.0%; EOT 7.8% $ 12,001 $ 12,393 $ 11,795
Tarana Wireless, Inc. Secured Loan June 30, 2021 July 1, 2025 Variable interest rate PRIME + 8.0% or Floor rate 11.5%; EOT 4.5% (11) $ 18,500 $ 17,353 $ 17,353
The Fynder Group, Inc. Equipment Financing October 14, 2020 May 1, 2024 Fixed interest rate 9.1%; EOT 10.0% $ 582 $ 592 $ 594
Vertical Communications, Inc. Secured Loan May 1, 2020 November 1, 2024 Fixed interest rate 9.5%; EOT 26.4% $ 12,000 $ 13,385 $ 13,148
Secured Loan June 18, 2020 July 1, 2022 Fixed interest rate 9.5% 565 565 571
Total Vertical Communications, Inc. (19) 12,565 13,950 13,719
VitaCup, Inc. Secured Loan June 23, 2021 July 1, 2025 Variable interest rate PRIME + 7.5% or Floor rate 11.5%; EOT 2.5% (11) $ 5,500 $ 5,438 $ 5,438
Sub-total: Manufacturing (31.7%)* $ 117,189 $ 120,589 $ 120,186

11

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities, Continued
Pharmaceutical (2)
Zosano Pharma Corporation Equipment Financing January 16, 2020 April 1, 2022 Fixed interest rate 9.4%; EOT 12.0% $ 1,385 $ 1,950 $ 1,833
Equipment Financing January 16, 2020 July 1, 2022 Fixed interest rate 9.7%; EOT 12.0% 1,025 1,325 1,256
Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 9.9%; EOT 12.0% 1,235 1,446 1,399
Equipment Financing January 16, 2020 April 1, 2023 Fixed interest rate 9.9%; EOT 12.0% 1,424 1,611 1,578
Equipment Financing January 16, 2020 May 1, 2023 Fixed interest rate 10.5%; EOT 12.0% 1,070 1,205 1,176
Total Zosano Pharma Corporation 6,139 7,537 7,242
Sub-total: Pharmaceutical (1.9%)* $ 6,139 $ 7,537 $ 7,242
Professional, Scientific, and Technical Services (2)
BackBlaze, Inc. Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 7.2%; EOT 11.5% $ 692 $ 853 $ 851
Equipment Financing January 16, 2020 April 1, 2023 Fixed interest rate 7.4%; EOT 11.5% 93 110 110
Equipment Financing January 16, 2020 June 1, 2023 Fixed interest rate 7.4%; EOT 11.5% 731 851 851
Equipment Financing January 16, 2020 August 1, 2023 Fixed interest rate 7.5%; EOT 11.5% 148 169 169
Equipment Financing January 16, 2020 September 1, 2023 Fixed interest rate 7.7%; EOT 11.5% 153 174 173
Equipment Financing January 16, 2020 October 1, 2023 Fixed interest rate 7.5%; EOT 11.5% 155 174 174
Equipment Financing January 16, 2020 November 1, 2023 Fixed interest rate 7.2%; EOT 11.5% 521 585 583
Equipment Financing January 16, 2020 December 1, 2023 Fixed interest rate 7.5%; EOT 11.5% 694 772 770
Equipment Financing January 16, 2020 January 1, 2024 Fixed interest rate 7.4%; EOT 11.5% 608 672 670
Equipment Financing January 20, 2020 February 1, 2024 Fixed interest rate 7.4%; EOT 11.5% 624 685 683
Equipment Financing February 1, 2020 March 1, 2024 Fixed interest rate 7.2%; EOT 11.5% 545 597 595
Equipment Financing March 26, 2020 April 1, 2024 Fixed interest rate 7.4%; EOT 11.5% 166 180 182
Equipment Financing April 17, 2020 May 1, 2024 Fixed interest rate 7.3%; EOT 11.5% 1,078 1,165 1,167
Equipment Financing July 27, 2020 August 1, 2024 Fixed interest rate 7.5%; EOT 11.5% 1,170 1,242 1,241
Equipment Financing September 4, 2020 October 1, 2024 Fixed interest rate 7.2%; EOT 11.5% 211 221 221
Equipment Financing March 29, 2021 April 1, 2025 Fixed interest rate 7.5%; EOT 11.5% 2,618 2,667 2,675
Total BackBlaze, Inc. 10,207 11,117 11,115
Edeniq, Inc. Secured Loan January 16, 2020 September 1, 2021 Fixed interest rate 13.0%; EOT 9.5% $ 2,072 $ 212 $ 212
Secured Loan January 16, 2020 September 1, 2021 Fixed interest rate 13.0%; EOT 9.5% 1,551 131 131
Total Edeniq, Inc. (13) (19) 3,623 343 343
Emergy, Inc. (16) Equipment Financing January 8, 2021 May 1, 2024 Fixed interest rate 9.1%; EOT 5.0% $ 515 $ 526 $ 527

12

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities, Continued
Professional, Scientific, and Technical Services, Continued
Greenlight Biosciences Inc. Equipment Financing March 29, 2021 April 1, 2024 Fixed interest rate 9.7%; EOT 8.0% $ 3,075 $ 3,068 $ 3,088
Equipment Financing June 17, 2021 July 1, 2024 Fixed interest rate 9.5%; EOT 8.0% 4,378 4313 4,313
Total Greenlight Biosciences Inc. 7,453 7,381 7,401
Incontext Solutions, Inc. Secured Loan January 16, 2020 October 1, 2023 Fixed interest rate 11.75%; EOT 11.4% $ 7,149 $ 6,670 $ 5,268
Matterport, Inc. Secured Loan January 16, 2020 May 1, 2022 Fixed interest rate 11.5%; EOT 5.0% $ 3,427 $ 3,888 $ 3,958
PebblePost, Inc. Secured Loan May 7, 2021 June 1, 2025 Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 3.8% ⁽⁹⁾ $ 12,500 $ 12,337 $ 12,337
Pendulum Therapeutics, Inc. Equipment Financing January 16, 2020 May 1, 2023 Fixed interest rate 7.7%; EOT 5.0% $ 278 $ 281 $ 285
Equipment Financing January 17, 2020 August 1, 2023 Fixed interest rate 7.8%; EOT 5.0% 1,712 1,800 1,844
Equipment Financing March 6, 2020 October 1, 2023 Fixed interest rate 7.7%; EOT 5.0% 513 528 542
Equipment Financing July 15, 2020 February 1, 2024 Fixed interest rate 9.8%; EOT 6.0% 766 785 809
Total Pendulum Therapeutics, Inc. 3,269 3,394 3,480
Reciprocity, Inc. Secured Loan September 25, 2020 October 1, 2024 Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% (11) $ 10,000 $ 9,918 $ 9,896
Secured Loan April 29, 2021 May 1, 2025 Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% (11) 5,000 4,955 4,955
Total Reciprocity, Inc. 15,000 14,873 14,851
Sun Basket, Inc. Secured Loan December 31, 2020 December 1, 2024 Variable interest rate PRIME + 8.5% or Floor rate 11.8%; EOT 5.0% (11) $ 18,375 $ 18,126 $ 18,269
Utility Associates, Inc. (13) Secured Loan January 16, 2020 October 1, 2023 Fixed interest rate 11.0% $ 750 $ 830 $ 603
Sub-total: Professional, Scientific, and Technical Services (20.6%)* $ 82,268 $ 79,485 $ 78,152

13

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities, Continued
Real Estate (2)
Knockaway, Inc. Secured Loan January 16, 2020 December 1, 2023 Fixed interest rate 11.0%; EOT 3.0% $ 8,553 $ 8,710 $ 8,724
Secured Loan January 16, 2020 February 1, 2024 Fixed interest rate 11.0%; EOT 3.0% 2,261 2,295 2,309
Secured Loan January 16, 2020 March 1, 2024 Fixed interest rate 11.0%; EOT 3.0% 2,322 2,352 2,369
Total Knockaway, Inc. 13,136 13,357 13,402
Orchard Technologies, Inc. Secured Loan March 11, 2021 April 1, 2026 Variable interest rate PRIME + 7.5% or Floor rate 11.0%; EOT 4.0% (11) $ 5,000 $ 4,995 $ 5,038
Wanderjaunt, Inc. Equipment Financing January 16, 2020 June 1, 2023 Fixed interest rate 10.2%; EOT 12.0% $ 314 $ 337 $ 328
Equipment Financing January 16, 2020 August 1, 2023 Fixed interest rate 10.2%; EOT 12.0% 1,016 1,132 1,115
Total Wanderjaunt, Inc. 1,330 1,469 1,443
Sub-total: Real Estate (5.2%)* $ 19,466 $ 19,821 $ 19,883
Rental and Leasing Services (2)
EquipmentShare, Inc. Equipment Financing June 24, 2020 July 1, 2023 Fixed interest rate 10.7%; EOT 5.0% $ 6,188 $ 6,438 $ 6,481
Equipment Financing July 2, 2020 August 1, 2023 Fixed interest rate 10.1%; EOT 5.0% 714 740 745
Equipment Financing August 7, 2020 September 1, 2023 Fixed interest rate 10.2%; EOT 5.0% 1,589 1,642 1,651
Equipment Financing September 18, 2020 October 1, 2023 Fixed interest rate 10.4%; EOT 5.0% 2,870 2,954 2,968
Equipment Financing September 29, 2020 October 1, 2024 Fixed interest rate 8.3%; EOT 10.0% 379 394 394
Equipment Financing October 2, 2020 November 1, 2023 Fixed interest rate 10.4%; EOT 5.0% 685 703 710
Equipment Financing October 9, 2020 November 1, 2023 Fixed interest rate 10.5%; EOT 5.0% 2,161 2,217 2,241
Equipment Financing November 4, 2020 December 1, 2023 Fixed interest rate 10.1%; EOT 5.0% 2,114 2,163 2,185
Equipment Financing December 4, 2020 January 1, 2024 Fixed interest rate 10.1%; EOT 5.0% 1,702 1,736 1,752
Equipment Financing December 21, 2020 January 1, 2024 Fixed interest rate 10.5%; EOT 5.0% 677 690 696
Equipment Financing January 26, 2021 February 1, 2024 Fixed interest rate 10.6%; EOT 5.0% 1,259 1,277 1,223
Equipment Financing February 26, 2021 March 1, 2024 Fixed interest rate 10.6%; EOT 5.0% 1,658 1,679 1,693
Equipment Financing March 16, 2021 April 1, 2024 Fixed interest rate 10.7%; EOT 5.0% 1,769 1,787 1,801
Total EquipmentShare, Inc. 23,765 24,420 24,540
Maxwell Financial Labs, Inc. Secured Loan October 7, 2020 November 1, 2024 Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% (11) $ 3,000 $ 2,992 $ 3,030
Secured Loan December 22, 2020 January 1, 2025 Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% (11) 3,000 2,969 2,997
Total Maxwell Financial Labs, Inc. 6,000 5,961 6,027
Sub-total: Rental and Leasing Services (8.1%)* $ 29,765 $ 30,381 $ 30,567
Retail Trade (2)
Birchbox, Inc. (19) Secured Loan January 16, 2020 July 1, 2024 Fixed interest rate 9.0%; EOT 7.5% $ 10,000 $ 10,497 $ 8,995
Boosted eCommerce, Inc. (16) Secured Loan December 18, 2020 January 1, 2023 Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% (11) $ 5,000 $ 4,987 $ 5,037
Secured Loan January 29, 2021 January 1, 2023 Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% (11) 2,500 2,488 2,510
Secured Loan February 26, 2021 January 1, 2023 Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% (11) 7,500 7,458 7,522
Secured Loan April 12, 2021 January 1, 2023 Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% (11) 6,000 5,949 5,949
Secured Loan April 26, 2021 January 1, 2023 Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% (11) 9,000 8,980 8,994
Total Boosted eCommerce, Inc. 30,000 29,862 30,012
Gobble, Inc. Secured Loan January 16, 2020 July 1, 2023 Fixed interest rate 11.3%; EOT 6.0% $ 2,852 $ 2,999 $ 3,010
Secured Loan January 16, 2020 July 1, 2023 Fixed interest rate 11.5%; EOT 6.0% 1,434 1,508 1,513
Total Gobble Inc. 4,286 4,507 4,523
Portofino Labs, Inc. (16) Secured Loan December 31, 2020 July 1, 2025 Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% (11) $ 2,000 $ 1,998 $ 2,010
Secured Loan March 12, 2021 October 1, 2025 Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% (11) 3,000 2,858 2,881
Secured Loan April 1, 2021 November 1, 2025 Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% (11) 2,000 1,820 1,820
Total Portofino Labs, Inc. 7,000 6,676 6,711
Super73, Inc. Secured Loan December 31, 2020 January 1, 2025 Variable interest rate PRIME + 7.3% or Floor rate 11.8%; EOT 4.0% (11) $ 5,500 $ 5,470 $ 5,519
UnTuckIt, Inc. Secured Loan January 16, 2020 June 1, 2024 Fixed interest rate 12.0%; EOT 5.0% $ 15,000 $ 15,800 $ 15,075
Sub-total: Retail Trade (18.7%)* $ 71,786 $ 72,812 $ 70,835

14

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Maturity Date Interest Rate (5) Principal Amount (6) Cost Fair Value (7)
Debt Securities, Continued
Space Research and Technology (2)
Axiom Space, Inc. (16) Secured Loan May 28, 2021 June 1, 2026 Variable interest rate PRIME + 6.0% or Floor rate 9.3%; EOT 2.5% (11) $ 30,000 $ 29,670 $ 29,670
Sub-total: Space Research and Technology (7.8%)* $ 30,000 $ 29,670 $ 29,670
Utilities (2)
Invenia, Inc. Secured Loan January 16, 2020 January 1, 2023 Fixed interest rate 11.5%; EOT 5.0% $ 5,133 $ 5,593 $ 5,525
Secured Loan January 16, 2020 May 1, 2023 Fixed interest rate 11.5%; EOT 5.0% 2,711 2,917 2,902
Secured Loan January 16, 2020 January 1, 2024 Fixed interest rate 11.5%; EOT 5.0% 2,642 2,726 2,777
Secured Loan January 17, 2020 February 1, 2024 Fixed interest rate 11.5%; EOT 5.0% 3,620 3,752 3,798
Secured Loan June 8, 2020 July 1, 2024 Fixed interest rate 11.5%: EOT 5.0% 4,000 4,078 4,183
Secured Loan October 29, 2020 November 1, 2024 Fixed interest rate 11.5%: EOT 5.0% 5,000 5,062 5,193
Total Invenia, Inc. (10) 23,106 24,128 24,378
Sub-total: Utilities (6.4%)* $ 23,106 $ 24,128 $ 24,378
Wholesale Trade (2)
BaubleBar, Inc. Secured Loan January 16, 2020 March 1, 2023 Fixed interest rate 11.5%; EOT 7.3% $ 4,599 $ 5,467 $ 5,160
Grandpad, Inc. Equipment Financing November 16, 2020 June 1, 2023 Fixed interest rate 10.6%; EOT 5.0% $ 2,359 $ 2,416 $ 2,431
Equipment Financing December 23, 2020 July 1, 2023 Fixed interest rate 10.8%; EOT 5.0% 2,996 3,055 3,072
Total Grandpad, Inc. (16) 5,355 5,471 5,503
Sub-total: Wholesale Trade (2.8%)* $ 9,954 $ 10,938 $ 10,663
Total: Debt Securities (136.5%)* (15) $ 511,661 $ 521,022 $ 518,433

15

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Expiration Date Series Shares Strike Price Cost Fair Value (7)
Warrant Investments
Agriculture, Forestry, Fishing and Hunting (2)
Bowery Farming, Inc. Warrant January 16, 2020 June 10, 2029 Common Stock 68,863 $ 5.08 $ 410 $ 1,790
Warrant December 22, 2020 December 22, 2030 Common Stock 29,925 $ 6.24 $ 160 $ 760
Total Bowery Farming, Inc. 570 2,550
Robotany, Inc. Warrant January 16, 2020 July 19, 2029 Common Stock 262,870 $ 0.26 $ 128 $ 84
Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.7%)* $ 698 $ 2,634
Construction (2)
Project Frog, Inc. (19) Warrant January 16, 2020 July 26, 2026 Preferred Series AA 391,990 $ 0.19 $ 18 $ 1
Sub-Total: Construction (0.0%)* $ 18 $ 1
Educational Services (2)
Medical Sales Training Holding Company Warrant March 18, 2021 March 18, 2031 Common Stock 3,232 $ 7.74 $ 21 $ 17
Yellowbrick Learning, Inc. Warrant January 16, 2020 September 28, 2028 Common Stock 222,222 $ 0.90 $ 120 $ 551
Sub-Total: Educational Services (0.1%)* $ 141 $ 568
Finance and Insurance (2)
DailyPay, Inc. Warrant September 30, 2020 September 30, 2030 Common Stock 89,264 $ 3.00 $ 151 $ 863
Petal Card, Inc. Warrant January 16, 2020 November 27, 2029 Preferred Series B 250,268 $ 1.32 $ 147 $ 471
Warrant January 11, 2021 January 11, 2031 Common Stock (16) 135,835 0.01 312 384
Total Petal Card, Inc. 459 855
Realty Mogul Warrant January 16, 2020 December 18, 2027 Preferred Series B 234,421 $ 3.88 $ 285 $ 25
Sub-Total: Finance and Insurance (0.5%)* $ 895 $ 1,743
Health Care and Social Assistance (2)
Lark Technologies, Inc. Warrant September 30, 2020 September 30, 2030 Common Stock 76,231 $ 1.76 $ 177 $ 248
Warrant June 30, 2021 June 30, 2031 Common Stock 79,325 $ 1.76 258 258
Total Lark Technologies, Inc. 435 506
Sub-Total: Health Care and Social Assistance (0.1%)* $ 435 $ 506
Information (2)
Everalbum, Inc. Warrant January 16, 2020 July 29, 2026 Preferred Series A 851,063 $ 0.10 $ 24 $ 8
Figg, Inc. (9) Warrant January 16, 2020 March 31, 2028 Common Stock 935,198 $ 0.07 $ $
Firefly Systems, Inc. Warrant January 31, 2020 January 29, 2030 Common Stock 133,147 $ 1.14 $ 282 $ 142
Gtxcel, Inc. Warrant January 16, 2020 September 24, 2025 Preferred Series C 1,000,000 $ 0.21 $ 83 $ 13
Warrant January 16, 2020 September 24, 2025 Preferred Series D 1,000,000 $ 0.21 83
Total Gtxcel, Inc. 166 13
Lucidworks, Inc. Warrant January 16, 2020 June 27, 2026 Preferred Series D 619,435 $ 0.77 $ 806 $ 1,718
Oto Analytics, Inc. Warrant January 16, 2020 August 31, 2028 Preferred Series B 1,018,718 $ 0.79 $ 295 $ 164
RapidMiner, Inc. Warrant January 16, 2020 March 25, 2029 Preferred Series C-1 11,624 $ 60.22 $ 528 $ 55
Rigetti & Co, Inc. Warrant May 18, 2021 May 18, 2031 Common Stock 995,099 $ 0.21 $ 506 $ 560
Sub-Total: Information (0.7%)* $ 2,607 $ 2,660

16

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Expiration Date Series Shares Strike Price Cost Fair Value (7)
Warrant Investments, Continued
Manufacturing (2)
Circle Media Labs, Inc. Warrant May 5, 2021 May 5, 2031 Common Stock 101,667 $ 0.31 $ 29 $ 31
Daring Foods, Inc. Warrant April 8, 2021 April 8, 2031 Common Stock 68,100 $ 0.27 $ 106 $ 440
Footprint International Holding, Inc. Warrant February 14, 2020 February 14, 2030 Common Stock 26,852 $ 0.31 $ 5 $ 32
Warrant June 22, 2020 June 22, 2030 Common Stock 10,836 $ 0.31 4 80
Total Footprint International Holding, Inc. 9 112
Happiest Baby, Inc. Warrant January 16, 2020 May 16, 2029 Common Stock 182,554 $ 0.33 $ 193 $ 177
Lensvector, Inc. Warrant January 16, 2020 December 30, 2021 Preferred Series C 85,065 $ 1.18 $ 32 $
Mainspring Energy, Inc. Warrant January 16, 2020 July 9, 2029 Common Stock 140,186 $ 1.15 $ 283 $ 480
Warrant November 20, 2020 November 20, 2030 Common Stock 81,294 $ 1.15 226 279
Total Mainspring Energy, Inc. 509 759
Molekule, Inc. Warrant June 19, 2020 June 19, 2030 Preferred Series C-1 32,051 $ 3.12 $ 16 $ 10
Quip NYC, Inc. Warrant March 9, 2021 March 9, 2031 Preferred Series A-1 10,833 $ 48.46 $ 204 $ 216
SBG Labs, Inc. Warrant January 16, 2020 June 29, 2023 Preferred Series A-1 42,857 $ 0.70 $ 13 $
Warrant January 16, 2020 September 18, 2024 Preferred Series A-1 25,714 $ 0.70 8
Warrant January 16, 2020 January 14, 2024 Preferred Series A-1 21,492 $ 0.70 7
Warrant January 16, 2020 March 24, 2025 Preferred Series A-1 12,155 $ 0.70 4
Warrant January 16, 2020 October 10, 2023 Preferred Series A-1 11,150 $ 0.70 4
Warrant January 16, 2020 May 6, 2024 Preferred Series A-1 11,145 $ 0.70 4
Warrant January 16, 2020 June 9, 2024 Preferred Series A-1 7,085 $ 0.70 2
Warrant January 16, 2020 May 20, 2024 Preferred Series A-1 342,857 $ 0.70 110
Warrant January 16, 2020 March 26, 2025 Preferred Series A-1 200,000 $ 0.70 65
Total SBG Labs, Inc. 217
Tarana Wireless, Inc. Warrant June 30, 2021 June 30, 2031 Common Stock 5,027,629 $ 0.19 $ 967 $ 967
The Fynder Group, Inc. Warrant October 14, 2020 October 14, 2030 Common Stock 107,190 $ 0.49 $ 201 $ 1,176
Vertical Communications, Inc. (9) (19) Warrant January 16, 2020 July 11, 2026 Preferred Series A 828,479 $ 1.00 $ $
VitaCup, Inc. Warrant June 23, 2021 June 23, 2031 Preferred Series C 68,996 $ 2.79 $ 9 $ 7
Sub-Total: Manufacturing (1.0%)* $ 2,492 $ 3,895

17

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Expiration Date Series Shares Strike Price Cost Fair Value (7)
Warrant Investments, Continued
Pharmaceutical (2)
Zosano Pharma Corporation Warrant January 16, 2020 September 25, 2025 Common Stock (8) 75,000 $ 3.59 $ 69 $ 36
Sub-Total: Pharmaceutical (0.0%)* $ 69 $ 36
Professional, Scientific, and Technical Services (2)
Augmedix, Inc. Warrant January 16, 2020 September 3, 2029 Common Stock 580,383 $ 2.88 $ 449 $ 1,281
Continuity, Inc. Warrant January 16, 2020 March 29, 2026 Preferred Series C 1,588,806 $ 0.25 $ 21 $ 32
Crowdtap, Inc. Warrant January 16, 2020 December 16, 2025 Preferred Series B 442,233 $ 1.09 $ 42 $ 120
Warrant January 16, 2020 November 30, 2027 Preferred Series B 100,000 $ 1.09 9 27
Total Crowdtap, Inc. 51 147
Dynamics, Inc. Warrant January 16, 2020 March 10, 2024 Common Stock 17,000 $ 10.59 $ 86 $
E La Carte, Inc. Warrant January 16, 2020 July 28, 2027 Common Stock 497,183 $ 0.30 $ 186 $ 128
Warrant January 16, 2020 July 28, 2027 Preferred Series A 104,284 $ 7.49 15 36
Warrant January 16, 2020 July 28, 2027 Preferred Series AA-1 106,841 $ 7.49 15 1
Total E La Carte, Inc. 216 165
Edeniq, Inc. Warrant January 16, 2020 December 23, 2026 Preferred Series B 2,685,501 $ 0.22 $ $
Warrant January 16, 2020 December 23, 2026 Preferred Series B 2,184,672 $ 0.01
Warrant January 16, 2020 March 12, 2028 Preferred Series C 5,106,972 $ 0.44
Warrant January 16, 2020 October 15, 2028 Preferred Series C 3,850,294 $ 0.01
Total Edeniq, Inc. (9)(19)
Greenlight Biosciences Inc. Warrant March 29, 2021 March 29, 2031 Common Stock 219,839 $ 0.81 $ 138 $ 164
Hologram, Inc. Warrant January 31, 2020 January 27, 2030 Common Stock 193,054 $ 0.26 $ 49 $ 51
Hospitalists Now, Inc. Warrant January 16, 2020 March 30, 2026 Preferred Series D-2 135,807 $ 5.89 $ 71 $ 181
Warrant January 16, 2020 December 6, 2026 Preferred Series D-2 750,000 $ 5.89 391 999
Total Hospitalists Now, Inc. 462 1,180
Incontext Solutions, Inc. Warrant January 16, 2020 September 28, 2028 Preferred Series AA-1 332,858 $ 1.47 $ 34 $ 2
Matterport, Inc. Warrant January 16, 2020 April 20, 2028 Common Stock 143,813 $ 1.43 $ 434 $ 6,667
PebblePost, Inc. (14) Warrant May 7, 2021 May 7, 2031 Common Stock 657,343 $ 1.76 $ 68 $ 142
Pendulum Therapeutics, Inc. Warrant January 16, 2020 October 9, 2029 Preferred Series B 55,263 $ 1.90 $ 44 $ 48
Warrant June 1, 2020 July 15, 2030 Preferred Series B 36,842 $ 1.90 36 32
Total Pendulum Therapeutics, Inc. 80 80
Reciprocity, Inc. Warrant September 25, 2020 September 25, 2030 Common Stock 114,678 $ 4.17 $ 99 $ 109
Warrant April 29, 2021 April 29, 2031 Common Stock 57,195 $ 1.90 54 54
Total Reciprocity, Inc. 153 163
Resilinc, Inc. Warrant January 16, 2020 December 15, 2025 Preferred Series A 589,275 $ 0.51 $ 40 $ 1
Sun Basket, Inc. Warrant January 16, 2020 October 5, 2027 Preferred Series C-2 249,306 $ 6.02 $ 111 $ 167
Warrant December 31, 2020 December 29, 2032 Common Stock 118,678 $ 0.89 545 499
656 666
Utility Associates, Inc. Warrant January 16, 2020 June 30, 2025 Preferred Series A 92,511 $ 4.54 $ 55 $ 1
Warrant January 16, 2020 May 1, 2026 Preferred Series A 60,000 $ 4.54 36
Warrant January 16, 2020 May 22, 2027 Preferred Series A 200,000 $ 4.54 120
Total Utility Associates, Inc. 211 1
Sub-Total: Professional, Scientific, and Technical Services (2.8%)* $ 3,148 $ 10,742

18

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Expiration Date Series Shares Strike Price Cost Fair Value (7)
Warrant Investments, Continued
Real Estate (2)
Egomotion Corporation Warrant January 16, 2020 December 10, 2028 Preferred Series A (9) 60,786 $ 1.32 $ $ 29
Warrant January 16, 2020 June 29, 2028 Preferred Series A 121,571 $ 1.32 219 57
Total Egomotion Corporation 219 86
Knockaway, Inc. Warrant January 16, 2020 May 24, 2029 Preferred Series B 87,955 $ 8.53 $ 209 $ 183
Sub-Total: Real Estate (0.1%)* $ 428 $ 269
Rental and Leasing Services (2)
Maxwell Financial Labs, Inc. Warrant October 7, 2020 October 7, 2030 Common Stock 106,735 $ 0.29 $ 21 $ 249
Warrant December 22, 2020 December 22, 2030 Common Stock 110,860 $ 0.29 34 259
Total Maxwell Financial Labs, Inc. 55 508
Sub-Total: Rental and Leasing Services (0.1%)* $ 55 $ 508
Retail Trade (2)
Boosted eCommerce, Inc. (16) Warrant December 18, 2020 December 14, 2030 Preferred Series A-1 759,263 $ 0.84 $ 259 $ 202
Gobble, Inc. Warrant January 16, 2020 May 9, 2028 Common Stock 74,635 $ 1.20 $ 73 $ 674
Warrant January 16, 2020 December 27, 2029 Common Stock 10,000 $ 1.22 617 90
Total Gobble, Inc. 690 764
Madison Reed, Inc. Warrant January 16, 2020 March 23, 2027 Preferred Series C 194,553 $ 2.57 $ 185 $ 416
Warrant January 16, 2020 July 18, 2028 Common Stock 43,158 $ 0.99 71 92
Warrant January 16, 2020 May 19, 2029 Common Stock 36,585 $ 1.23 56 78
Total Madison Reed, Inc. 312 586
Portofino Labs, Inc. (16) Warrant December 31, 2020 December 31, 2030 Common Stock 39,659 $ 1.53 $ 160 $ 321
Warrant April 1, 2021 April 1, 2031 Common Stock 39,912 $ 1.90 99 131
Total Portofino Labs, Inc. 259 452
Super73, Inc. Warrant December 31, 2020 December 31, 2030 Common Stock 177,305 $ 3.16 $ 105 $ 68
Trendly, Inc. Warrant January 16, 2020 August 10, 2026 Preferred Series A 245,506 $ 1.14 $ 222 $ 154
Sub-Total: Retail Trade (0.6%)* $ 1,847 $ 2,226
Space Research and Technology (2)
Axiom Space, Inc. (16) Warrant May 28, 2021 May 28, 2031 Common Stock 1,773 $ 169.24 $ 121 $ 108
Warrant May 28, 2021 May 28, 2031 Common Stock 882 $ 340.11 39 33
Total Axiom Space, Inc. 160 141
Sub-Total: Space Research and Technology (0.0%)* $ 160 $ 141
Wholesale Trade (2)
BaubleBar, Inc. Warrant January 16, 2020 March 29, 2027 Preferred Series C 531,806 $ 1.96 $ 638 $ 210
Warrant January 16, 2020 April 20, 2028 Preferred Series C 60,000 $ 1.96 72 24
Total BaubleBar, Inc. 710 234
GrubMarket, Inc. Warrant June 15, 2020 June 15, 2030 Common Stock 405,000 $ 1.10 $ 115 $ 585
Sub-Total: Wholesale Trade (0.2%)* $ 825 $ 819
Total: Warrant Investments (7.0%)* (15) $ 13,818 $ 26,748

19

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

Portfolio Company (1) Type of Investment (3) Investment Date (4) Shares / Principal Series Cost Fair Value (7)
Equity Investments
Construction (2)
Project Frog, Inc. Equity January 16, 2020 8,118,527 Preferred Series AA-1 (18) $ 702 $ 82
Equity January 16, 2020 6,300,134 Preferred Series BB (18) 2,667 891
Total Project Frog, Inc. (19) 3,369 973
Sub-Total: Construction (0.3%)* $ 3,369 $ 973
Health Care and Social Assistance (2)
WorkWell Prevention & Care Inc. Equity January 16, 2020 7,000,000 Common Stock $ 51 $ 500
Equity January 16, 2020 3,450 Preferred Series P (18) 3,450
Equity January 16, 2020 $ 2,470 Convertible Notes (12) 2,519 1,637
Total WorkWell Prevention & Care Inc. (19) 6,020 2,137
Sub-Total: Health Care and Social Assistance (0.6%)* $ 6,020 $ 2,137
Manufacturing (2)
Atieva, Inc. (10) Equity February 24, 2021 585,022 Preferred Series D (8)(18) $ 7,600 $ 32,419
Equity April 2, 2021 121,473 Preferred Series E (8)(18) 960 6,731
Total Atieva, Inc. 8,560 39,150
indie Semiconductor, Inc. Equity June 2, 2021 6,250 Preferred Series G (18) $ 31 $ 1,534
Store Intelligence, Inc. (19) Equity May 2, 2020 1,430,000 Preferred Series A (18) $ 608 $
Vertical Communications, Inc. Equity January 16, 2020 3,892,485 Preferred Series 1 (9)(18) $ $
Equity January 16, 2020 $ 5,500 Convertible Notes (12) 3,966 2,405
Total Vertical Communications, Inc. (19) 3,966 2,405
Sub-Total: Manufacturing (11.3%)* $ 13,165 $ 43,089
Professional, Scientific, and Technical Services (2)
Dynamics, Inc. Equity January 16, 2020 17,726 Preferred Series A (18) $ 390 $
Edeniq, Inc. Equity January 16, 2020 7,807,499 Preferred Series B (9)(18) $ $
Equity January 16, 2020 2,441,082 Preferred Series C (9)(18)
Equity January 16, 2020 $ 1,303 Convertible Notes (9)(12)
Total Edeniq, Inc. (19)
Emergy, Inc. Equity June 28, 2021 75,958 Preferred Series B (18) $ 500 $ 500
Sub-Total: Professional, Scientific, and Technical Services (0.1%)* $ 890 $ 500
Rental and Leasing Services (2)
Maxwell Financial Labs, Inc (16) Equity January 22, 2021 135,641 Preferred Series B (18) $ 500 $ 503
Sub-Total: Rental and Leasing Services (0.1%)* $ 500 $ 503
Retail Trade (2)
Birchbox, Inc. Equity April 20, 2020 3,140,927 Preferred Series D (18) $ 10,271 $ 1
Equity March 26, 2021 2,002,416 Preferred Series E (18) 5,500 5,312
Total Birchbox, Inc. (19) 15,771 5,313
Sub-Total: Retail Trade (1.4%)* $ 15,771 $ 5,313
Total: Equity Investments (13.8%)* (15) $ 39,715 $ 52,515
Total Investment in Securities (157.4%)* $ 574,555 $ 597,696
Cash, Cash Equivalents, and Restricted Cash
Goldman Sachs Financial Square Government Institutional Fund $ 34,072 $ 34,072
Other cash accounts 393 393
Cash, Cash Equivalents, and Restricted Cash (9.1%)* 34,465 34,465
Total Portfolio Investments and Cash and Cash Equivalents (166.5% of net assets) $ 609,020 $ 632,161

20

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

June 30, 2021

(In thousands, except share and per share data)

(Unaudited)

(1) All portfolio companies are located in North America. As of June 30, 2021, the Company had two foreign domiciled portfolio companies - one in Canada (6.5% of NAV) and one in Cayman Islands (10.3% of NAV). The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.

(2) The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.

(3) All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

(4) Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions, investment date is January 16, 2020, the date of the Formation Transactions.

(5) Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or any additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair market value in certain cases subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt securities

(6) Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

(7) Except as noted, all investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.

(8) Asset is valued using Level 2 inputs.

(9) Investment has zero cost basis as it was purchased at a fair market value of zero as part of the Formation Transactions.

(10) Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended. The Company’s percentage of non-qualifying assets at fair value represents 9.9% of the Company’s total assets as of June 30, 2021. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Invenia, Inc. is a Canadian corporation, and Atieva, Inc. is a Cayman Island corporation.

(11) The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 3.25% as of June 30, 2021.

21

Table of Contents

(12) Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not take place.

(13) Debt is on non-accrual status as of June 30, 2021, and is therefore considered non-income producing.

(14) Investment has an unfunded commitment as of June 30, 2021 (see “Note 6 – Commitments and Contingencies”). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(15) All of the Company’s debt, warrant and equity securities are pledged as collateral supporting the amounts outstanding under the credit facility with Credit Suisse AG (see “Note 5 – Borrowings”), except as noted.

(16) Investment is not pledged as collateral supporting amounts outstanding under the credit facility with Credit Suisse AG.

(17) Investment is considered non-income producing.

(18) Preferred stock represent investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

(19) This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of June 30, 2021, along with transactions during the six months ended June 30, 2021 in these control or affiliated investments are as follows:

Net change in
Unrealized
Fair Value at Gross Gross Realized (Depreciation)/ Fair Value at Interest
December 31, 2020 Additions (1) Reductions (2) Gain/(Loss) Appreciation June 30, 2021 Income
For the Six Months Ended June 30, 2021
Control Investments
Birchbox, Inc. $ 19,369 $ 5,564 $ $ $ (10,624) $ 14,309 $ 514
Edeniq, Inc. 1,507 178 (1,698) 356 343 557
Project Frog, Inc. 4,516 26 194 4,736 273
Vertical Communications, Inc. 16,953 447 (242) (1,035) 16,123 1,049
WorkWell Prevention and Care Inc. 6,385 1,017 (975) 6,427 179
Total Control Investments $ 48,730 $ 7,232 $ (1,940) $ $ (12,084) $ 41,938 $ 2,572
Affiliate Investments
Ology Bioservices, Inc. $ 15,072 $ $ (9,304) $ 1,491 $ (7,259) $ $
Store Intelligence, Inc. 12,578 162 (945) 11,795 882
Total Affiliate Investments $ 27,650 $ 162 $ (9,304) $ 1,491 $ (8,204) $ 11,795 $ 882
Total Control and Affiliate Investments $ 76,380 $ 7,394 $ (11,244) $ 1,491 $ (20,288) $ 53,733 $ 3,454

(1) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one

22

Table of Contents

or more new securities and the movement of an existing portfolio company into this category from a different category.

(2) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

23

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities
Administrative and Support and Waste Management and Remediation (2)
SeaOn Environmental, LLC Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 9.0%; EOT 12.0% $ 2,134 $ 2,370 $ 2,328
Sub-total: Administrative and Support and Waste Management and Remediation (1.0%)* $ 2,134 $ 2,370 $ 2,328
Agriculture, Forestry, Fishing and Hunting (2)
Bowery Farming, Inc. Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 8.5%; EOT 8.5% $ 2,481 $ 2,742 $ 2,574
Equipment Financing January 16, 2020 February 1, 2023 Fixed interest rate 8.7%; EOT 8.5% 2,453 2,650 2,684
Equipment Financing January 16, 2020 May 1, 2023 Fixed interest rate 8.7%; EOT 8.5% 3,054 3,259 3,303
Equipment Financing December 22, 2020 January 1, 2024 Fixed interest rate 7.5%; EOT 8.5% 10,000 9,912 9,912
Total Bowery Farming, Inc. 17,988 18,563 18,473
Robotany, Inc. Equipment Financing January 16, 2020 January 1, 2024 Fixed interest rate 7.6%; EOT 22.0% $ 1,667 $ 1,720 $ 1,709
Sub-total: Agriculture, Forestry, Fishing and Hunting (8.5%)* $ 19,655 $ 20,283 $ 20,182
Construction (2)
Dandelion Energy, Inc. Equipment Financing March 17, 2020 April 1, 2024 Fixed interest rate 9.0%; EOT 12.5% $ 460 $ 467 $ 471
Equipment Financing October 27, 2020 November 1, 2024 Fixed interest rate 9.2%; EOT 12.5% 545 551 551
Equipment Financing (12) November 19, 2020 December 1, 2024 Fixed interest rate 9.1%; EOT 12.5% 558 563 563
Equipment Financing December 29, 2020 January 1, 2025 Fixed interest rate 9.2%; EOT 12.5% 791 791 791
Total Dandelion Energy, Inc. 2,354 2,372 2,376
Project Frog, Inc. (19) Secured Loan April 30, 2020 May 1, 2023 Fixed interest rate 12.0% $ 4,128 $ 4,045 $ 4,029
Sub-total: Construction (2.7%)* $ 6,482 $ 6,417 $ 6,405
Educational Services (2)
Examity, Inc. Secured Loan January 16, 2020 February 1, 2022 Fixed interest rate 11.5%; EOT 8.0% $ 3,280 $ 4,028 $ 3,994
Secured Loan January 16, 2020 February 1, 2022 Fixed interest rate 11.5%; EOT 4.0% 3,516 1,775 1,775
Secured Loan January 16, 2020 January 1, 2023 Fixed interest rate 12.25%; EOT 4.0% 1,658 1,005 1,004
Total Examity, Inc. 8,454 6,808 6,773
Qubed, Inc. dba Yellowbrick Secured Loan January 16, 2020 October 1, 2023 Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 5.0% (9) $ 1,906 $ 1,950 $ 1,957
Secured Loan January 16, 2020 October 1, 2023 Fixed interest rate 11.5%; EOT 4.0% 476 481 493
Total Qubed, Inc. dba Yellowbrick 2,382 2,431 2,450
Sub-total: Educational Services (3.9%)* $ 10,836 $ 9,239 $ 9,223

24

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities, Continued
Finance and Insurance (2)
DailyPay, Inc. Secured Loan September 30, 2020 November 1, 2024 Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% (9) $ 20,000 $ 19,800 $ 20,062
Secured Loan December 30, 2020 January 1, 2025 Variable interest rate PRIME + 7.0% or Floor rate 12.0%; EOT 6.0% (9) 5,000 4,939 4,939
Total DailyPay, Inc. 25,000 24,739 25,001
Petal Card, Inc. Secured Loan January 16, 2020 December 1, 2023 Fixed interest rate 11.0%; EOT 3.0% $ 10,000 $ 9,998 $ 10,116
Sub-total: Finance and Insurance (14.7%)* $ 35,000 $ 34,737 $ 35,117
Health Care and Social Assistance (2)
Lark Technologies, Inc. Secured Loan September 30, 2020 April 1, 2025 Variable interest rate PRIME + 8.3% or Floor rate 11.5%; EOT 4.0% (9) $ 5,000 $ 4,809 $ 4,874
WorkWell Prevention & Care Inc. Secured Loan January 16, 2020 March 1, 2024 Fixed interest rate 8.0%; EOT 10.0% $ 3,370 $ 3,608 $ 3,493
Secured Loan January 16, 2020 March 1, 2024 Fixed interest rate 8.0%; EOT 10.0% 700 734 693
Total WorkWell Prevention & Care Inc. (19) 4,070 4,342 4,186
Sub-total: Health Care and Social Assistance (3.8%)* $ 9,070 $ 9,151 $ 9,060
Information (2)
Firefly Systems, Inc. Equipment Financing January 29, 2020 February 1, 2023 Fixed interest rate 9.0%; EOT 10.0% $ 3,946 $ 4,080 $ 4,052
Equipment Financing August 28, 2020 September 1, 2023 Fixed interest rate 9.0%; EOT 10.0% 3,208 3,308 3,307
Equipment Financing September 18, 2020 October 1, 2023 Fixed interest rate 9.0%; EOT 10.0% 386 396 396
Total Firefly Systems, Inc. 7,540 7,784 7,755
Gobiquity, Inc. Equipment Financing January 16, 2020 April 1, 2022 Fixed interest rate 7.5%; EOT 20.0% $ 296 $ 394 $ 395
Hytrust, Inc. Secured Loan January 16, 2020 February 1, 2021 Fixed interest rate 11.1%; EOT 10.5% $ 194 $ 717 $ 621
Oto Analytics, Inc. Secured Loan January 16, 2020 March 1, 2023 Fixed interest rate 11.5%; EOT 6.0% $ 7,294 $ 7,755 $ 7,735
RapidMiner, Inc. Secured Loan January 16, 2020 April 1, 2024 Fixed interest rate 12.0%; EOT 7.5% $ 10,000 $ 10,099 $ 10,113
Smule, Inc. Secured Loan July 1, 2020 January 1, 2022 Fixed interest rate 0.0% (15) $ 145 $ 145 $ 145
STS Media, Inc. (11) Secured Loan January 16, 2020 May 1, 2022 Fixed interest rate 11.9%; EOT 4.0% $ 7,811 $ 737 $ 100
Unitas Global, Inc. Equipment Financing January 16, 2020 July 1, 2021 Fixed interest rate 9.0%; EOT 12.0% $ 580 $ 938 $ 921
Equipment Financing January 16, 2020 April 1, 2021 Fixed interest rate 7.8%; EOT 6.0% 53 76 74
Total Unitas Global, Inc. 633 1,014 995
Sub-total: Information (11.7%)* $ 33,913 $ 28,645 $ 27,859

25

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities, Continued
Manufacturing (2)
AyDeeKay LLC Secured Loan January 16, 2020 August 1, 2024 Variable interest rate PRIME + 7.5% or Floor rate 10.8%; EOT 3.0% (9) $ 12,000 $ 11,893 $ 11,779
BHCosmetics, LLC Equipment Financing January 16, 2020 March 1, 2021 Fixed interest rate 8.9%; EOT 5.0% $ 106 $ 165 $ 165
Equipment Financing January 16, 2020 April 1, 2021 Fixed interest rate 8.7%; EOT 5.0% 159 217 218
Total BHCosmetics, LLC 265 382 383
Footprint International Holding, Inc. Equipment Financing February 14, 2020 March 1, 2024 Fixed interest rate 10.3%; EOT 8.0% $ 14,771 $ 15,244 $ 15,352
Secured Loan June 22, 2020 July 1, 2024 Fixed interest rate 12.0%; EOT 9.0% 7,000 7,095 7,177
Total Footprint International Holding, Inc. 21,771 22,339 22,529
Happiest Baby, Inc. Equipment Financing January 16, 2020 September 1, 2022 Fixed interest rate 8.4%; EOT 9.5% $ 924 $ 1,031 $ 998
Equipment Financing January 16, 2020 November 1, 2022 Fixed interest rate 8.6%; EOT 9.5% 748 822 830
Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 8.6%; EOT 9.5% 719 775 786
Equipment Financing February 7, 2020 June 1, 2023 Fixed interest rate 8.2%; EOT 9.5% 901 953 955
Equipment Financing September 16, 2020 January 1, 2024 Fixed interest rate 7.8%; EOT 9.5% 1,248 1,270 1,278
Total Happiest Baby, Inc. 4,540 4,851 4,847
Health-Ade, LLC Equipment Financing January 16, 2020 February 1, 2022 Fixed interest rate 9.4%; EOT 15.0% $ 1,361 $ 1,887 $ 1,877
Equipment Financing January 16, 2020 April 1, 2022 Fixed interest rate 8.6%; EOT 15.0% 784 1,031 1,030
Equipment Financing January 16, 2020 July 1, 2022 Fixed interest rate 9.1%; EOT 15.0% 1,956 2,436 2,441
Total Health-Ade, LLC 4,101 5,354 5,348
Mainspring Energy, Inc. Secured Loan January 16, 2020 August 1, 2023 Fixed interest rate 11.0%; EOT 3.8% $ 8,592 $ 8,759 $ 8,801
Secured Loan November 20, 2020 December 1, 2024 Fixed interest rate 11.0%; EOT 3.8% 5,500 5,267 5,267
Total Mainspring Energy, Inc. 14,092 14,026 14,068
Miyoko's Kitchen Equipment Financing February 19, 2020 September 1, 2022 Fixed interest rate 8.8%; EOT 9.0% $ 580 $ 617 $ 618
Equipment Financing August 27, 2020 March 1, 2023 Fixed interest rate 8.9%; EOT 9.0% 867 889 896
Total Miyoko's Kitchen 1,447 1,506 1,514
Molekule, Inc. Equipment Financing June 19, 2020 January 1, 2024 Fixed interest rate 8.8%; EOT 10.0% $ 2,526 $ 2,571 $ 2,588
Equipment Financing September 29, 2020 April 1, 2024 Fixed interest rate 9.0%; EOT 10.0% 542 550 554
Equipment Financing December 18, 2020 July 1, 2024 Fixed interest rate 8.8%; EOT 10.0% 879 879 881
Total Molekule, Inc. 3,947 4,000 4,023
Second Nature Brands, Inc. Equipment Financing September 29, 2020 April 1, 2024 Fixed interest rate 9.7%; EOT 11.50% $ 2,196 $ 2,157 $ 2,144
Store Intelligence, Inc. (19) Secured Loan May 2, 2020 June 1, 2024 Fixed interest rate 12.0%; EOT 7.8% $ 12,001 $ 12,232 $ 11,884
The Fynder Group, Inc. Equipment Financing October 14, 2020 May 1, 2024 Fixed interest rate 9.1%; EOT 10.0% $ 612 $ 604 $ 604
Vertical Communications, Inc. Secured Loan May 1, 2020 November 1, 2024 Fixed interest rate 9.5%; EOT 26.4% $ 12,000 $ 12,937 $ 12,787
Secured Loan June 18, 2020 July 1, 2022 Fixed interest rate 9.5% 807 807 816
Total Vertical Communications, Inc. (19) 12,807 13,744 13,603
Sub-total: Manufacturing (38.9%)* $ 89,779 $ 93,088 $ 92,726

26

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities, Continued
Pharmaceutical (2)
Zosano Pharma Corporation Equipment Financing January 16, 2020 April 1, 2022 Fixed interest rate 9.4%; EOT 12.0% $ 2,256 $ 2,756 $ 2,530
Equipment Financing January 16, 2020 July 1, 2022 Fixed interest rate 9.7%; EOT 12.0% 1,501 1,757 1,642
Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 9.9%; EOT 12.0% 1,608 1,769 1,710
Equipment Financing January 16, 2020 April 1, 2023 Fixed interest rate 9.9%; EOT 12.0% 1,787 1,919 1,884
Equipment Financing January 16, 2020 May 1, 2023 Fixed interest rate 10.5%; EOT 12.0% 1,316 1,420 1,384
Total Zosano Pharma Corporation 8,468 9,621 9,150
Sub-total: Pharmaceutical (3.8%)* $ 8,468 $ 9,621 $ 9,150
Professional, Scientific, and Technical Services (2)
Augmedix, Inc. Secured Loan January 16, 2020 April 1, 2023 Fixed interest rate 12.0%; EOT 6.5% $ 9,422 $ 9,602 $ 9,629
BackBlaze, Inc. Equipment Financing January 16, 2020 January 1, 2023 Fixed interest rate 7.2%; EOT 11.5% $ 907 $ 1,042 $ 1,046
Equipment Financing January 16, 2020 April 1, 2023 Fixed interest rate 7.4%; EOT 11.5% 117 131 132
Equipment Financing January 16, 2020 June 1, 2023 Fixed interest rate 7.4%; EOT 11.5% 905 1,001 1,006
Equipment Financing January 16, 2020 August 1, 2023 Fixed interest rate 7.5%; EOT 11.5% 180 196 197
Equipment Financing January 16, 2020 September 1, 2023 Fixed interest rate 7.7%; EOT 11.5% 185 201 201
Equipment Financing January 16, 2020 October 1, 2023 Fixed interest rate 7.5%; EOT 11.5% 186 200 201
Equipment Financing January 16, 2020 November 1, 2023 Fixed interest rate 7.2%; EOT 11.5% 621 670 670
Equipment Financing January 16, 2020 December 1, 2023 Fixed interest rate 7.5%; EOT 11.5% 822 881 881
Equipment Financing January 16, 2020 January 1, 2024 Fixed interest rate 7.4%; EOT 11.5% 717 764 763
Equipment Financing January 20, 2020 February 1, 2024 Fixed interest rate 7.4%; EOT 11.5% 732 775 775
Equipment Financing February 1, 2020 March 1, 2024 Fixed interest rate 7.2%; EOT 11.5% 636 673 672
Equipment Financing March 26, 2020 April 1, 2024 Fixed interest rate 7.4%; EOT 11.5% 192 201 206
Equipment Financing April 17, 2020 May 1, 2024 Fixed interest rate 7.3%; EOT 11.5% 1,246 1,303 1,311
Equipment Financing July 27, 2020 August 1, 2024 Fixed interest rate 7.5%; EOT 11.5% 1,336 1,374 1,378
Equipment Financing September 4, 2020 October 1, 2024 Fixed interest rate 7.2%; EOT 11.5% 239 243 237
Total BackBlaze, Inc. 9,021 9,655 9,676
Cuebiq, Inc. Secured Loan March 4, 2020 April 1, 2024 Variable interest rate PRIME + 7.3% or Floor rate 12.0%; EOT 4.5% (9) $ 5,000 $ 5,030 $ 4,963
Edeniq, Inc. Secured Loan January 16, 2020 September 1, 2021 Fixed interest rate 13.0%; EOT 9.5% $ 3,039 $ 1,102 $ 859
Secured Loan January 16, 2020 September 1, 2021 Fixed interest rate 13.0%; EOT 9.5% 2,282 762 648
Total Edeniq, Inc. (11) (19) 5,321 1,864 1,507

27

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities, Continued
Professional, Scientific, and Technical Services, Continued
Incontext Solutions, Inc. Secured Loan January 16, 2020 October 1, 2023 Fixed interest rate 11.75%; EOT 11.4% $ 7,149 $ 7,401 $ 6,998
Matterport, Inc. Secured Loan January 16, 2020 May 1, 2022 Fixed interest rate 11.5%; EOT 5.0% $ 4,870 $ 5,560 $ 5,599
Pendulum Therapeutics, Inc. Equipment Financing January 16, 2020 May 1, 2023 Fixed interest rate 7.7%; EOT 5.0% $ 347 $ 338 $ 338
Equipment Financing January 17, 2020 August 1, 2023 Fixed interest rate 7.8%; EOT 5.0% 2,084 2,147 2,164
Equipment Financing March 6, 2020 October 1, 2023 Fixed interest rate 7.7%; EOT 5.0% 616 620 626
Equipment Financing July 15, 2020 February 1, 2024 Fixed interest rate 9.8%; EOT 6.0% 894 895 881
Total Pendulum Therapeutics, Inc. 3,941 4,000 4,009
Reciprocity, Inc. Secured Loan September 25, 2020 October 1, 2024 Variable interest rate PRIME + 8.0% or Floor rate 11.3%; EOT 2.0% (9) $ 10,000 $ 9,862 $ 9,805
Sun Basket, Inc. Secured Loan December 31, 2020 December 1, 2024 Variable interest rate PRIME + 8.5% or Floor rate 11.8%; EOT 5.0% (9) 18,375 17,831 17,831
Utility Associates, Inc. (11) Secured Loan January 16, 2020 October 1, 2023 Fixed interest rate 11.0% $ 750 $ 830 $ 604
Sub-total: Professional, Scientific, and Technical Services (29.6%)* $ 73,849 $ 71,635 $ 70,621

28

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities, Continued
Real Estate (2)
Knockaway, Inc. Secured Loan January 16, 2020 December 1, 2023 Fixed interest rate 11.0%; EOT 3.0% $ 10,000 $ 10,103 $ 10,112
Secured Loan January 16, 2020 February 1 , 2024 Fixed interest rate 11.0%; EOT 3.0% 2,500 2,519 2,549
Secured Loan January 16, 2020 March 1, 2024 Fixed interest rate 11.0%; EOT 3.0% 2,500 2,516 2,548
Total Knockaway, Inc. 15,000 15,138 15,209
Wanderjaunt, Inc. Equipment Financing January 16, 2020 June 1, 2023 Fixed interest rate 10.2%; EOT 12.0% $ 387 $ 388 $ 380
Equipment Financing January 16, 2020 August 1, 2023 Fixed interest rate 10.2%; EOT 12.0% 1,230 1,313 1,296
Total Wanderjaunt, Inc. 1,617 1,701 1,676
Sub-total: Real Estate (9.6%)* $ 16,617 $ 16,839 $ 16,885
Rental and Leasing Services (2)
EquipmentShare, Inc. Equipment Financing June 24, 2020 July 1, 2023 Fixed interest rate 10.7%; EOT 5.0% $ 7,538 $ 7,685 $ 7,730
Equipment Financing July 2, 2020 August 1, 2023 Fixed interest rate 10.1%; EOT 5.0% 864 879 884
Equipment Financing August 7, 2020 September 1, 2023 Fixed interest rate 10.2%; EOT 5.0% 1,908 1,935 1,944
Equipment Financing September 18, 2020 October 1, 2023 Fixed interest rate 10.4%; EOT 5.0% 3,422 3,458 3,470
Equipment Financing September 29, 2020 October 1, 2024 Fixed interest rate 8.3%; EOT 10.0% 429 435 435
Equipment Financing October 2, 2020 November 1, 2023 Fixed interest rate 10.4%; EOT 5.0% 811 818 818
Equipment Financing October 9, 2020 November 1, 2023 Fixed interest rate 10.5%; EOT 5.0% 2,560 2,581 2,581
Equipment Financing November 4, 2020 December 1, 2023 Fixed interest rate 10.1%; EOT 5.0% 2,491 2,506 2,506
Equipment Financing December 4, 2020 January 1, 2024 Fixed interest rate 10.1%; EOT 5.0% 1,995 2,002 2,002
Equipment Financing December 21, 2020 January 1, 2024 Fixed interest rate 10.5%; EOT 5.0% 797 799 799
Total EquipmentShare, Inc. 22,815 23,098 23,169
Maxwell Financial Labs, Inc. Secured Loan October 7, 2020 November 1, 2024 Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% (9) $ 3,000 $ 2,964 $ 2,964
Secured Loan December 22, 2020 January 1, 2025 Variable interest rate PRIME + 8.0% or Floor rate 11.25%; EOT 4.0% (9) 3,000 2,938 2,938
Total Maxwell Financial Labs, Inc. 6,000 5,902 5,902
Sub-total: Rental and Leasing Services (12.2%)* $ 28,815 $ 29,000 $ 29,071
Retail Trade (2)
Birchbox, Inc. (19) Secured Loan January 16, 2020 July 1, 2024 Fixed interest rate 9.0%; EOT 7.5% $ 10,000 $ 10,433 $ 9,924
Boosted eCommerce, Inc. (14) Secured Loan December 18, 2020 January 1, 2023 Variable interest rate PRIME + 7.75% or Floor rate 11.0%; EOT 3.25% (9) $ 5,000 $ 4,933 $ 4,933
Gobble, Inc. Secured Loan January 16, 2020 July 1, 2023 Fixed interest rate 11.3%; EOT 6.0% $ 3,443 $ 3,544 $ 3,556
Secured Loan January 16, 2020 July 1, 2023 Fixed interest rate 11.5%; EOT 6.0% 1,730 1,781 1,795
Total Gobble Inc. 5,173 5,325 5,351
Madison Reed, Inc. Secured Loan April 23, 2020 May 1, 2024 Variable interest rate PRIME + 6.0% or Floor rate 10.3%; EOT 4.0% (9) $ 17,500 $ 17,471 $ 17,835
Portofino Labs, Inc. (14) Secured Loan December 31, 2020 July 1, 2025 Variable interest rate PRIME + 8.25% or Floor rate 11.5%; EOT 4.0% (9) $ 2,000 $ 1,984 $ 1,984
Super73, Inc. (14) Secured Loan December 31, 2020 January 1, 2025 Variable interest rate PRIME + 7.3% or Floor rate 11.8%; EOT 4.0% (9) $ 5,500 $ 5,416 $ 5,416
UnTuckIt, Inc. Secured Loan January 16, 2020 June 1, 2024 Fixed interest rate 12.0%; EOT 5.0% $ 20,000 $ 21,098 $ 19,230
Sub-total: Retail Trade (27.1%)* $ 65,173 $ 66,660 $ 64,673

29

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Maturity Date Interest Rate (4) Principal Amount (5) Cost Fair Value (6)
Debt Securities, Continued
Utilities (2)
Invenia, Inc. Secured Loan January 16, 2020 January 1, 2023 Fixed interest rate 11.5%; EOT 5.0% $ 6,570 $ 7,042 $ 6,991
Secured Loan January 16, 2020 May 1, 2023 Fixed interest rate 11.5%; EOT 5.0% 3,326 3,537 3,550
Secured Loan January 16, 2020 January 1, 2024 Fixed interest rate 11.5%; EOT 5.0% 3,000 3,058 3,165
Secured Loan January 17, 2020 February 1, 2024 Fixed interest rate 11.5%; EOT 5.0% 4,000 4,103 4,200
Secured Loan June 8, 2020 July 1, 2024 Fixed interest rate 11.5%: EOT 5.0% 4,000 4,043 4,160
Secured Loan October 29, 2020 November 1, 2024 Fixed interest rate 11.5%: EOT 5.0% 5,000 5,017 5,017
Total Invenia, Inc. (8) 25,896 26,800 27,083
Sub-total: Utilities (11.4%)* $ 25,896 $ 26,800 $ 27,083
Wholesale Trade (2)
BaubleBar, Inc. Secured Loan January 16, 2020 March 1, 2023 Fixed interest rate 11.5%; EOT 7.3% $ 5,752 $ 6,576 $ 6,148
Grandpad, Inc. Equipment Financing November 16, 2020 June 1, 2023 Fixed interest rate 10.6%; EOT 5.0% $ 2,899 $ 2,907 $ 2,907
Equipment Financing December 23, 2020 July 1, 2023 Fixed interest rate 10.8%; EOT 5.0% 3,672 3,667 3,667
Total Grandpad, Inc. (14) 6,571 6,574 6,574
GrubMarket, Inc. Secured Loan June 15, 2020 July 1, 2024 Fixed interest rate 10.5%; EOT 3.0% $ 10,000 $ 9,875 $ 10,114
Sub-total: Wholesale Trade (9.6%)* $ 22,323 $ 23,025 $ 22,836
Total: Debt Securities (186.0%)* (13) $ 448,010 $ 447,510 $ 443,219

30

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Expiration Date Series Shares Strike Price Cost Fair Value (6)
Warrant Investments
Agriculture, Forestry, Fishing and Hunting (2)
Bowery Farming, Inc. Warrant January 16, 2020 June 10, 2029 Common Stock 68,863 $ 5.08 $ 410 $ 403
Warrant December 22, 2020 December 22, 2030 Common Stock 29,925 $ 6.24 $ 160 $ 160
Total Bowery Farming, Inc. 570 563
Robotany, Inc. Warrant January 16, 2020 July 19, 2029 Common Stock 262,870 $ 0.26 $ 128 $ 92
Sub-Total: Agriculture, Forestry, Fishing and Hunting (0.3%)* $ 698 $ 655
Construction (2)
Project Frog, Inc. (19) Warrant January 16, 2020 July 26, 2026 Preferred Series AA 391,990 $ 0.19 $ 18 $ 2
Sub-Total: Construction (0.0%)* $ 18 $ 2
Educational Services (2)
Qubed, Inc. dba Yellowbrick Warrant January 16, 2020 September 28, 2028 Common Stock 222,222 $ 0.90 $ 120 $ 593
Sub-Total: Educational Services (0.2%)* $ 120 $ 593
Finance and Insurance (2)
DailyPay, Inc. Warrant September 30, 2020 September 30, 2030 Common Stock 89,264 $ 3.00 $ 151 $ 206
Petal Card, Inc. Warrant January 16, 2020 November 27, 2029 Preferred Series B 250,268 $ 1.32 $ 147 $ 350
Realty Mogul, Co Warrant January 16, 2020 December 18, 2027 Preferred Series B 234,421 $ 3.88 $ 285 $ 25
Sub-Total: Finance and Insurance (0.2%)* $ 583 $ 581
Health Care and Social Assistance (2)
Lark Technologies, Inc. Warrant September 30, 2020 September 30, 2030 Common Stock 76,231 $ 1.76 $ 177 $ 163
Sub-Total: Health Care and Social Assistance (0.1%)* $ 177 $ 163
Information (2)
Convercent, Inc. Warrant January 16, 2020 November 30, 2025 Preferred Series 1 3,139,579 $ 0.16 $ 924 $ 610
Figg, Inc. (7) Warrant January 16, 2020 March 31, 2028 Common Stock 935,198 $ 0.07 $ $
Everalbum, Inc. Warrant January 16, 2020 July 29, 2026 Preferred Series A 851,063 $ 0.10 $ 24 $ 6
Firefly Systems, Inc. Warrant January 31, 2020 January 29, 2030 Common Stock 133,147 $ 1.14 $ 282 $ 132
Gtxcel, Inc. Warrant January 16, 2020 September 24, 2025 Preferred Series C 1,000,000 $ 0.21 $ 83 $ 4
Warrant January 16, 2020 September 24, 2025 Preferred Series D 1,000,000 $ 0.21 83 12
Total Gtxcel, Inc. 166 16
Hytrust, Inc. Warrant January 16, 2020 June 23, 2026 Preferred Series D2 424,808 $ 0.82 $ 172 $
Lucidworks, Inc. Warrant January 16, 2020 June 27, 2026 Preferred Series D 619,435 $ 0.77 $ 806 $ 1,509
Oto Analytics, Inc. Warrant January 16, 2020 August 31, 2028 Preferred Series B 1,018,718 $ 0.79 $ 295 $ 221
RapidMiner, Inc. Warrant January 16, 2020 March 25, 2029 Preferred Series C-1 11,624 $ 60.22 $ 528 $ 357
STS Media, Inc. (7) Warrant January 16, 2020 March 15, 2028 Preferred Series C 20,210 $ 24.74 $ $
Sub-Total: Information (1.2%)* $ 3,197 $ 2,851

31

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Expiration Date Series Shares Strike Price Cost Fair Value (6)
Warrant Investments, Continued
Manufacturing (2)
Atieva, Inc. (13) Warrant January 16, 2020 March 31, 2027 Preferred Series D 390,016 $ 5.13 $ 3,067 $ 1,053
Warrant January 16, 2020 September 8, 2027 Preferred Series D 195,008 $ 5.13 1,533 526
Total Atieva, Inc. 4,600 1,579
AyDeeKay LLC Warrant January 16, 2020 March 30, 2028 Preferred Series G 6,250 $ 35.42 $ 31 $ 32
Footprint International Holding, Inc. Warrant February 14, 2020 February 14, 2030 Common Stock 26,852 $ 0.31 $ 5 $ 81
Warrant June 22, 2020 June 22, 2030 Common Stock 10,836 $ 0.31 4 33
Total Footprint International Holding, Inc. 9 114
Happiest Baby, Inc. Warrant January 16, 2020 May 16, 2029 Common Stock 182,554 $ 0.33 $ 193 $ 126
Hexatech, Inc. (7) Warrant January 16, 2020 April 2, 2022 Preferred Series A 226 $ 2.77 $ $
Lensvector, Inc. Warrant January 16, 2020 December 30, 2021 Preferred Series C 85,065 $ 1.18 $ 32 $
Mainspring Energy, Inc. Warrant January 16, 2020 July 9, 2029 Common Stock 140,186 $ 1.15 $ 283 $ 394
Warrant November 20, 2020 November 20, 2030 Common Stock 81,294 $ 1.15 226 229
Total Mainspring Energy, Inc. 509 623
Molekule, Inc. Warrant June 19, 2020 June 19, 2030 Preferred Series C-1 32,051 3.12 $ 16 $ 23
SBG Labs, Inc. Warrant January 16, 2020 June 29, 2023 Preferred Series A-1 42,857 $ 0.70 $ 13 $ 10
Warrant January 16, 2020 September 18, 2024 Preferred Series A-1 25,714 $ 0.70 8 6
Warrant January 16, 2020 January 14, 2024 Preferred Series A-1 21,492 $ 0.70 7 5
Warrant January 16, 2020 March 24, 2025 Preferred Series A-1 12,155 $ 0.70 4 3
Warrant January 16, 2020 October 10, 2023 Preferred Series A-1 11,150 $ 0.70 4 3
Warrant January 16, 2020 May 6, 2024 Preferred Series A-1 11,145 $ 0.70 4 3
Warrant January 16, 2020 June 9, 2024 Preferred Series A-1 7,085 $ 0.70 2 2
Warrant January 16, 2020 May 20, 2024 Preferred Series A-1 342,857 $ 0.70 110 80
Warrant January 16, 2020 March 26, 2025 Preferred Series A-1 200,000 $ 0.70 65 48
Total SBG Labs, Inc. 217 160
The Fynder Group, Inc. Warrant October 14, 2020 October 14, 2030 Common Stock 107,190 $ 0.49 $ 201 $ 282
Vertical Communications, Inc. (7) (19) Warrant January 16, 2020 July 11, 2026 Preferred Series A 828,479 $ 1.00 $ $
Sub-Total: Manufacturing (1.2%)* $ 5,808 $ 2,939

32

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Expiration Date Series Shares Strike Price Cost Fair Value (6)
Warrant Investments, Continued
Pharmaceutical (2)
Ology Bioservices, Inc. (19) Warrant January 16, 2020 November 14, 2021 Common Stock 67,961 $ 1.03 $ 1,122 $ 2,216
Zosano Pharma Corporation Warrant January 16, 2020 September 25, 2025 Common Stock 75,000 $ 3.59 $ 69 $ 18
Sub-Total: Pharmaceutical (0.9%)* $ 1,191 $ 2,234
Professional, Scientific, and Technical Services (2)
Augmedix, Inc. Warrant January 16, 2020 September 3, 2029 Preferred Series B 580,383 $ 2.88 $ 449 $ 379
Continuity, Inc. Warrant January 16, 2020 March 29, 2026 Preferred Series C 1,588,806 $ 0.25 $ 21 $ 45
Crowdtap, Inc. Warrant January 16, 2020 December 16, 2025 Preferred Series B 442,233 $ 1.09 $ 42 $ 140
Warrant January 16, 2020 November 30, 2027 Preferred Series B 100,000 $ 1.09 9 32
Total Crowdtap, Inc. 51 172
Dynamics, Inc. Warrant January 16, 2020 March 10, 2024 Common Stock 17,000 $ 10.59 $ 86 $
E La Carte, Inc. Warrant January 16, 2020 July 28, 2027 Common Stock 497,183 $ 0.30 $ 186 $ 123
Warrant January 16, 2020 July 28, 2027 Preferred Series A 104,284 $ 7.49 15 34
Warrant January 16, 2020 July 28, 2027 Preferred Series AA-1 106,841 $ 7.49 15 1
Total E La Carte, Inc. 216 158
Edeniq, Inc. Warrant January 16, 2020 December 23, 2026 Preferred Series B 2,685,501 $ 0.22 $ $
Warrant January 16, 2020 December 23, 2026 Preferred Series B 2,184,672 $ 0.01
Warrant January 16, 2020 March 12, 2028 Preferred Series C 5,106,972 $ 0.44
Warrant January 16, 2020 October 15, 2028 Preferred Series C 3,850,294 $ 0.01
Total Edeniq, Inc. (7)(19)
Fingerprint Digital, Inc. Warrant January 16, 2020 April 29, 2026 Preferred Series B 48,102 $ 10.39 $ 165 $ 84
Hologram, Inc. Warrant January 31, 2020 January 27, 2030 Common Stock 193,054 $ 0.26 $ 49 $ 33
Hospitalists Now, Inc. Warrant January 16, 2020 March 30, 2026 Preferred Series D2 135,807 $ 5.89 $ 71 $ 272
Warrant January 16, 2020 December 6, 2026 Preferred Series D2 750,000 $ 5.89 391 1,505
Total Hospitalists Now, Inc. 462 1,777
Incontext Solutions, Inc. Warrant January 16, 2020 September 28, 2028 Preferred Series AA-1 332,858 $ 1.47 $ 34 $ 47
Matterport, Inc. Warrant January 16, 2020 April 20, 2028 Common Stock 143,813 $ 1.43 $ 434 $ 603
Pendulum Therapeutics, Inc. Warrant January 16, 2020 October 9, 2029 Preferred Series B 55,263 $ 1.90 $ 44 $ 65
Warrant June 1, 2020 July 15, 2030 Preferred Series B 36,842 $ 1.90 36 43
Total Pendulum Therapeutics, Inc. 80 108
Reciprocity, Inc. Warrant September 25, 2020 September 25, 2030 Common Stock 114,678 $ 4.17 $ 99 $ 145
Resilinc, Inc. Warrant January 16, 2020 December 15, 2025 Preferred Series A 589,275 $ 0.51 $ 40 $ 100
Saylent Technologies, Inc. Warrant January 16, 2020 March 31, 2027 Preferred Series C 24,096 $ 9.96 $ 108 $ 94
Sun Basket, Inc. Warrant January 16, 2020 October 5, 2027 Preferred Series C-2 249,306 $ 6.02 $ 111 $ 343
Warrant December 31, 2020 December 31, 2030 Common Stock 118,678 $ 0.89 545 546
656 889
Utility Associates, Inc. Warrant January 16, 2020 June 30, 2025 Preferred Series A 92,511 $ 4.54 $ 55 $ 4
Warrant January 16, 2020 May 1, 2026 Preferred Series A 60,000 $ 4.54 36 3
Warrant January 16, 2020 May 22, 2027 Preferred Series A 200,000 $ 4.54 120 8
Total Utility Associates, Inc. 211 15
Sub-Total: Professional, Scientific, and Technical Services (2.0%)* $ 3,161 $ 4,649

33

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Expiration Date Series Shares Strike Price Cost Fair Value (6)
Warrant Investments, Continued
Real Estate (2)
Egomotion Corporation Warrant January 16, 2020 December 10, 2028 Preferred Series A (7) 60,786 $ 1.32 $ $ 53
Warrant January 16, 2020 June 29, 2028 Preferred Series A 121,571 $ 1.32 219 106
Total Egomotion Corporation 219 159
Knockaway, Inc. Warrant January 16, 2020 May 24, 2029 Preferred Series B 87,955 $ 8.53 $ 209 $ 272
Sub-Total: Real Estate (0.2%)* $ 428 $ 431
Rental and Leasing Services (2)
Maxwell Financial Labs, Inc. Warrant October 7, 2020 October 7, 2030 Common Stock 106,735 $ 0.29 $ 21 $ 33
Warrant December 22, 2020 December 22, 2030 Common Stock 110,860 $ 0.29 34 34
Total Maxwell Financial Labs, Inc. 55 67
Sub-Total: Rental and Leasing Services (0.0%)* $ 55 $ 67
Retail Trade (2)
Boosted eCommerce, Inc. (14) Warrant December 18, 2020 December 14, 2030 Preferred Series A-1 759,263 $ 0.84 $ 259 $ 259
Gobble, Inc. Warrant January 16, 2020 May 9, 2028 Common Stock 74,635 $ 1.20 $ 73 $ 63
Warrant January 16, 2020 December 27, 2029 Common Stock 10,000 $ 1.22 617 467
Total Gobble, Inc. 690 530
Madison Reed, Inc. Warrant January 16, 2020 March 23, 2027 Preferred Series C 194,553 $ 2.57 $ 185 $ 241
Warrant January 16, 2020 July 18, 2028 Common Stock 43,158 $ 0.99 71 78
Warrant January 16, 2020 May 19, 2029 Common Stock 36,585 $ 1.23 56 62
Total Madison Reed, Inc. 312 381
Portofino Labs, Inc. (14) Warrant December 31, 2020 December 31, 2030 Common Stock 39,659 $ 1.53 $ 15 $ 15
Super73, Inc. (14) Warrant December 31, 2020 December 31, 2030 Common Stock 177,305 $ 3.16 $ 105 $ 105
Trendly, Inc. Warrant January 16, 2020 August 10, 2026 Preferred Series A 245,506 $ 1.14 $ 222 $ 256
Sub-Total: Retail Trade (0.6%)* $ 1,603 $ 1,546
Wholesale Trade (2)
BaubleBar, Inc. Warrant January 16, 2020 March 29, 2027 Preferred Series C 531,806 $ 1.96 $ 638 $ 207
Warrant January 16, 2020 April 20, 2028 Preferred Series C 60,000 $ 1.96 72 23
Total BaubleBar, Inc. 710 230
GrubMarket, Inc. Warrant June 15, 2020 June 15, 2030 Common Stock 405,000 $ 1.10 $ 116 $ 837
Sub-Total: Wholesale Trade (0.4%)* $ 826 $ 1,067
Total: Warrant Investments (7.4%)* (13) $ 17,865 $ 17,778

34

Table of Contents

TRINITY CAPITAL INC.

Consolidated Schedule of Investments

December 31, 2020

(In thousands, except share and per share data)

Portfolio Company (1) Type of Investment (3) Investment Date (17) Shares / Principal Series Cost Fair Value (6)
Equity Investments
Construction (2)
Project Frog, Inc. Equity January 16, 2020 8,118,527 Preferred Series AA-1 (18) $ 702 $ 36
Equity January 16, 2020 6,300,134 Preferred Series BB (18) 2,667 449
Total Project Frog, Inc. (19) 3,369 485
Sub-Total: Construction (0.2%)* $ 3,369 $ 485
Health Care and Social Assistance (2)
WorkWell Prevention & Care Inc. Equity January 16, 2020 7,000,000 Common Stock $ 51 $
Equity January 16, 2020 3,450 Preferred Series P (18) 3,450 657
Equity January 16, 2020 $ 1,470 Convertible Notes (10) 1,519 1,542
Total WorkWell Prevention & Care Inc. (19) 5,020 2,199
Sub-Total: Health Care and Social Assistance (0.9%)* $ 5,020 $ 2,199
Manufacturing (2)
Store Intelligence, Inc. (19) Equity May 2, 2020 1,430,000 Preferred Series A (18) $ 608 $ 694
Vertical Communications, Inc. Equity January 16, 2020 3,892,485 Preferred Series 1 (7)(18) $ $
Equity January 16, 2020 $ 5,500,000 Convertible Notes (10) 3,966 3,350
Total Vertical Communications, Inc. (19) 3,966 3,350
Sub-Total: Manufacturing (1.7%)* $ 4,574 $ 4,044
Pharmaceutical (2)
Ology Bioservices, Inc. (19) Equity January 16, 2020 382,277 Common Stock (16) $ 6,691 $ 12,856
Sub-Total: Pharmaceutical (5.4%)* $ 6,691 $ 12,856
Professional, Scientific, and Technical Services (2)
Dynamics, Inc. Equity January 16, 2020 17,726 Preferred Series A (18) $ 390 $
Equity January 16, 2020 15,000 Common Stock (7)
Total Dynamics, Inc. 390
Edeniq, Inc. Equity January 16, 2020 7,807,499 Preferred Series B (7)(18) $ $
Equity January 16, 2020 2,441,082 Preferred Series C (7)(18)
Equity January 16, 2020 $ 1,303,373 Convertible Notes (7)(10)
Total Edeniq, Inc. (19)
Instart Logic, Inc. Equity January 16, 2020 $ 2,600,000 Convertible Notes (10) $ 2,646 $ 3,625
Sub-Total: Professional, Scientific, and Technical Services (1.5%)* $ 3,036 $ 3,625
Retail Trade (2)
Birchbox, Inc. (19) Equity April 20, 2020 3,140,927 Preferred Series D (18) $ 10,271 $ 9,445
Sub-Total: Retail Trade (4.0%)* $ 10,271 $ 9,445
Total: Equity Investments (13.7%)* (13) $ 32,961 $ 32,654
Total Investment in Securities (207.2%)* $ 498,336 $ 493,651
Cash, Cash Equivalents, and Restricted Cash
Goldman Sachs Financial Square Government Institutional Fund $ 60,284 $ 60,284
Other cash accounts 817 817
Cash, Cash Equivalents, and Restricted Cash (25.6%)* 61,101 61,101
Total Portfolio Investments and Cash and Cash Equivalents (232.9% of net assets) $ 559,437 $ 554,752

35

Table of Contents

TRINITY CAPITAL INC. Consolidated Schedule of Investments December 31, 2020 (In thousands, except share and per share data)

(1) All portfolio companies are located in North America. As of December 31, 2020, the Company had two foreign domiciled portfolio companies - one in Canada (11.3% of NAV) and one in Cayman Islands (0.7% of NAV). The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale and may be deemed to be “restricted securities” under the Securities Act.

(2) The Company uses the North American Industry Classification System (“NAICS”) code for classifying the industry grouping of its portfolio companies.

(3) All debt investments are income producing unless otherwise noted. All equity and warrant investments are non-income producing unless otherwise noted. Equipment financed under our equipment financing investments relates to operational equipment essential to revenue production for the portfolio company in the industry noted.

(4) Interest rate is the fixed or variable rate of the debt investments and does not include any original issue discount, end-of-term (“EOT”) payment, or any additional fees related to such investments, such as deferred interest, commitment fees, prepayment fees or exit fees. EOT payments are contractual payments due in cash at the maturity date of the loan, including upon prepayment, and are a fixed rate determined at the inception of the loan. At the end of the term of certain equipment financings, the borrower has the option to purchase the underlying assets at fair market value in certain cases subject to a cap, or return the equipment and pay a restocking fee. The fair values of the financed assets have been estimated as a percentage of original cost for purpose of the EOT payment value. The EOT payment is amortized and recognized as non-cash income over the loan or equipment financing prior to its payment and is included as a component of the cost basis of the Company’s current debt securities

(5) Principal is net of repayments, if any, as per the terms of the debt instrument’s contract.

(6) All investments were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s board of directors.

(7) Investment has zero cost basis as it was purchased at a fair market value of zero as part of the Formation Transaction.

(8) Indicates a “non-qualifying asset” under section 55(a) by the Investment Company Act of 1940, as amended. The Company’s percentage of non-qualifying assets represents 5.1% of the Company’s total assets as of December 31, 2020. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. Asset is not a U.S. entity. Invenia, Inc. is a Canadian corporation, and Atieva, Inc. is a Cayman Island corporation.

(9) The interest rate on variable interest rate investments represents a benchmark rate plus spread. The benchmark interest rate is subject to an interest rate floor. The benchmark rate Prime was 3.25% as of December 30, 2020.

(10) Convertible notes represent investments through which the Company will participate in future equity rounds at preferential rates. There are no principal or interest payments made against the note unless conversion does not take place.

(11) Debt is on non-accrual status as of December 30, 2020 and is therefore considered non-income producing.

36

Table of Contents

(12) Investment has an unfunded commitment as of December 31, 2020 (see “Note 6 – Commitments and Contingencies”). The fair value of the investment includes the impact of the fair value of any unfunded commitments.

(13) All of the Company’s debt, warrant and equity securities are pledged as collateral supporting the amounts outstanding under the credit facility with Credit Suisse AG (see “Note 5 – Borrowings”), except as noted.

(14) Investment is not pledged as collateral supporting amounts outstanding under the credit facility with Credit Suisse AG.

(15) Investment is considered non-income producing.

(16) Certain third parties have rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020.

(17) Investment date represents the date of initial investment date, either purchases or funding, not adjusted for modifications. For assets purchased from the Legacy Funds as part of the Formation Transactions, investment date is January 16, 2020, the date of the Formation Transactions.

(18) Preferred stock represent investments through which the Company will have preference in liquidation rights and do not contain any cumulative preferred dividends.

37

Table of Contents

(19) This investment is deemed to be a “Control Investment” or an “Affiliate Investment.” The Company classifies its investment portfolio in accordance with the requirements of the 1940 Act. Control Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation. Affiliate Investments are defined by the Investment Company Act of 1940, as amended, as investments in companies in which the Company owns between 5% and 25% (inclusive) of the voting securities and does not have rights to maintain greater than 50% of the board representation. As defined in the Investment Company Act, the Company is deemed to be an “Affiliated Person” of this portfolio company. Fair value as of December 31, 2020 along with transactions during the year ended December 31, 2020 in these control or affiliated investments are as follows:

Net change in
Unrealized
Fair Value at Gross Gross Realized (Depreciation)/ Fair Value at Interest
December 31, 2019 Additions (1) Reductions (2) Gain/(Loss) Appreciation December 31, 2020 Income
For the Year Ended December 31, 2020
Control Investments
Birchbox, Inc. $ $ 20,704 $ $ $ (1,335) $ 19,369 $ 1,289
Edeniq, Inc. 3,278 (1,414) (357) 1,507
Project Frog, Inc. 7,432 (2,916) 4,516 552
Vertical Communications, Inc. 17,904 (194) (757) 16,953 1,425
WorkWell Prevention and Care Inc. 9,362 (2,977) 6,385 395
Total Control Investments $ $ 58,680 $ (1,608) $ $ (8,342) $ 48,730 $ 3,661
Affiliate Investments
Ology Bioservices, Inc. $ $ 7,813 $ $ $ 7,259 $ 15,072 $
Store Intelligence, Inc. 12,840 (262) 12,578 1,191
Total Affiliate Investments $ $ 20,653 $ $ $ 6,997 $ 27,650 $ 1,191
Total Control and Affiliate Investments $ $ 79,333 $ (1,608) $ $ (1,345) $ 76,380 $ 4,852

(1) Gross additions may include increases in the cost basis of investments resulting from new portfolio investments, PIK interest, the accretion of discounts, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company into this category from a different category.

(2) Gross reductions may include decreases in the cost basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing securities for one or more new securities and the movement of an existing portfolio company out of this category into a different category.

38

Table of Contents

TRINITY CAPITAL INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1. Organization and Basis of Presentation

Trinity Capital Inc., (“Trinity Capital” and, together with its subsidiary, the “Company”) is a specialty lending company focused on providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity Capital was formed on August 12, 2019 as a Maryland corporation and commenced operations on January 16, 2020. Prior to January 16, 2020, Trinity Capital had no operations, except for matters relating to its formation and organization as a business development company (“BDC”).

Trinity Capital is an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Trinity Capital intends to elect to be treated, and intends to qualify annually thereafter, as a regulated investment company (a “RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), for U.S. federal income tax purposes. This election will be made in conjunction with the filing of the Company’s 2020 tax return.

On September 27, 2019, Trinity Capital was initially capitalized with the issuance of 10 shares of its common stock for $150 to its sole stockholder. On January 16, 2020, Trinity Capital completed a series of transactions, including a private equity offering, a private debt offering, and the acquisition of Trinity Capital Investment, LLC (“TCI”), Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P. (“Fund III”), Trinity Capital Fund IV, L.P. (“Fund IV”), and Trinity Sidecar Income Fund, L.P. (“Sidecar Fund”) (collectively the “Legacy Funds”) through mergers of the Legacy Funds with and into Trinity Capital as well as Trinity Capital’s acquisition of Trinity Capital Holdings, LLC (“Trinity Capital Holdings”) (collectively, the “Formation Transactions”).

Trinity Capital’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN” in connection with its initial public offering of shares of its common stock (“IPO”).

Basis of Presentation

The Company’s interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Articles 6, 10 and 12 of Regulation S-X. Accordingly, certain disclosures accompanying annual financial statements prepared in accordance with GAAP are omitted. In the opinion of management, the unaudited financial results included herein contain all adjustments, consisting solely of normal accruals, considered necessary for the fair statement of the results for the interim period included herein. The current period’s consolidated results of operations are not necessarily indicative of results that may be achieved for the year. The interim consolidated financial statements and notes thereto should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission (“SEC”). As an investment company, the Company follows accounting and reporting guidance determined by the Financial Accounting Standards Board (“FASB”), in Accounting Standards Codification, as amended (“ASC”) Topic 946 - Financial Services – Investment Companies (“ASC 946”).

Formation Transactions

The Formation Transactions were accounted for as a business combination in accordance with FASB ASC 805, Business Combinations (“ASC 805”) , and as a result the assets acquired, and liabilities assumed were recorded at fair values as of January 16, 2020. Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of the consideration transferred.

39

Table of Contents

On January 16, 2020, the Company completed a private offering of shares of its common stock (the “Private Common Stock Offering”) in reliance upon the available exemptions from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to which the Company issued and sold 7,000,000 shares of its common stock for aggregate gross proceeds of approximately $105.0 million. Keefe, Bruyette & Woods, Inc. (“KBW”) acted as the initial purchaser and placement agent in connection with the Private Common Stock Offering pursuant to a purchase/placement agreement, dated January 8, 2020, by and between the Company and KBW. KBW exercised in full its option to purchase or place additional shares and on January 29, 2020 the Company issued and sold an additional 1,333,333 shares of its common stock for gross proceeds of approximately $20.0 million. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock pursuant to the Private Common Stock Offering for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million.

On January 16, 2020, concurrent with the initial closing of the Private Common Stock Offering, the Company completed a private debt offering (the “144A Note Offering” and together with the Private Common Stock Offering, the “Private Offerings”) of $105.0 million in aggregate principal amount of the Company’s unsecured 7.00% Notes due 2025 (the “2025 Notes”). On January 29, 2020, an over-allotment option related to the 144A Note Offering was exercised in full and on the Company issued and sold an additional $20.0 million in aggregate principal amount of the Notes. As a result, the Company issued and sold $125.0 million in aggregate principal amount of the Notes. See “Note 5 - Borrowings” and “Note 7 – Stockholder’s Equity.”

On January 16, 2020, immediately following the consummation of the Private Offerings, the Company used a portion of the proceeds of the Private Offerings to acquire, through the Formation Transactions, the Legacy Funds and Trinity Capital Holdings. Each member/limited partner of the Legacy Funds was given the option to elect to receive cash and or shares of the Company’s common stock in exchange for its limited partner interests or membership interests, as applicable. The general partners, managers or managing members of the Legacy Funds received only shares in exchange for their interests held in such capacities. As a result of the Formation Transactions, the Legacy Funds were merged with and into the Company and Trinity Capital Holdings became a wholly owned subsidiary of the Company.

As consideration for the partnership and membership interests in the Legacy Funds, the Company issued 9,183,185 shares of its common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners/managers of the Legacy Funds (the “Legacy Investors”). The acquisition consideration of the Formation Transactions was based on valuations as of September 30, 2019, as adjusted for assets that were disposed of by the Legacy Funds, as well as earnings, capital contributions and distributions paid to the general partners, managers or managing members, and material events affecting the portfolio companies of the Legacy Funds subsequent to September 30, 2019 and through the closing date of the Formation Transactions.

A summary of the fair value of the assets acquired and liabilities assumed from the Legacy Funds as of the acquisition date is as follows (in thousands):

Investments acquired $ 417,023
Interest receivable and other assets acquired 1,191
Accounts payable and accrued liabilities assumed (680)
Customer deposits assumed (4,250)
Credit facility assumed (190,000)
Financing fees related to credit facility acquired 1,900
Cash acquired 19,183
Total net assets acquired $ 244,367

The total merger consideration of the Legacy Funds of approximately $246.4 million exceeded the fair value of the net assets acquired as of the acquisition date, and as a result, the Company included a loss of approximately $2.1 million in Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. During the quarter ended December 31, 2020, upon filing the final tax returns for the Legacy Funds, the Company reversed approximately $0.4 million of accrued liabilities assumed related to expected tax expense of the Legacy Funds.

40

Table of Contents

Additionally, as part of the Formation Transactions, the Company also used a portion of the proceeds of the Private Offerings to acquire 100% of the equity interests of Trinity Capital Holdings, the sole member of Trinity Management IV, LLC, the investment manager to Fund IV and the sub-adviser to Fund II and Fund III, the Company issued 533,332 shares of common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash. In connection with the acquisition of Trinity Capital Holdings, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. Prior to the completion of the Formation Transactions, Trinity Capital Holdings acquired approximately $0.2 million of certain net assets from Trinity SBIC Management, LLC, the investment manager to Fund II and Fund III.

In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. Under ASC 805, such amount represents the settlement price, based on the estimated fair value of the future profits and cash flows that would otherwise have been contractually due to Trinity Capital Holdings, had the underlying management agreements with each of the Legacy Funds not been canceled in order to enter into the Formation Transactions and operate the Company as an internally managed BDC.

Principles of Consolidation

Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 3 - Investments,” with any adjustments to fair value recognized as "Net unrealized appreciation (depreciation) from investments" on the Consolidated Statements of Operations.

The Company’s consolidated operations include the activities of its wholly owned subsidiary, Trinity Funding 1, LLC (“TF1”). On January 16, 2020, in connection with the Formation Transactions, the Company acquired TF1 through Fund II and became a party to, and assumed, a $300 million credit agreement (as amended, the “Credit Facility”) with Credit Suisse AG (“Credit Suisse”) through TF1. TF1 was formed on August 14, 2019 as a Delaware limited liability company with Fund II as its sole equity member. TF1 is a special purpose bankruptcy-remote entity and is a separate legal entity from the Company. Any assets conveyed to TF1 are not available to creditors of the Company or any other entity other than TF1’s lenders. TF1 is consolidated for financial reporting purposes and in accordance with GAAP, and the portfolio investments held by this subsidiary are included in the Company’s consolidated financial statements and recorded at fair value. All intercompany balances and transactions have been eliminated.

In accordance with Rule 10-01(b)(1) of Regulation S-X, as amended, Trinity Capital must determine which of its unconsolidated controlled portfolio companies, if any, are considered “significant subsidiaries.” In evaluating these unconsolidated controlled portfolio companies, there are two significance tests utilized per Rule 1-02(w) of Regulation S-X to determine if any of Trinity Capital’s Control Investments (as defined in “Note 2 - Summary of Significant Accounting Policies”) are considered significant subsidiaries: the investment test, and the income test. As of June 30, 2021 and December 31, 2020, Trinity Capital had no single investment that met either of these two tests.

41

Table of Contents

Note 2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ materially from those estimates.

Investment Transactions

Loan originations are recorded on the date of the legally binding commitment. Realized gains or losses are recorded using the specific identification method as the difference between the net proceeds received, excluding prepayment fees, if any, and the amortized cost basis of the investment without regard to unrealized gains or losses previously recognized, and include investments written off during the period, net of recoveries. The net change in unrealized gains or losses primarily reflects the change in investment fair values as of the last business day of the reporting period and also includes the reversal of previously recorded unrealized gains or losses with respect to investments realized during the period.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded.

The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith pursuant to a consistent valuation policy by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on the Company’s Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

42

Table of Contents

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth stage companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanges. Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Debt Securities

The debt securities identified on the Consolidated Schedule of Investments are secured loans and equipment financings made to growth stage companies. For portfolio investments in debt securities for which the Company has determined that third-party quotes or other independent pricing are not available, the Company generally estimates the fair value based on the assumptions that hypothetical market participants would use to value the investment in a current hypothetical sale using an income approach.

In its application of the income approach to determine the fair value of debt securities, the Company bases its assessment of fair value on projections of the discounted future free cash flows that the security will likely generate, including analyzing the discounted cash flows of interest and principal amounts for the security, as set forth in the associated loan and equipment financing agreements, as well as market yields and the financial position and credit risk of the portfolio company (the “Hypothetical Market Yield Method”). The discount rate applied to the future cash flows of the security is based on the calibrated yield implied by the terms of the Company’s investment adjusted for changes in market yields and performance of the subject company. The Company’s estimate of the expected repayment date of its loans and equipment financings securities is either the maturity date of the instrument or the anticipated pre-payment date, depending on the facts and circumstances. The Hypothetical Market Yield Method analysis also considers changes in leverage levels, credit quality, portfolio company performance, market yield movements, and other factors. If there is deterioration in credit quality or if a security is in workout status, the Company may consider other factors in determining the fair value of the security, including, but not limited to, the value attributable to the security from the enterprise value of the portfolio company or the proceeds that would most likely be received in a liquidation analysis.

Equity-Related Securities and Warrants

Often the Company is issued warrants by issuers as yield enhancements. These warrants are recorded as assets at estimated fair value on the grant date. Depending on the facts and circumstances, the Company usually utilizes a combination of one or several forms of the market approach as well as contingent claim analyses (a form of option analysis) to estimate the fair value of the securities as of the measurement date. As part of its application of the market approach, the Company estimates the enterprise value of a portfolio company utilizing customary pricing multiples, based on the development stage of the underlying issuers, or other appropriate valuation methods, such as considering recent transactions in the equity securities of the portfolio company or third-party valuations that are assessed to be indicative of fair value of the respective portfolio company, and, if appropriate based on the facts and circumstances performs an allocation of the enterprise value to the equity securities utilizing a contingent claim analysis and/or other waterfall calculation by which it allocates the enterprise value across the portfolio company’s securities in order of their preference relative to one another.

43

Table of Contents

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments. Refer to “Note 4 – Fair Value of Financial Instruments” for further discussion.

Cash, Cash Equivalents and Restricted Cash

Cash, cash equivalents and restricted cash consist of funds deposited with financial institutions and short-term (original maturity of three months or less) liquid investments in money market deposit accounts. Cash equivalents are classified as Level 1 assets and are valued using the Net Asset Value (“NAV”) per share of the money market fund. As of June 30, 2021 and December 31, 2020, cash, cash equivalents and restricted cash consisted of $34.5 million and $61.1 million, respectively, of which $34.1 million and $60.3 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large, established, high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, 2021 and December 31, 2020, restricted cash consisted of approximately $15.3 million and $15.7 million, respectively, related to the Credit Facility covenants (See “Note 5 – Borrowings”), and an additional amount of approximately $0.7 million as of December 31, 2020 was held in escrow related to the payout of a severance related liability assumed as part of the Formation Transactions with respect to a former member of certain general partners of certain Legacy Funds.

Other Assets

Other assets generally consist of fixed assets net of accumulated depreciation, right of use asset, security deposits and other assets.

Equity Offering Costs

Equity offering costs consist of fees and expenses incurred in connection with the sale of the Company’s common stock, including legal, accounting and printing fees. These costs are deferred at the time of incurrence and are subsequently charged as a reduction to capital when the offering takes place or as shares are issued. Deferred costs are periodically reviewed and expensed if the related registration is no longer active.

Debt Financing Costs

The Company records costs related to the issuance of debt obligations as deferred debt financing costs. These costs are deferred and amortized using the straight-line method over the stated maturity life of the obligations.

Security Deposits

Security deposits are collected upon funding equipment financings and are applied in lieu of regular payments at the end of the term.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. EOT fees to be paid at the termination of the debt agreements are accreted into interest income over the contractual life of the debt

44

Table of Contents

based on the effective yield method. As of June 30, 2021 and December 31, 2020, the EOT payment receivable of approximately $37.0 million and $37.9 million, respectively, is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.

The Company had a limited number of debt investments in its portfolio that contain a payment-in-kind (“PIK”) provision. Contractual PIK interest, which represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company will generally cease accruing PIK interest if there is insufficient value to support the accrual or management does not expect the portfolio company to be able to pay all principal and interest due. No PIK interest income was recorded during the three and six months ended June 30, 2021. The Company recorded approximately $0.4 million and $0.5 million in PIK interest income during the three and six months ended June 30, 2020, respectively.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Non-Accrual Policy

When a debt security becomes 90 days or more past due, or if management otherwise does not expect that principal, interest, and other obligations due will be collected in full, the Company will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, the Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $1.2 million, and a total fair market value of approximately $0.9 million, or 0.2%, of the fair value of the Company’s investment portfolio. As of December 31, 2020, loans to three portfolio companies were on non-accrual status with a total cost of approximately $3.4 million, and a total fair value of approximately $2.2 million, or 0.5%, of the total fair value of the Company’s investment portfolio.

Net Realized Gains / (Losses)

Realized gains / (losses) are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period net of recoveries and realized gains or losses from in-kind redemptions. Net proceeds excludes any prepayment penalties, exit fees, and OID and EOT acceleration. Prepayment penalties and exit fees received at the time of sale or redemption are included in fee income on the Consolidated Statements of Operations. OID and EOT acceleration is included in interest income on the Consolidated Statement of Operations.

45

Table of Contents

Net Unrealized Appreciation / (Depreciation)

Net change in unrealized appreciation / (depreciation) reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Other potentially dilutive common shares, and the related impact to earnings are considered when calculating earnings per share on a diluted basis. Potential common shares associated with the conversion option embedded in the Convertible Notes are anti-dilutive when the Company’s average NAV is below the conversion price.

Income Taxes

The Company intends to elect to be treated for U.S. federal tax purposes as a RIC under Subchapter M of the Code and operate in a manner so as to qualify annually thereafter for the tax treatment applicable to RICs. As a RIC, the Company generally will not pay corporate-level income tax on the portion of its taxable income distributed to stockholders, generally required to be at least 90% of its investment company taxable income (which is generally its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its tax-exempt income to maintain its RIC status (pass-through tax treatment for amounts distributed).

The Company evaluates tax positions taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority in accordance with ASC Topic 740, Income Taxes (“ASC 740”) , as modified by ASC 946. Tax benefits of positions not deemed to meet the more-likely-than-not threshold, or uncertain tax positions, would be recorded as tax expense in the current year. It is the Company’s policy to recognize accrued interest and penalties related to uncertain tax benefits in income tax expense. The Company has no material uncertain tax positions as of June 30, 2021 and December 31, 2020. All the Company’s tax returns remain subject to examination by U.S. federal and state tax authorities.

In order for the Company not to be subject to federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its ordinary income (taking into account certain deferrals and elections), (ii) 98.2% of its net capital gains from the current year and (iii) any undistributed ordinary income and net capital gains from preceding year on which it paid corporate-level U.S. federal income tax. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. If the Company chooses to do so, this generally would increase expenses and reduce the amount available to be distributed to stockholders. The Company will accrue excise tax on estimated undistributed taxable income as required on an annual basis.

Distributions

Distributions to common stockholders are recorded on the record date. The amount to be paid out as a distribution is determined by the Board each quarter and is generally based upon the earnings estimated by management. Net realized capital gains, if any, are distributed at least annually, although the Company may decide to retain such capital gains for investment.

46

Table of Contents

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. Included in interest income for the three and six months ended June 30, 2020 is the acceleration of OID and EOT of approximately $1.0 million and $1.4 million, respectively, which was reclassified from net realized gain/(loss) on investments. Included in fee income for the three and six months ended June 30, 2020 is non-recurring fees of approximately $0.4 million and $1.8 million, respectively, of which $0.1 million and $1.0 million, respectively, were reclassified from net realized gain/(loss) on investment and $0.3 million and $0.8 million, respectively, were reclassified from interest income. These reclassifications had no effect on the previously reported net increase (decrease) in net assets.

Note 3. Investments

The Company provides debt, including loans and equipment financings, to growth stage companies, including venture capital-backed companies and companies with institutional equity investors, primarily in the United States. The Company’s investment strategy includes making investments consisting primarily of term loans and equipment financings, and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, the Company may obtain warrants or contingent exit fees at funding from many of the portfolio companies.

Debt Securities

The Company’s debt securities primarily consist of direct investments in interest-bearing secured loans and equipment financings to privately held companies based in the United States. Secured loans are generally secured by a blanket first lien or a blanket second lien on the assets of the portfolio company. Equipment financings typically include a specific asset lien on mission critical assets as well as a second lien on the assets of the portfolio company. These debt securities typically have a term of between three and five years from the original investment date. Certain of the debt securities are “covenant-lite” loans, which generally are loans that do not have a complete set of financial maintenance covenants and have covenants that are incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower rather than by a deterioration in the borrower’s financial condition. The equipment financings in the investment portfolio generally have fixed interest rates. The loans in the investment portfolio generally have fixed interest rates or floating interest rates subject to interest rate floors. Both equipment financings and loans generally include an EOT payment.

The specific terms of each debt security vary depending on the creditworthiness of the portfolio company and the projected value of the financed assets. Companies with stronger creditworthiness may receive an initial period of lower financing factor, which is analogous to an interest-only period on a traditional term loan. Equipment financings may include upfront interim payments and security deposits. Equipment financing arrangements have various structural protections, including customary default penalties, information and reporting rights, material adverse change or investor abandonment provisions, consent rights for any additions or changes to senior debt, and, as needed, intercreditor agreements with cross-default provisions to protect the Company’s second lien positions.

Warrant Investments

In connection with the Company’s debt investments, the Company may receive warrants in the portfolio company. Warrants received in connection with a debt investment typically include a potentially discounted contract price to exercise, and thus, as a portfolio company appreciates in value, the Company may achieve additional investment return from this equity interest. The warrants typically contain provisions that protect the Company as a minority-interest holder, as well as secured or unsecured put rights, or rights to sell such securities back to the portfolio company, upon the occurrence of specified events. In certain cases, the Company may also obtain follow-up rights in connection with these equity interests, which allow the Company to participate in future financing rounds.

47

Table of Contents

Equity Investments

In specific circumstances, the Company may seek to make direct equity investments in situations where it is appropriate to align the interests of the Company with key management and stockholders of the portfolio company, and to allow for participation in the appreciation in the equity values of portfolio company. These equity investments are generally made in connection with debt investments. The Company seeks to maintain fully diluted equity positions in the portfolio companies of 5% to 50% and may have controlling equity interests in some instances.

Portfolio Industry Classification

The Company’s portfolio investments are in companies conducting business in a variety of industries. The following table summarizes the composition of the Company’s portfolio investments by industry at cost and fair value and as a percentage of the total portfolio as of June 30, 2021 and December 31, 2020 (dollars in thousands):

June 30, 2021 December 31, 2020
Cost Fair Value Cost Fair Value
Industry Amount % Amount % Amount % Amount %
Manufacturing $ 136,246 23.7% 167,170 28.0% $ 103,471 20.8% $ 99,709 20.2%
Professional, Scientific, and Technical Services 83,523 14.5% 89,394 15.0% 77,831 15.6% 78,893 16.0%
Retail Trade 90,430 15.7% 78,374 13.1% 78,534 15.7% 75,664 15.4%
Finance and Insurance 41,007 7.1% 42,316 7.1% 35,320 7.0% 35,699 7.2%
Information 34,102 5.9% 34,208 5.7% 31,843 6.4% 30,709 6.2%
Rental and Leasing Services 30,936 5.4% 31,578 5.3% 29,055 5.8% 29,138 5.9%
Space Research and Technology 29,830 5.2% 29,811 5.0% 0.0% 0.0%
Utilities 24,128 4.2% 24,378 4.1% 26,800 5.4% 27,083 5.5%
Agriculture, Forestry, Fishing and Hunting 18,032 3.1% 20,855 3.5% 20,981 4.2% 20,837 4.2%
Real Estate 20,249 3.5% 20,152 3.4% 17,267 3.5% 17,316 3.5%
Health Care and Social Assistance 20,427 3.6% 16,606 2.8% 14,348 2.9% 11,422 2.3%
Educational Services 13,614 2.4% 14,147 2.4% 9,359 1.9% 9,816 2.0%
Wholesale Trade 11,763 2.0% 11,482 1.9% 23,850 4.8% 23,903 4.8%
Construction 10,711 1.9% 8,000 1.3% 9,804 2.0% 6,894 1.4%
Pharmaceutical 7,606 1.3% 7,278 1.2% 17,503 3.5% 24,240 4.9%
Administrative and Support and Waste Management and Remediation Services 1,951 0.5% 1,947 0.2% 2,370 0.5% 2,328 0.5%
Total $ 574,555 100.0% $ 597,696 100.0% $ 498,336 100.0% $ 493,651 100.0%

48

Table of Contents

The geographic composition is determined by the location of the corporate headquarters of the portfolio company. The following table summarizes the composition of the Company’s portfolio investments by geographic region of the United States and other countries at cost and fair value and as a percentage of the total portfolio as of June 30, 2021 and December 31, 2020 (dollars in thousands):

June 30, 2021 December 31, 2020
Cost Fair Value Cost Fair Value
Geographic Region Amount % Amount % Amount % Amount %
United States:
West $ 279,721 48.7% $ 315,133 52.7% $ 247,204 49.6% $ 241,096 48.8%
Northeast 153,156 26.7% 143,474 24.0% 131,692 26.4% 127,801 25.9%
Midwest 47,815 8.3% 43,561 7.3% 47,324 9.5% 44,092 8.9%
Mountain 38,401 6.7% 39,555 6.6% 33,842 6.8% 33,969 6.9%
Southeast 1,041 0.2% 606 0.1% 11,011 2.2% 17,834 3.6%
South 30,293 5.2% 30,989 5.2% 463 0.1% 1,777 0.4%
Canada 24,128 4.2% 24,378 4.1% 26,800 5.4% 27,082 5.5%
Total $ 574,555 100.0% $ 597,696 100.0% $ 498,336 100.0% $ 493,651 100.0%

The following table summarizes the composition of the Company’s portfolio investments by investment type at cost and fair value and as a percentage of the total portfolio as of June 30, 2021 and December 31, 2020 (dollars in thousands):

June 30, 2021 December 31, 2020
Cost Fair Value Cost Fair Value
Investment Amount % Amount % Amount % Amount %
Secured Loan $ 400,944 69.8% $ 397,530 66.4% $ 324,544 65.1% $ 320,718 65.0%
Equipment Financing 120,078 20.9% 120,903 20.2% 122,966 24.7% 122,501 24.8%
Equity 39,715 6.9% 52,515 8.8% 32,961 6.6% 32,654 6.6%
Warrants 13,818 2.4% 26,748 4.6% 17,865 3.6% 17,778 3.6%
Total $ 574,555 100.0% $ 597,696 100.0% $ 498,336 100.0% $ 493,651 100.0%

Certain Risk Factors

In the ordinary course of business, the Company manages a variety of risks including market risk, credit risk and liquidity risk. The Company identifies, measures and monitors risk through various control mechanisms, including trading limits and diversifying exposures and activities across a variety of instruments, markets and counterparties.

Market risk is the risk of potential adverse changes to the value of financial instruments because of changes in market conditions, including as a result of changes in the credit quality of a particular issuer, credit spreads, interest rates, and other movements and volatility in security prices or commodities. In particular, the Company may invest in issuers that are experiencing or have experienced financial or business difficulties (including difficulties resulting from the initiation or prospect of significant litigation or bankruptcy proceedings), which involves significant risks. The Company manages its exposure to market risk through the use of risk management strategies and various analytical monitoring techniques.

The Company’s investments may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.

The Company’s investments consist of growth stage companies, many of which have relatively limited operating histories and also may experience variation in operating results. Many of these companies conduct business in regulated industries and could be affected by the changes in government regulations. Most of the Company’s borrowers will need

49

Table of Contents

additional capital to satisfy their continuing working capital needs and other requirements, and in many instances, to service the interest and principal payments on the debt.

Note 4. Fair Value of Financial Instruments

ASC 820 defines fair value, establishes a framework for measuring fair value, and establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. The Company accounts for its investments at fair value. As of June 30, 2021 and December 31, 2020, the Company’s portfolio investments consisted primarily of investments in secured loans and equipment financings. The fair value amounts have been measured as of the reporting date and have not been reevaluated or updated for purposes of these financial statements subsequent to that date. As such, the fair values of these financial instruments subsequent to the reporting date may be different than amounts reported

In accordance with ASC 820, the Company has categorized its investments based on the priority of the inputs to the valuation technique into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical investments (Level 1) and the lowest priority to unobservable inputs (Level 3). See “Note 2 - Summary of Significant Accounting Policies.”

As required by ASC 820, when the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Therefore, unrealized appreciation and depreciation related to such investments categorized within the Level 3 tables below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).

The fair value determination of each portfolio investment categorized as Level 3 required one or more of the following unobservable inputs:

● Financial information obtained from each portfolio company, including unaudited statements of operations and balance sheets for the most recent period available as compared to budgeted numbers;

● Current and projected financial condition of the portfolio company;

● Current and projected ability of the portfolio company to service its debt obligations;

● Type and amount of collateral, if any, underlying the investment;

● Current financial ratios (e.g., fixed charge coverage ratio, interest coverage ratio and net debt/EBITDA ratio) applicable to the investment;

● Current liquidity of the investment and related financial ratios (e.g., current ratio and quick ratio);

● Pending debt or capital restructuring of the portfolio company;

● Projected operating results of the portfolio company;

● Current information regarding any offers to purchase the investment;

● Current ability of the portfolio company to raise any additional financing as needed;

● Changes in the economic environment, which may have a material impact on the operating results of the portfolio company;

● Internal occurrences that may have an impact (both positive and negative) on the operating performance of the portfolio company;

50

Table of Contents

● Qualitative assessment of key management;

● Contractual rights, obligations or restrictions associated with the investment; and

● Time to exit.

The use of significant unobservable inputs creates uncertainty in the measurement of fair value as of the reporting date. The significant unobservable inputs used in the fair value measurement of the Company’s investments, are (i) earnings before interest, tax, depreciation, and amortization (“EBITDA”) and revenue multiples (both projected and historic), and (ii) volatility assumptions. Significant increases (decreases) in EBITDA and revenue multiple inputs in isolation would result in a significantly higher (lower) fair value measurement. Similarly, significant increases (decreases) in volatility inputs in isolation would result in a significantly higher (lower) fair value assessment. On the contrary, significant increases (decreases) in weighted average cost of capital inputs in isolation would result in a significantly lower (higher) fair value measurement. However, due to the nature of certain investments, fair value measurements may be based on other criteria, such as third-party appraisals of collateral and fair values as determined by independent third parties, which are not presented in the tables below.

The Company’s assets measured at fair value by investment type on a recurring basis as of June 30, 2021 were as follows:

Fair Value Measurements at Reporting Date Using
Quoted Prices Significant
in Active Other Significant
Markets for Observable Unobservable
Identical Assets Inputs Inputs
Assets (Level 1) (Level 2) (Level 3) Total
Secured Loans $ $ $ 397,530 $ 397,530
Equipment Financings 120,903 120,903
Equity 1,534 50,981 52,515
Warrants 36 26,712 26,748
Total Investments at fair value 1,570 596,126 597,696
Cash, cash equivalents and restricted cash 34,465 34,465
$ 34,465 $ 1,570 $ 596,126 $ 632,161

The Company’s assets measured at fair value by investment type on a recurring basis as of December 31, 2020 were as follows:

Fair Value Measurements at Reporting Date Using
Quoted Prices Significant
in Active Other Significant
Markets for Observable Unobservable
Identical Assets Inputs Inputs
Assets (Level 1) (Level 2) (Level 3) Total
Secured Loans $ $ $ 320,718 $ 320,718
Equipment Financings 122,501 122,501
Equity 32,654 32,654
Warrants 17,778 17,778
Total Investments at fair value 493,651 493,651
Cash, cash equivalents and restricted cash 61,101 61,101
$ 61,101 $ $ 493,651 $ 554,752

51

Table of Contents

Debt investments include both secured loans and equipment financing securities. The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of June 30, 2021 (dollars in thousands):

Fair Value as of
June 30, Valuation Techniques/ Unobservable Weighted
Investment Type 2021 Methodologies Inputs (1) Range Average (2)
Debt investments $ 382,482 Discounted Cash Flows Hypothetical Market Yield 9.2% - 31.1% 15.1 %
114,368 Originated within the past three months Origination Market Yield 10.2% - 16.0% 12.9 %
20,637 Transactions Precedent (6) Transaction Price n/a n/a
946 Liquidation Scenario Probability Weighting of Alternative Outcomes 60.0% - 90.0% n/a
Equity investments 4,542 Market Approach Revenue Multiple Only (3) 0.7x - 1.1x 0.8 x
6,789 Market Approach Revenue Multiple (3) 0.4x - 0.7x 0.4 x
Volatility (5) 37.6% - 82.1% 43.7 %
Risk-Free Interest Rate 0.1% - 0.5% 0.1 %
Estimated Time to Exit (in years) 0.7 - 3.3 2.7
Discount for Lack of Marketability (8) 16.5% - 26.7% 23.3 %
500 Transactions Precedent (6) Transaction Price n/a n/a
39,150 Other ⁽ ⁷ ⁾ Discount for Lack of Marketability (8) 20.6% n/a
Warrants 18,764 Market Approach Revenue Multiple (3) 0.3x - 30.0x 2.7 x
Company Specific Adjustment (4) 8.6% - 32.2% 12.8 %
Volatility (5) 38.4% - 103.7% 66.2 %
Risk-Free Interest Rate 0.1% - 0.8% 0.3 %
Estimated Time to Exit (in years) 0.1 - 4.5 2.4
7,948 Other ⁽ ⁷ ⁾ Discount for Lack of Marketability (8) 18.2% - 32.3% 20.5 %
Total Level 3 Investments $ 596,126

(1) The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.

(2) Weighted averages are calculated based on the fair market value of each investment.

(3) Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

(4) Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5) Represents the range of industry volatility used by market participants when pricing the investment.

(6) Represents investments where there is an observable transaction or pending event for the investment.

52

Table of Contents

(7) The fair market value of these investments is derived based on recent private market and merger and acquisition transaction prices.

(8) Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

The following table provides a summary of the significant unobservable inputs used to fair value the Level 3 portfolio investments as of December 31, 2020 (dollars in thousands):

Fair Value as of
December 31, Valuation Techniques/ Unobservable Weighted
Investment Type 2020 Methodologies Inputs (1) Range Average (2)
Debt investments $ 330,184 Discounted Cash Flows Hypothetical Market Yield 9.5% - 31.2% 15.1 %
99,053 Originated within the past three months Origination Market Yield 12.9% - 15.2% 14.2 %
11,771 Transactions Precedent (6) Transaction Price n/a n/a
2,211 Liquidation Scenario Probability Weighting of Alternative Outcomes 60.0% - 90.0% n/a
Equity investments 3,623 Liquidation Scenario Probability Weighting of Alternative Outcomes 30.0% - 70.0% n/a
5,550 Market Approach Revenue Multiple Only (3) 0.5x - 0.9x 0.7 x
23,481 Market Approach Revenue Multiple (3) 0.36x - 3.0x 1.8 x
Company Specific Adjustment (4) (17.5)% - 150.0% 74.9 %
Volatility (5) 45.0% - 80.0% 59.8 %
Risk-Free Interest Rate 0.1% - 0.2% 0.1 %
Estimated Time to Exit (in years) 0.5 - 2.0 1.1
Warrants 15,133 Market Approach Revenue Multiple (3) 0.3x - 20.75x 3.2 x
EBITDA Multiple n/a 10.9 x
Company Specific Adjustment (4) (50.0)% - 10.0% (13.1) %
Volatility (5) 20.0% - 104.7% 53.4 %
Risk-Free Interest Rate 0.1% - 3.0% 0.9 %
Estimated Time to Exit (in years) 0.2 - 10.0 3.3
2,645 Black Scholes Option Pricing Model Volatility (5) 46.8% - 132.3% 52.0 %
Risk-Free Interest Rate 0.1% - 0.7% 0.1 %
Estimated Time to Exit (in years) 0.5 - 7.3 0.8
Total Level 3 Investments $ 493,651

(1) The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are hypothetical market yields and premiums/(discounts). The hypothetical market yield is defined as the exit price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The significant unobservable inputs used in the fair value measurement of the Company’s equity and warrant securities are revenue multiples and portfolio company specific adjustment factors. Additional inputs used in the option pricing model (“OPM”) include industry volatility, risk free interest rate and estimated time to exit. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date.

(2) Weighted averages are calculated based on the fair market value of each investment.

(3) Represents amounts used when the Company has determined that market participants would use such multiples when pricing the investments.

53

Table of Contents

(4) Represents amounts used when the Company has determined market participants would take into account these discounts when pricing the investments.

(5) Represents the range of industry volatility used by market participants when pricing the investment.

(6) Represents investments where there is an observable transaction or pending event for the investment.

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the six months ended June 30, 2021 (in thousands):

Type of Investment
Debt Equity Warrants Total
Fair Value as of December 31, 2020 $ 443,219 $ 32,654 $ 17,778 $ 493,651
Purchases, net of deferred fees 193,696 11,460 3,076 208,232
Non-cash conversion (1) 1,579 (1,579)
Transfer out of Level 3 (2) (50) (50)
Proceeds from sales and paydowns (130,251) (13,536) (3,092) (146,879)
Accretion of OID and EOT payments 10,279 10,279
Net realized gain/(loss) (210) 4,200 600 4,590
Third party participation (3) (283) (283)
Change in unrealized appreciation/(depreciation) 1,700 14,907 9,979 26,586
Fair Value as of June 30, 2021 $ 518,433 $ 50,981 $ 26,712 $ 596,126
Net change in unrealized appreciation/depreciation on Level 3 investments still held as of June 30, 2021 $ 1,363 $ 23,270 $ 10,509 $ 35,142

(1) The non-cash conversion includes the non-cash exercise of warrants held in one portfolio company to equity instruments during the period.

(2) Transfers out of Level 3 during the six months ended June 30, 2021 primarily relates to the exercise of the warrants held in one portfolio company to equity investments during the period and the corresponding company’s public offering transaction. During the six months ended June 30, 2021, there were no transfers into Level 3.

(3) Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. In March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

54

Table of Contents

The following table provides a summary of changes in the debt, including loans and equipment financings (collectively “Debt”), equity, and warrants fair value of the Company’s Level 3 portfolio investments for the year ended December 31, 2020 (in thousands):

Type of Investment
Debt Equity Warrants Total
Fair Value as of January 1, 2020 $ $ $ $
Formation Transactions acquisitions 375,858 24,066 17,099 417,023
Purchases, net of deferred fees 234,418 2,170 1,976 238,564
Non-cash conversion (1) (10,148) 10,879 532 1,263
Proceeds from sales and paydowns (157,046) (3,855) (160,901)
Accretion of OID and EOT payments 11,788 11,788
Net realized gain/(loss) (7,361) (300) (1,742) (9,403)
Third party participation (2) 283 283
Change in unrealized appreciation/(depreciation) (4,290) (589) (87) (4,966)
Fair Value as of December 31, 2020 (3) $ 443,219 $ 32,654 $ 17,778 $ 493,651
Net change in unrealized appreciation/depreciation on Level 3 investments still held as of December 31, 2020 $ (4,290) $ (589) $ (87) $ (4,966)

(1) The non-cash conversion includes non-cash restructuring transactions of two portfolio companies in which our outstanding loan investments were converted to equity instruments during the period.

(2) Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

(3) During the year ended December 31, 2020, there were no transfers into or out of Level 3.

Fair Value of Financial Instruments Carried at Cost

As of June 30, 2021 and December 31, 2020, the carrying value of the Credit Facility is approximately $68.9 million and $132.9 million, net of unamortized deferred financing costs of $1.1 million and $2.1 million, respectively. The carrying value of the Company’s Credit Facility as of June 30, 2021 and December 31, 2020 approximates the fair value, which was estimated using a market yield approach with Level 3 inputs.

As of June 30, 2021 and December 31, 2020, the carrying value of the 2025 Notes is approximately $120.8 million and $120.3 million, respectively, net of unamortized deferred financing costs of $4.2 million and $4.7 million, respectively. The 2025 Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the 2025 Notes as of June 30, 2021 and December 31, 2020 was approximately $130.0 million and $131.4 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

As of June 30, 2021 and December 31, 2020, the carrying value of the Convertible Notes is approximately $47.2 million and $46.6 million, respectively, net of unamortized deferred financing costs and discount of $2.8 million and $3.4 million, respectively. The Convertible Notes have a fixed interest rate as discussed in “Note 5 – Borrowings.” The fair value of the Company’s Convertible Notes as of June 30, 2021 and December 31, 2020 was approximately $48.1 million and $46.6 million, respectively, which was estimated using a relative market yield approach with Level 3 inputs.

55

Table of Contents

Note 5. Borrowings

Credit Suisse Credit Facility

On January 9, 2020, TF1 and its affiliates borrowed $190.0 million under the Credit Facility. On January 16, 2020, in connection with the Formation Transactions, through its wholly owned subsidiary, TF1, the Company became a party to, and assumed, the Credit Facility with Credit Suisse. The Credit Facility matures on January 8, 2022, unless extended. Borrowings under the Credit Facility bear interest at a rate of the three-month London Interbank Offered Rate (“LIBOR”) plus 3.25%. The Credit Facility is collateralized by all investments held by TF1 and permits an advance rate of up to 65% of eligible investments. The Credit Facility contains covenants that, among other things, require the Company to maintain minimum tangible net worth and leverage ratios, minimum cash balance of $15.0 million, and a cash reserve of 60 days for interest. The Company has the ability to borrow up to an aggregate of $300.0 million, and the Credit Facility borrowing base contains certain criteria for eligible investments and includes concentration limits as defined in the Credit Facility. As of June 30, 2021 and December 31, 2020, the Company had $70.0 million and $135.0 million, respectively, in borrowings outstanding under the Credit Facility and a borrowing availability of approximately $88.6 million and $42.0 million, respectively.

During the three months ended June 30, 2021, the Company borrowed and additional $25.0 million on the Credit Facility and did not make any repayments. During the six months ended June 30, 2021, the Company borrowed an additional $25.0 million and made repayments of $90.0 million. During the year ended December 31, 2020, the Company borrowed an additional $30.0 million and made repayments of $85.0 million and incurred approximately $4.0 million of financing costs in connection with the Credit Facility that are capitalized and deferred using the straight-line method over the life of the facility. As of June 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the Credit Facility were $1.1 million and $2.1 million, respectively and presented as a direct deduction from the carrying amount of the debt liability on the Consolidated Statements of Assets and Liabilities.

The summary information regarding the Credit Facility is as follows (dollars in thousands):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Stated interest expense $ 482 $ 1,287 $ 1,159 $ 3,000
Amortization of deferred financing costs 527 473 1,054 907
Total interest and amortization of deferred financing costs $ 1,009 $ 1,760 $ 2,213 $ 3,907
Weighted average effective interest rate 7.2 % 5.5 % 6.6 % 5.6 %
Weighted average outstanding balance $ 55,769 $ 128,626 $ 66,823 $ 138,592

2025 Notes

Concurrent with the completion of a private common stock offering, on January 16, 2020, the Company completed the 144A Note Offering of $105.0 million in aggregate principal amount of the unsecured 2025 Notes in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW, as the initial purchaser, exercised in full its option to purchase or place additional Notes and on January 29, 2020 the Company issued and sold an additional $20.0 million in aggregate principal amount of the 2025 Notes. As a result, the Company issued and sold a total of $125.0 million in aggregate principal amount of the 2025 Notes pursuant to the 144A Note Offering.

The 2025 Notes were issued pursuant to an Indenture dated as of January 16, 2020 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”), and a First Supplemental Indenture, dated as of January 16, 2020 (the “First Supplemental Indenture” and together with the Base Indenture, the “2025 Notes Indenture”), between the Company and the Trustee. The 2025 Notes mature on January 16, 2025 (the “Maturity Date”), unless repurchased or redeemed in accordance with their terms prior to such date. The 2025 Notes are redeemable, in

56

Table of Contents

whole or in part, at any time, or from time to time, at the Company’s option, on or after January 16, 2023 at a redemption price equal to 100% of the outstanding principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of redemption. The holders of the 2025 Notes do not have the option to have the notes repaid or repurchased by the Company prior to the Maturity Date.

The 2025 Notes bear interest at a fixed rate of 7.00% per year payable quarterly on March 15, June 15, September 15 and December 15 of each year, commencing on March 15, 2020. The 2025 Notes are direct, general unsecured obligations of the Company and rank pari passu, or equal in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated.

Concurrent with the closing of the 144A Note Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of the 2025 Notes in the 144A Note Offering. Pursuant to the terms of this registration rights agreement, the Company filed with the SEC a registration statement, which was initially declared effective on October 20, 2020, registering the public resale of the 2025 Notes by the holders thereof that elected to include their 2025 Notes in such registration statement.

Aggregate offering costs in connection with the 2025 Notes issuance, including the underwriter’s discount and commissions, were approximately $5.8 million, which were capitalized and deferred. As of June 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the 2025 Notes were $4.2 million and $4.7 million, respectively.

The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Stated interest expense $ 2,188 $ 2,212 $ 4,375 $ 4,059
Amortization of deferred financing costs 292 277 583 509
Total interest and amortization of deferred financing costs $ 2,480 $ 2,489 $ 4,958 $ 4,568
Weighted average effective interest rate 7.9 % 8.0 % 7.9 % 7.3 %

Convertible Notes

On December 11, 2020, the Company completed a private offering (the “Private Convertible Note Offering”) of $50 million in aggregate principal amount of its unsecured 6.00% Convertible Notes due 2025 (the “Convertible Notes”) in reliance upon the available exemptions from the registration requirements of the Securities Act. KBW acted as the initial purchaser and placement agent in connection with the Private Convertible Note Offering pursuant to a purchase/placement agreement dated December 4, 2020 by and between the Company and KBW.

The Convertible Notes were issued pursuant to the Base Indenture and a Second Supplemental Indenture, dated as of December 11, 2020 (the “Second Supplemental Indenture” and together with the Base Indenture, the “Convertible Notes Indenture”), between the Company and the Trustee. Concurrent with the closing of the Convertible Note Offering, on December 11, 2020, the Company entered into a registration rights agreement for the benefit of the holders of the Convertible Notes and the shares of common stock issuable upon conversion thereof.

The Convertible Notes bear interest at a fixed rate of 6.00% per year, subject to additional interest upon certain events, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2021. If an investment grade rating is not maintained with respect to the Convertible Notes, additional interest of 0.75% per annum will accrue on the Convertible Notes until such time as the Convertible Notes have received an investment grade rating of “BBB-” (or its equivalent) or better. The rating remained unchanged as of June 30, 2021 and December 31, 2020. The Convertible Notes mature on December 11, 2025 (the “Convertible Notes Maturity Date”), unless earlier converted or repurchased in accordance with their terms.

57

Table of Contents

Holders may convert their Convertible Notes, at their option, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date. The conversion rate is initially 66.6667 shares of the Company’s common stock, per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $15.00 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events, further described in the Convertible Note Indenture, that occur prior to the Convertible Notes Maturity Date, the Company will increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event in certain circumstances. Upon conversion of the Convertible Notes, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes, equal to the then existing conversion rate.

At the Company’s option, it may cause holders to convert all or a portion of the then outstanding principal amount of the Convertible Notes plus accrued but unpaid interest, at any time on or prior to the close of business on the business day immediately preceding the Convertible Notes Maturity Date, if the closing sale price of the Company’s common stock for any 30 consecutive trading days exceeds 120% of the conversion price, as may be adjusted. Upon such conversion, the Company will pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock, at the Company’s election, per $1,000 principal amount of the Convertible Notes , equal to the then existing conversion rate, and a forced conversion make-whole payment (as defined in the Second Supplemental Indenture), if any, in cash.

The Company may not redeem the Convertible Notes at its option prior to maturity. In addition, if the Company undergoes a fundamental change (as defined in the Second Supplemental Indenture), holders may require the Company to repurchase for cash all or part of such holders’ Convertible Notes at a repurchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

The Convertible Notes are direct unsecured obligations of the Company and rank pari passu, or equal, in right of payment with all of the Company’s existing and future unsecured indebtedness or other obligations that are not so subordinated, including, without limitation, the 2025 Notes, and senior in right of payment to all of the Company’s future indebtedness or other obligations that are expressly subordinated, or junior, in right of payment to the Convertible Notes.

Aggregate offering costs in connection with the Convertible Note Offering, including the initial purchaser and placement agent discount and commissions, were approximately $1.8 million which were capitalized and deferred. As of June 30, 2021 and December 31, 2020, unamortized deferred financing costs related to the Convertible Notes were $1.6 million and $1.7 million, respectively.

The Convertible Notes are accounted for in accordance with ASC 470-20 Debt Instruments with Conversion and Other Options . In accounting for the Convertible Notes, the Company estimated at the time of issuance that the values of the debt and the embedded conversion feature of the Convertible Notes were approximately 99.1% and 0.9%, respectively. The original issue discount of 0.9%, or approximately $0.5 million, attributable to the conversion feature of the Convertible Notes was recorded in “capital in excess of par value” in the Consolidated Statements of Assets and Liabilities as of December 31, 2020. The estimated effective interest rate of the Convertible Notes was approximately 7.2% annualized.

In January 2021, the Company early adopted Accounting Standard Update (“ASU”) No. 2020-06, Debt – Debt with Conversion and Other Options (“ASU 2020-06”), under which the accounting for convertible instruments was simplified by removing the separate accounting for embedded conversion features. As such approximately $0.5 million was reversed out of net assets and reduced the original issue discount for the Convertible Notes.

58

Table of Contents

The components of the carrying value of the Convertible Notes were as follows (in thousands):

June 30, 2021 December 31, 2020
Principal amount of debt $ 50,000 $ 50,000
Unamortized debt issuance cost (1,619) (1,672)
Original issue discount related to equity component, net of accretion (468)
Original issue discount, net of accretion (1,167) (1,308)
Carrying value of Convertible Notes $ 47,214 $ 46,552

The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Stated interest expense $ 750 $ $ 1,492 $
Amortization of deferred financing costs and original issue discount 155 311
Total interest and amortization of deferred financing costs and original issue discount $ 905 $ $ 1,803 $
Weighted average effective interest rate 7.2 % n/a 7.2 % n/a

As of June 30, 2021 and December 31, 2020, the Company was in compliance with the terms of the Credit Facility, the 2025 Notes Indenture, and the Convertible Notes Indenture.

Note 6. Commitments and Contingencies

Unfunded Commitments

The Company’s commitments and contingencies consist primarily of unused commitments to extend credit in the form of loans or equipment financings to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of June 30, 2021 and December 31, 2020 are generally dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements contain customary lending provisions that allow the Company relief from funding obligations for previously made commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the Company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments as of June 30, 2021 and December 31, 2020 includes only those commitments which are available at the request of the portfolio company and are unencumbered by milestones or additional lending provisions.

As of June 30, 2021, the Company had an aggregate of approximately $4.0 million of unfunded commitments to two portfolio companies, Dandelion, Inc. and Greenlight Biosciences, Inc. As of December 31, 2020, the Company had outstanding unfunded commitments of approximately $0.1 million to one portfolio company, Dandelion, Inc. These unfunded commitments are available at the request of such portfolio companies and unencumbered by milestones. The fair value of these unfunded commitments is considered to approximate the cost of such commitments as the yields determined at the time of underwriting are expected to be materially consistent with the yields upon funding. The Company will fund its unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the Credit Facility) and maintains adequate liquidity to fund its unfunded commitments through these sources.

59

Table of Contents

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Leases

FASB ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”) requires that a lessee evaluate its leases to determine whether they should be classified as operating or financing leases. The Company identified two significant operating leases for its office space in Chandler, AZ and its new headquarters in Phoenix, AZ. The lease for the Chandler office commenced February 21, 2017 and expires July 31, 2022. The Chandler lease contains a five-year extension option for a final expiration date of July 31, 2027, which the company will not exercise. The Company has also entered into a lease for new office space in downtown Phoenix, Arizona (“PHX”), which commenced on June 4, 2021 and expires on December 31, 2028. The PHX lease contains two five-years extension options for a final expiration date of December 31, 2038.

The total lease expense incurred related to the Chandler office lease for the three months ended June 30, 2021 and 2020 was approximately $0.1 million for each period. The total lease expense related to the Chandler office lease for the six months ended June 30, 2021 and 2020 was approximately $0.1 million for each period. As of June 30, 2021 and December 31, 2020, the right of use asset related to the Chandler office operating lease was $0.2 million and $0.4 million, respectively, and the lease liability was $0.2 million and $0.4 million, respectively. As of June 30, 2021, the remaining lease term was 1.1 years and the discount rate was 3.25%. As of June 30, 2021, the right of use asset related to the PHX office operating lease was $2.4 million and the lease liability was $2.4 million and the discount rate was 3.75%. The total lease expense related to the PHX office for the three and six months ended June 30, 2021 was approximately $30,000.

The following table shows future minimum payments under the Company’s operating leases as of June 30, 2021 (in thousands):

For the Years Ended December 31, Total
2021 $ 112
2022 484
2023 361
2023 371
2024 380
Thereafter 1,619
Total $ 3,327

Legal Proceedings

The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. As of June 30, 2021, there are no material legal matters or material litigation pending of which the Company is aware.

Note 7. Stockholder’s Equity

The Company authorized 200,000,000 shares of its common stock with a par value of $0.001 per share. On September 27, 2019, the Company was initially capitalized with the issuance of 10 shares of its common stock for an aggregate purchase price of $150 to its sole shareholder.

60

Table of Contents

Private Common Stock Offerings

On January 16, 2020, the Company completed the Private Common Stock Offering. As a result, the Company issued and sold a total of 8,333,333 shares of its common stock for aggregate net proceeds of approximately $114.4 million, net of offering costs of approximately $10.6 million. Refer to “Note 1 – Organization and Basis of Presentation” for further details.

Concurrent with the closing of the Private Common Stock Offering, on January 16, 2020, the Company entered into a registration rights agreement for the benefit of the purchasers of shares of its common stock in such offering and the Legacy Investors that received shares of its common stock in connection with the Formation Transactions that were not the Company’s directors, officers and affiliates. Pursuant to the terms of this registration rights agreement, the Company no longer has any registration obligations with respect to such shares because (i) such shares may be sold by any such stockholder in a single transaction without registration pursuant to Rule 144 under the Securities Act, (ii) the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, for a period of at least 90 days and is current in the filing of all such required reports and (iii) such shares have been listed for trading on the Nasdaq Global Select Market.

Formation Transactions

On January 16, 2020, immediately following the initial closings of the Private Offerings, the Company used the proceeds from the Private Offerings to complete the Formation Transactions, pursuant to which the Company acquired the Legacy Funds and Trinity Capital Holdings. In consideration for the Legacy Funds, the Company issued 9,183,185 shares of common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Investors. As consideration for all of the equity interests in Trinity Capital Holdings, the Company issued 533,332 shares of its common stock at $15.00 per share for a total value of approximately $8.0 million and paid approximately $2.0 million in cash. Refer to “Note 1 – Organization and Basis of Presentation” for further details regarding the Formation Transactions.

Initial Public Offering

The Company’s common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” On February 2, 2021, the Company completed its initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

2019 Long-Term Incentive Plan

The Company’s Board adopted and approved the 2019 Trinity Capital Inc. Long-Term Incentive Plan (the “2019 Long-Term Incentive Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Long-Term Incentive Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders, with the 2019 Long-Term Incentive Plan becoming effective on June 17, 2021. Under the 2019 Long-Term Incentive Plan, awards of restricted stock, incentive stock options and non-statutory stock options (together with incentive stock options, “Options”) may be granted to certain of the Company’s executive officers, employee directors and other employees (collectively, the “Employee Participants”) in accordance with the SEC exemptive order the Company received on May 27, 2021 (the “SEC Exemptive Order”). While the 2019 Long-Term Incentive Plan contemplates grants of restricted stock, restricted stock units, Options, dividend equivalent rights, performance awards and other stock-based awards to the Employee Participants, the Company only sought and received exemptive relief from the SEC pursuant to the SEC Exemptive Order to grant awards of restricted stock and Options. As a result, the Company will only grant awards of such securities under the 2019 Long-Term Incentive Plan.

Subject to certain adjustments under the 2019 Long-Term Incentive Plan, the maximum aggregate number of shares of the Company’s common stock authorized for issuance under the 2019 Long-Term Incentive Plan is 3,600,000 shares. The 2019 Long-Term Incentive Plan is to be administered by the Board, unless the Board delegates its administrative

61

Table of Contents

authority to the Compensation Committee of the Board (the “Compensation Committee”) in accordance with the terms of the 2019 Long-Term Incentive Plan. The 2019 Long-Term Incentive Plan will terminate on the day prior to the tenth anniversary of the date it was initially adopted by the Board, unless terminated sooner by action of the Board or the Compensation Committee, as applicable. As of June 30, 2021, no securities have been issued under the 2019 Long-Term Incentive Plan.

For additional information regarding the 2019 Long-Term Incentive Plan, please refer to the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 28, 2021.

2019 Restricted Stock Plan

The Company’s Board adopted and approved the Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (the “2019 Restricted Stock Plan”) on October 17, 2019 and the Company’s stockholders approved the 2019 Restricted Stock Plan on June 17, 2021 at the Company’s 2021 Annual Meeting of Stockholders. The 2019 Restricted Stock Plan became effective on June 17, 2021 and provides for grants of restricted stock awards (“Non-Employee Director Awards”) to the Company’s non-employee directors (the “Non-Employee Director Participants”), which are directors who are not “interested persons” of the Company (as such term is defined in Section 2(a)(19) of the 1940 Act)in accordance with the SEC Exemptive Order.

Subject to certain adjustments under the 2019 Restricted Stock Plan, the total number of shares of the Company’s common stock that may be subject to Non-Employee Director Awards is 60,000 shares. The 2019 Restricted Stock Plan is to be administered by the Compensation Committee, subject to the discretion of the Board. The 2019 Restricted Stock Plan will terminate on the day prior to the tenth anniversary of the date it was approved by the Company’s stockholders, unless terminated sooner by action of the Board. As of June 30, 2021, no restricted stock has been issued under the 2019 Restricted Stock Plan.

For additional information regarding the 2019 Restricted Stock Plan, please refer to the Company’s Current Report on Form 8-K, filed with the SEC on June 23, 2021, and the Company’s definitive proxy statement filed with the SEC on April 28, 2021.

Distribution Reinvestment Plan

The Company’s amended and restated distribution reinvestment plan (“DRIP”) provides for the reinvestment of distributions in the form of common stock on behalf of its stockholders, unless a stockholder has elected to receive distributions in cash. As a result, if the Company declares a cash distribution, its stockholders who have not “opted out” of the DRIP by the opt out date will have their cash distribution automatically reinvested into additional shares of the Company’s common stock. The share requirements of the DRIP may be satisfied through the issuance of common shares or through open market purchases of common shares by the DRIP plan administrator. Newly issued shares will be valued based upon the final closing price of the Company’s common stock on the valuation date determined for each distribution by the Board.

The Company’s DRIP is administered by its transfer agent on behalf of the Company’s record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company’s DRIP but may provide a similar distribution reinvestment plan for their clients. During the three months ended June 30, 2021, the Company issued 75,999 shares of common stock for a total of approximately $1.1 million under the DRIP. During the six months ended June 30, 2021, the Company issued 163,709 shares of common stock for a total of approximately $2.3 million under the DRIP. During the year ended December 31, 2020, the Company issued 271,414 shares of common stock for a total of approximately $3.4 million under the DRIP.

62

Table of Contents

Distributions

The following table summarizes distributions declared and/or paid by the Company since inception:

Declaration Date Record Date Payment Date Per Share Amount
May 7, 2020 May 29, 2020 June 5, 2020 $ 0.22
August 10, 2020 August 21, 2020 September 4, 2020 0.27
November 9, 2020 November 20, 2020 December 4, 2020 0.27
December 22, 2020 December 30, 2020 January 15, 2021 0.27
March 23, 2021 March 31, 2021 April 16, 2021 0.28
June 15, 2021 June 30, 2021 July 15, 2021 0.29
Total $ 1.60
  1. Earnings Per Share

In accordance with the provisions of ASC Topic 260 – Earnings per Share (“ASC 260”), basic earnings per share is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Other potentially dilutive common shares, and the related impact to earnings are considered when calculating earnings per share on a diluted basis. Potential common shares associated with the conversion option embedded in the Convertible Notes are anti-dilutive when the Company’s average NAV per share / market price per share is below the conversion price. The following table sets forth the computation of the weighted average basic and diluted net increase (decrease) in net assets per share from operations for the three and six months ended June 30, 2021 and 2020 (in thousands except shares and per share information):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Net increase/(decrease) in net assets resulting from operations $ 24,705 $ 6,882 $ 50,030 $ (28,169)
Weighted average common shares outstanding 26,478,747 18,074,929 25,024,925 17,959,728
Net increase/(decrease) in net assets resulting from operations per common share - basic and diluted $ 0.93 $ 0.38 $ 2.00 $ (1.57)

For the three and six months ended June 30, 2021, the effect of the Convertible Notes was anti-dilutive and, accordingly, was excluded from the calculation of diluted earnings per share.

Note 9. Income Taxes

When filing its 2020 tax return, the Company intends to elect to be treated for U.S. federal tax purposes as a RIC under Subchapter M of the Code and operate in a manner so as to qualify annually thereafter for the tax treatment applicable to RICs. As a RIC, the Company generally will not pay corporate-level income tax on the portion of its taxable income distributed to stockholders, generally required to be at least 90% of its investment company taxable income (which is generally its net ordinary taxable income and realized net short-term capital gains in excess of realized net long-term capital losses) and 90% of its tax-exempt income to maintain its RIC status (pass-through tax treatment for amounts distributed). The amount to be paid out as a distribution is determined by the Board each quarter and is based upon the annual earnings estimated by the management of the Company. To the extent the Company’s earnings fall below the amount of dividend distributions declared, however, a portion of the total amount of the Company’s distributions for the fiscal year may be deemed a return of capital for tax purposes to the Company’s stockholders.

63

Table of Contents

Because federal income tax regulations differ from accounting principles generally accepted in the United States, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their appropriate tax character. Temporary differences arise when certain items of income, expense, gain or loss are recognized at some time in the future. Also, recent tax legislation requires that income be recognized for tax purposes no later than when recognized for financial reporting purposes.

The following table sets forth the tax cost basis and the estimated aggregate gross unrealized appreciation and depreciation from investments for federal income tax purposes as of and for the period ended June 30, 2021 and December 31, 2020 (in thousands):

June 30, 2021 December 31, 2020
Tax Cost of Investments (1) $ 609,020 $ 559,437
June 30, 2021 December 31, 2020
Unrealized appreciation $ 55,415 $ 14,879
Unrealized depreciation (32,274) (19,845)
Net unrealized appreciation/(depreciation) from investments $ 23,141 $ (4,966)

(1) Includes cost of short-term investments, including cash and cash equivalents.

64

Table of Contents

Note 10. Financial Highlights

The following presents financial highlights (in thousands except share and per share information):

Six Months Ended
June 30, 2021 June 30, 2020
Per Share Data: (1)
Net asset value, beginning of period $ 13.03 $ 14.97 (2) ​
Net investment income 0.69 0.69 (3) ​
Net realized and unrealized gains/(losses) on investments (4) 1.31 (1.37)
Costs related to acquisition of Trinity Capital Holdings and Legacy Funds (0.87)
Net increase/(decrease) in net assets resulting from operations 2.00 (1.55)
Offering costs (0.30) (0.58)
Effect of shares issued (5) 0.19 (0.01)
Equity component of convertible notes (0.02)
Distributions (6) (0.57) (0.22)
Total increase/(decrease) in net assets 1.30 (2.36)
Net asset value, end of period $ 14.33 $ 12.61
Shares outstanding, end of period 26,491,274 18,137,600
Weighted average shares outstanding 25,024,925 17,959,728 (3) ​
Total return based on net asset value (7) (8) 14.4 % (14.3) % (9)
Total return based on market value (10) 7.5 % na
Ratio/Supplemental Data:
Per share market value at end of period $ 14.48 n/a
Net assets, end of period* $ 379,720 $ 228,646
Ratio of total expenses to average net assets (11) 11.7 % 13.2 %
Ratio of net investment income to average net assets (11) 10.4 % 12.1 %
Ratio of interest and credit facility expenses to average net assets (11) 5.4 % 8.3 %
Portfolio turnover rate (8) (12) 27.9 % 18.5 %
Asset coverage ratio (13) 255.0 % 199.1 %
  • Rounded to the nearest thousand.

(1) Based on actual number of shares outstanding at the end of the corresponding period or the weighted average shares outstanding for the period, unless otherwise noted, as appropriate.

(2) The net asset value as of January 16, 2020 (commencement of operations) is calculated based on the initial common stock purchase price of $15.00 per share less the accumulated loss of $0.03 per share from August 12, 2019 (the date of inception) through December 31, 2019.

(3) Calculated based upon weighted average shares outstanding for the period from January 16, 2020 (commencement of operations) through June 30, 2020.

(4) Net realized and unrealized gains/(losses) on investments include rounding adjustments to reconcile the change in net asset value per share.

65

Table of Contents

(5) Includes the impact of the different share amounts as a result of calculating certain per share data based on the weighted-average basic shares outstanding during the period and certain per share data based on the shares outstanding as of a period end or transaction date.

(6) The per share data reflects the actual amount of distributions declared per share for the applicable period.

(7) Total return based on net asset value is calculated as the change in net asset value per share during the period plus declared distributions per share during the period, divided by the beginning net asset value per share.

(8) Not annualized.

(9) Total return excluding costs related to acquisition of Trinity Capital Holdings and the Legacy Funds would have been (8.6)%.

(10) Total return based on market value is calculated as the change in market value per share during the period, taking into account dividends. The beginning market value per share is based on the market price of $14.00 per share on January 29, 2021, the date of the Company’s listing on Nasdaq, and not annualized.

(11) Annualized.

(12) Portfolio turnover rate is calculated using the lesser of year-to-date cash sales/repayments or year-to-date cash purchases over the average of the total investments at fair value.

(13) Based on outstanding debt of $245.0 million and $230.0 million as of June 30, 2021 and 2020, respectively.

66

Table of Contents

Senior Securities

Information about the Company’s senior securities (including debt securities and other indebtedness) is shown in the following table as of June 30, 2021 and December 31, 2020. No senior securities were outstanding as of December 31, 2019.

Class and Period Total Amount Outstanding Exclusive of Treasury Securities (1) Asset Coverage per Unit (2) Involuntary Liquidating Preference per Unit (3) Average Market Value per Unit (4)
Credit Facility
June 30, 2021 $ 70,000 2,550 - na
December 31, 2020 135,000 1,770 - na
December 31, 2019 - - - na
2025 Notes
June 30, 2021 $ 125,000 2,550 - na
December 31, 2020 125,000 1,770 - na
December 31, 2019 - - - na
Convertible Notes
June 30, 2021 $ 50,000 2,550 - na
December 31, 2020 50,000 1,770 - na
December 31, 2019 - - - na
Total
June 30, 2021 $ 245,000 2,550 - na
December 31, 2020 310,000 1,770 - na
December 31, 2019 - - - na

(1) Total amount of each class of senior securities outstanding at the end of the period presented.

(2) Asset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis.

(3) The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The “–” in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities.

(4) Not applicable because the senior securities are not registered for public trading.

Note 11. Related Party Transactions

Through the Formation Transactions, the Company acquired 100% of the equity interests of Trinity Capital Holdings and the Legacy Funds were merged with and into the Company. Members of the Company’s management, including Steven L. Brown, Kyle Brown, Gerald Harder and Ron Kundich, owned 100% of the equity interests in Trinity Capital Holdings and controlling interests in the general partners/managers of the Legacy Funds.

67

Table of Contents

As a result of the Formation Transactions, Messrs. S. Brown, K. Brown, Harder and Kundich collectively received (i) 533,332 shares of the Company’s common stock valued at approximately $8.0 million and approximately $2.0 million in cash in exchange for their equity interests in Trinity Capital Holdings, and (ii) 377,441 shares of the Company’s common stock valued at approximately $5.7 million for their limited partner and general partner interests in the Legacy Funds.

During the three and six months ended June 30, 2021 and the year ended December 31, 2020, certain related parties received distributions from the Company relating to their shares held. Refer to “Note 7 – Stockholder’s Equity” for further details on the Company’s Distribution Reinvestment Plan and the distributions declared. Additionally, during the Company’s IPO certain related parties purchased additional shares of the Company’s common stock. These acquisitions were made at the IPO price of $14.00 per share.

The Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements are intended to provide the Company’s directors and executive officers the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that the Company shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Note 12. Recent Accounting Pronouncements

In March 2020, the FASB issued ASU 2020-04, “ Reference rate reform (Topic 848) - Facilitation of the effects of reference rate reform on financial reporting ” and in January 2021, the FASB issued ASU 2021-01, “Reference rate reform (Topic 848).” The amendments in these updates provide optional expedients and exceptions for applying U.S. GAAP to certain contracts and hedging relationships that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform and became effective upon issuance for all entities. ASU 2020-04 and ASU 2021-01 are elective and are effective on March 12, 2020 through December 31, 2022. The Company does not plan on adopting, as it expects that the adoption of the guidance will not have a material impact on its consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (“ASU 2020-06”) under which the accounting for convertible instruments will be simplified by removing major separation models required under current GAAP. Accordingly, more convertible instruments will be reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception will be removed and, as a result, more equity contracts will qualify for the scope exception. ASU 2020-06 will also simplify the diluted earnings-per-share calculation in certain areas. ASU 2020-06 will be effective for years beginning after December 31, 2021, including interim periods within those fiscal years. Early adoption will be permitted for fiscal periods beginning after December 15, 2020 (including interim periods within the same fiscal year). The Company early adopted ASU 2020-06 on January 1, 2021, with no material impact to the consolidated financial statements other than no longer separately accounting for the embedded conversion feature.

Rule 2a-5 under the 1940 Act was recently adopted by the SEC and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. The Company is evaluating the impact of adopting Rule 2a-5 and intends to comply with the new rule’s requirements on or before the compliance date in September 2022.

Note 13. Subsequent Events

The Company’s management evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. Other than the item below, there have been no subsequent events that occurred during such period that would require recognition or disclosure.

Departure of Certain Officers

68

Table of Contents

On August 2, 2021, Scott Harvey, the Company’s Chief Legal Officer and Chief Compliance Officer, resigned from such positions and from his employment with the Company in connection with his retirement. The Board accepted Mr. Harvey’s resignation, and there was no disagreement between Mr. Harvey and the Company on any matter relating to the Company’s operations, policies or practices. Also on August 2, 2021, the Board appointed Sarah Stanton as the Chief Compliance Officer of the Company. Ms. Stanton also serves, and will continue to serve, as the General Counsel and Secretary of the Company.

69

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “the Company” refer to Trinity Capital Inc. and its consolidated subsidiaries. The information contained in this section should be read in conjunction with our consolidated financial statements and related notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.

Forward-Looking Statements

This quarterly report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. Any statements about our expectations, beliefs, plans, predictions, forecasts, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases such as “anticipate,” “believes,” “can,” “could,” “may,” “predicts,” “potential,” “should,” “will,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “expects,” “intends” and similar words or phrases. Accordingly, these statements are only predictions and involve estimates, known and unknown risks, assumptions and uncertainties that could cause actual results to differ materially from those expressed in them. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of several factors discussed under Item 1A. “Risk Factors” of Part II of this quarterly report and Item 1A. “Risk Factors” of Part I of our Annual Report on Form 10-K, filed with the SEC on March 4, 2021, including the following factors, among others:

● our limited operating history as a business development company (“BDC”);

● our future operating results, including the impact of the SARS-CoV-2 (“COVID-19”) pandemic;

● our dependence upon our management team and key investment professionals;

● our ability to manage our business and future growth;

● risks related to investments in growth stage companies, other venture capital-backed companies and generally U.S. companies;

● the ability of our portfolio companies to achieve their objectives, including as a result of the COVID-19 pandemic;

● the use of leverage;

● risks related to the uncertainty of the value of our portfolio investments;

● changes in political, economic or industry conditions, the interest rate and inflation rate environments or conditions affecting the financial and capital markets, including as a result of the COVID-19 pandemic;

● uncertainty surrounding the financial and/or political stability of the United States, the United Kingdom, the European Union and China, including as a result of the COVID-19 pandemic;

● the dependence of our future success on the general economy and its impact on the industries in which we invest;

● risks related to changes in interest rates and inflation rates, our expenses, and other general economic conditions and the effect on our net investment income;

● the effect of changes in tax laws and regulations and interpretations thereof;

70

Table of Contents

● the impact on our business of new or amended legislation or regulations, including the Coronavirus Aid, Relief and Economic Security Act, the stimulus package passed by Congress and signed into law in December 2020 and the American Rescue Plan Act of 2021 signed into law in March 2021;

● risks related to market volatility, including general price and volume fluctuations in stock markets;

● our ability to make distributions, including as a result of the COVID-19 pandemic; and

● our ability to maintain our status as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”), and qualify annually for tax treatment as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Additionally, there may be other risks that are otherwise described from time to time in the reports that we file with the Securities and Exchange Commission. Any forward-looking statements in this report should be considered in light of various important factors, including the risks and uncertainties listed above, as well as others. All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Any forward-looking statements are qualified in their entirety by reference to the risk factors discussed throughout this quarterly report. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. Because we are an investment company, the forward-looking statements and projections contained in this quarterly report are excluded from the safe harbor protections provided by Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995).

Overview

We are a specialty lending company providing debt, including loans and equipment financings, to growth stage companies, including venture-backed companies and companies with institutional equity investors. We are an internally managed, closed-end, non-diversified management investment company that has elected to be regulated as BDC under the 1940 Act. We also intend to elect to be treated, and intend to qualify annually thereafter, as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As a BDC and a RIC, we are required to comply with certain regulatory requirements.

Our investment objective is to generate current income and, to a lesser extent, capital appreciation through our investments. We seek to achieve our investment objective by making investments consisting primarily of term loans and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. In addition, we may obtain warrants or contingent exit fees at funding from many of our portfolio companies, providing an additional potential source of investment returns. We generally are required to invest at least 70% of our total assets in qualifying assets in accordance with the 1940 Act but may invest up to 30% of our total assets in non-qualifying assets, as permitted by the 1940 Act.

We target investments in growth stage companies, which are typically private companies, including venture-backed companies and companies with institutional equity investors. We define “growth stage companies” as companies that have significant ownership and active participation by sponsors, such as institutional investors or private equity firms, and expected annual revenues of up to $100.0 million. Subject to the requirements of the 1940 Act, we are not limited to investing in any particular industry or geographic area and seek to invest in under-financed segments of the private credit markets.

Our loans and equipment financings may have initial interest-only periods of up to 24 months and generally fully amortize over a total term of up to 60 months. These investments are typically secured by a blanket first position lien, a specific asset lien on mission critical assets and/or a blanket second position lien. We may also make a limited number of direct equity and equity-related investments in conjunction with our debt investments. We target growth stage companies that have recently issued equity to raise cash to offset potential cash flow needs related to projected growth, have

71

Table of Contents

achieved positive cash flow to cover debt service, or have institutional investors committed to providing additional funding. A loan or equipment financing may be structured to tie the amortization of the loan or equipment financing to the portfolio company’s projected cash balances while cash is still available for operations. As such, the loan or equipment financing may have a reduced risk of default. We believe that the amortizing nature of our investments will mitigate risk and significantly reduce the risk of our investments over a relatively short period. We focus on protecting and recovering principal in each investment and structure our investments to provide downside protection.

Our History

Trinity Capital Inc. was incorporated under the general corporation laws of the State of Maryland on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for matters relating to our formation and organization as a BDC.

On January 16, 2020, through a series of transactions (the “Formation Transactions”), we acquired Trinity Capital Investment, LLC ( “TCI, LLC”), Trinity Capital Fund II, L.P. (“Fund II”), Trinity Capital Fund III, L.P. (“Fund III”), Trinity Capital Fund IV, L.P. (“Fund IV”) and Trinity Sidecar Income Fund, L.P. (“Sidecar Fund,” and collectively, the “Legacy Funds”) and all of their respective assets (the “Legacy Assets”), including their respective investment portfolios (the “Legacy Portfolio”), as well as Trinity Capital Holdings, LLC (“Trinity Capital Holdings”), a holding company whose subsidiaries managed and/or had the right to receive fees from certain of the Legacy Funds. In order to complete these transactions we used a portion of the proceeds from our private equity offering and private debt offering that occurred on January 16, 2020 (refer to "Item 8. Consolidated Financial Statements and Supplementary Data - Note 1. Organization and Basis of Presentation" for further discussion of these transactions).

The Legacy Funds were merged with and into the Company, and we issued 9,183,185 shares of our common stock for an aggregate amount of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Funds’ investors, which included the general partners, managers or managing members of the Legacy Funds (the “Legacy Investors”), to acquire the Legacy Funds and all of their respective assets, including the Legacy Portfolio. Our senior management team, led by Steven L. Brown, comprises the majority of the senior management team that managed the Legacy Funds and sourced the Legacy Portfolio.

As part of the Formation Transactions, we also acquired 100% of the equity interests of Trinity Capital Holdings for an aggregate purchase price of $10.0 million, which was comprised of 533,332 shares of our common stock, totaling approximately $8.0 million, and approximately $2.0 million in cash. In connection with the acquisition of such equity interests, the Company also assumed a $3.5 million severance related liability with respect to a former member of certain general partners of certain Legacy Funds. In connection with the acquisition of Trinity Capital Holdings, approximately $13.5 million (consisting of the aggregate purchase price and severance related liability assumed) was expensed to Costs related to the acquisition of Trinity Capital Holdings and Legacy Funds in the Consolidated Statements of Operations. As a result of the Formation Transactions, Trinity Capital Holdings became a wholly owned subsidiary of the Company.

On February 2, 2021, we completed our initial public offering of 8,006,291 shares of our common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Our common stock began trading on the Nasdaq Global Select Market on January 29, 2021 under the symbol “TRIN.” Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

Critical Accounting Policies

The Company’s financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”). The Company follows accounting and reporting guidance as determined by the Financial Accounting Standards Board (“FASB”), in FASB Accounting Standards Codification (“ASC”) 946, Financial Services — Investment Companies .

72

Table of Contents

The preparation of our financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ materially. Valuation of investments, income recognition, realized / unrealized gains or losses and U.S. federal income taxes are considered to be our critical accounting policies and estimates. –For additional information, please refer to “Note 2 - Summary of Significant Accounting Policies” in the notes to the consolidated financial statements included with this Quarterly Report on Form 10-Q.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. Included in interest income for the three and six months ended June 30, 2020 is the acceleration of OID and EOT of approximately $1.0 million and $1.4 million, respectively, which was reclassified from net realized gain/(loss) on investments. Included in fee income for the three and six months ended June 30, 2020 is non-recurring fees of approximately $0.4 million and $1.8 million, respectively, of which $0.1 million and $1.0 million, respectively, were reclassified from net realized gain/(loss) on investment and $0.3 million and $0.8 million, respectively, were reclassified from interest income. These reclassifications had no effect on the previously reported net increase (decrease) in net assets.

Valuation of Investments

The most significant estimate inherent in the preparation of the Company’s consolidated financial statements is the valuation of investments and the related amounts of unrealized appreciation and depreciation of investments recorded. The Company’s investments are carried at fair value in accordance with the 1940 Act and ASC 946 and measured in accordance with ASC 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the observability of inputs used to measure fair value, and provides disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that each of the portfolio investments is sold in a hypothetical transaction in the principal or, as applicable, most advantageous market using market participant assumptions as of the measurement date. Market participants are defined as buyers and sellers in the principal market that are independent, knowledgeable and willing and able to transact. The Company values its investments at fair value as determined in good faith by the Company’s Board of Directors (the “Board”) in accordance with the provisions of ASC 820 and the 1940 Act.

While the Board is ultimately and solely responsible for determining the fair value of the Company’s investments, the Company has engaged independent valuation firms to provide the Company with valuation assistance with respect to its investments. The Company engages independent valuation firms on a discretionary basis. Specifically, on a quarterly basis, the Company will identify portfolio investments with respect to which an independent valuation firm will assist in valuing certain investments. The Company selects these portfolio investments based on a number of factors, including, but not limited to, the potential for material fluctuations in valuation results, size, credit quality and the time lapse since the last valuation of the portfolio investment by an independent valuation firm.

Investments recorded on our Consolidated Statements of Assets and Liabilities are categorized based on the inputs to the valuation techniques as follows:

Level 1 — Investments whose values are based on unadjusted quoted prices for identical assets in an active market that the Company has the ability to access (examples include investments in active exchange-traded equity securities and investments in most U.S. government and agency securities).

Level 2 — Investments whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the investment.

Level 3 — Investments whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (for example, investments

73

Table of Contents

in illiquid securities issued by privately held companies). These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the investment.

Given the nature of lending to venture capital-backed growth stage companies, substantially all of the Company’s investments in these portfolio companies are considered Level 3 assets under ASC 820 because there is no known or accessible market or market indexes for these investment securities to be traded or exchanged. The Company uses an internally developed portfolio investment rating system in connection with its investment oversight, portfolio management and analysis and investment valuation procedures. This system takes into account both quantitative and qualitative factors of the portfolio companies. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.

Fair value estimates are made at discrete points in time based on relevant information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amounts of the Company’s financial instruments, consisting of cash, investments, receivables, payables and other liabilities approximate the fair values of such items due to the short-term nature of these instruments.

Income Recognition

Interest Income

The Company recognizes interest income on an accrual basis and recognizes it as earned in accordance with the contractual terms of the loan agreement to the extent that such amounts are expected to be collected. Original issue discount (“OID”) initially includes the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, and is accreted into interest income over the term of the loan as a yield enhancement based on the effective yield method. In addition, the Company may also be entitled to an end-of-term (“EOT”) fee. Debt EOT fees to be paid at the termination of the financing arrangements are accreted into interest income over the contractual life of the debt based on the effective yield method. As of June 30, 2021 and December 31, 2020, the Company had an EOT payment receivable of approximately $37.0 million and $37.9 million, respectively, which is included as a component of the cost basis of the Company’s current debt securities. When a portfolio company pre-pays their indebtedness prior to the scheduled maturity date, then the acceleration of the unaccreted OID and EOT is recognized as interest income.

Income related to application or origination payments, including facility commitment fees, net of related expenses and generally collected in advance, are amortized into interest income over the contractual life of the loan. The Company recognizes nonrecurring fees and additional OID and EOT received in consideration for contract modifications commencing in the quarter relating to the specific modification.

Fee Income

The Company recognizes one-time fee income, including, but not limited to, structuring fees, prepayment penalties, and exit fees related to a change in ownership of the portfolio company, as other income when earned. These fees are generally earned when the portfolio company enters into an equipment financing arrangement or pays off their outstanding indebtedness prior to the scheduled maturity.

Portfolio Composition and Investment Activity

Portfolio Composition

Through the Formation Transactions, we acquired the Legacy Assets, including the Legacy Portfolio, from the Legacy Funds, as well as Trinity Capital Holdings. The Legacy Portfolio became our investment portfolio. As of June 30, 2021, our investment portfolio had an aggregate fair value of approximately $597.7 million and was comprised of

74

Table of Contents

approximately $397.5 million in secured loans, $120.9 million in equipment financings, and $79.3 million in equity and equity-related investments, including warrants, across 80 portfolio companies. As of December 31, 2020, our investment portfolio had an aggregate fair value of approximately $493.7 million and was comprised of approximately $320.7 million in secured loans, $122.5 million in equipment financings, and $50.5 million in equity and equity-related investments, including warrants, across 80 portfolio companies.

A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments are shown in following table as of June 30, 2021 and December 31, 2020:

June 30, 2021 December 31, 2020
Fair Fair
Type Cost Value Cost Value
Secured Loans 69.8% 66.4% 65.1% 65.0%
Equipment Financings 20.9% 20.2% 24.7% 24.8%
Equity 6.9% 8.8% 6.6% 6.6%
Warrants 2.4% 4.6% 3.6% 3.6%
Total 100.0% 100.0% 100.0% 100.0%

The following table shows the composition of our investment portfolio by geographic region at cost and fair value as a percentage of total investments as of June 30, 2021 and December 31, 2020. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

June 30, 2021 December 31, 2020
Fair Fair
Geographic Region Cost Value Cost Value
United States x x
West 48.7% 52.7% 49.6% 48.8%
Northeast 26.7% x 24.0% 26.4% x 25.9%
Midwest 8.3% 7.3% 9.5% 8.9%
Mountain 6.7% 6.6% 6.8% 6.9%
Southeast 0.2% 0.1% 2.2% 3.6%
South 5.2% 5.2% 0.1% 0.4%
Canada 4.2% 4.1% 5.4% 5.5%
Total 100.0% 100.0% 100.0% 100.0%

75

Table of Contents

Set forth below is a table showing the industry composition of our investment portfolio at cost and fair value as a percentage of total investments as of June 30, 2021 and December 31, 2020:

June 30, 2021 December 31, 2020
Fair Fair
Industry Cost Value Cost Value
Manufacturing 23.7% 28.0% 20.8% 20.2%
Professional, Scientific, and Technical Services 14.5% 15.0% 15.6% 16.0%
Retail Trade 15.7% 13.1% 15.7% 15.4%
Finance and Insurance 7.1% 7.1% 7.0% 7.2%
Information 5.9% 5.7% 6.4% 6.2%
Rental and Leasing Services 5.4% 5.3% 5.8% 5.9%
Space Research and Technology 5.2% 5.0% 0.0% 0.0%
Utilities 4.2% 4.1% 5.4% 5.5%
Agriculture, Forestry, Fishing and Hunting 3.1% 3.5% 4.2% 4.2%
Real Estate 3.5% 3.4% 3.5% 3.5%
Health Care and Social Assistance 3.6% 2.8% 2.9% 2.3%
Educational Services 2.4% 2.4% 1.9% 2.0%
Wholesale Trade 2.0% 1.9% 4.8% 4.8%
Construction 1.9% 1.3% 2.0% 1.4%
Pharmaceutical 1.3% 1.2% 3.5% 4.9%
Administrative and Support and Waste Management and Remediation Services 0.5% 0.2% 0.5% 0.5%
Total 100.0% 100.0% 100.0% 100.0%

As of June 30, 2021 and December 31, 2020, the debt, including loans and equipment financings, in our portfolio had a weighted average time to maturity of approximately 3.1 years. Additional information regarding our portfolio is set forth in the schedule of investments and the related notes thereto included with this Quarterly Report on Form 10-Q.

Concentrations of Credit Risk

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. Industry and sector concentrations will vary from period to period based on portfolio activity.

As of June 30, 2021 and December 31, 2020, the Company’s ten largest portfolio companies represented approximately 42.4% and 42.5%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of June 30, 2021 and December 31, 2020, the Company had 9 and 14 portfolio companies that represented 5% or more of the Company’s net assets, respectively.

Investment Activity

During the six months ended June 30, 2021, we made an aggregate of approximately $139.3 million of investments in 13 new portfolio companies and approximately $70.2 million of investments in 15 existing portfolio companies, excluding fees. During the six months ended June 30, 2021, we received an aggregate of $146.9 million in proceeds from repayments and sales of our investments, including proceeds of approximately $92.0 million from early repayments on our debt investments.

During the year ended December 31, 2020, in addition to $417.0 million in investments we acquired in connection with the Formation Transactions, we made an aggregate of approximately $144.3 million of investments in 18 new portfolio companies and approximately $95.7 million of investments in 18 existing portfolio companies. During the year ended December 31, 2020, we received an aggregate of $160.9 million in proceeds from repayments and sales of our investments including proceeds of approximately $108.8 million from early repayments.

76

Table of Contents

The following table provides a summary of the changes in the investment portfolio for the six months ended June 30, 2021 and the year ended December 31, 2020 (in thousands):

Six Months
Ended Year Ended
June 30, 2021 December 31, 2020
Beginning Portfolio $ 493,651 $
Formation Transactions acquisitions 417,023
Purchases, net of deferred fees 208,232 238,564
Non-cash conversion 1,263
Proceeds from Paydowns and Sales (54,921) (52,111)
Proceeds from early debt repayments (91,958) (108,790)
Accretion of OID and EOT payments 10,279 11,788
Net realized gain/(loss) 4,590 (9,403)
Third party participation (1) (283) 283
Change in unrealized appreciation/(depreciation) 28,106 (4,966)
Ending Portfolio $ 597,696 $ 493,651

(1) Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

The level of our investment activity can vary substantially from period to period depending on many factors, including the amount of debt, including loans and equipment financings, and equity capital required by growth stage companies, the general economic environment and market conditions and the competitive environment for the types of investments we make.

Portfolio Asset Quality

Our portfolio management team uses an ongoing investment risk rating system to characterize and monitor our outstanding loans and equipment financings. Our portfolio management team monitors and, when appropriate, recommends changes to the investment risk ratings. Our Investment Committee reviews the recommendations and/or changes to the investment risk ratings, which are submitted on a quarterly basis to the Board and its Audit Committee.

For our investment risk rating system, we review seven different criteria and, based on our review of such criteria, we assign a risk rating on a scale of 1 to 5, as set forth in the following illustration.

77

Table of Contents

The following table shows the distribution of our loan and equipment financing investments on the 1 to 5 investment risk rating scale range at fair value as of June 30, 2021 and December 31, 2020 (dollars in thousands):

June 30, 2021 December 31, 2020
Investment Risk Rating Investments at Percentage of Investments at Percentage of
Scale Range Designation Fair Value Total Portfolio Fair Value Total Portfolio
4.0 - 5.0 Very Strong Performance $ 83,915 16.2% $ 92,519 20.9%
3.0 - 3.9 Strong Performance 206,852 39.9% 212,969 48.0%
2.0 - 2.9 Performing 197,503 38.1% 116,895 26.4%
1.6 - 1.9 Watch 29,820 5.7% 19,230 4.3%
1.0 - 1.5 Default/Workout 343 0.1% 1,606 0.4%
Total $ 518,433 100.0% $ 443,219 100.0%

At June 30, 2021 and December 31, 2020, our loan and equipment financing investments had a weighted average risk rating score of 3.1.

Debt Investments on Non-Accrual Status

When a debt security becomes 90 days or more past due, or if our management otherwise does not expect that principal, interest, and other obligations due will be collected in full, we will generally place the debt security on non-accrual status and cease recognizing interest income on that debt security until all principal and interest due has been paid or we believe the borrower has demonstrated the ability to repay its current and future contractual obligations. Any uncollected interest is reversed from income in the period that collection of the interest receivable is determined to be doubtful. However, we may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection.

As of June 30, 2021, loans to two portfolio companies were on non-accrual status with a total cost of approximately $1.2 million, and a total fair market value of approximately $0.9 million, or 0.2%, of the fair value of the Company’s investment portfolio. As of December 31, 2020, loans to three portfolio companies were on non-accrual status with a total cost of approximately $3.4 million, and a total fair value of approximately $2.2 million, or 0.5%, of the total fair value of the Company’s investment portfolio.

78

Table of Contents

Results of Operations

The following discussion and analysis of our results of operations encompasses our consolidated results for the three and six months ended June 30, 2021 and 2020. We were formed on August 12, 2019 and commenced operations on January 16, 2020. Prior to January 16, 2020, we had no operations, except for immaterial matters relating to our formation and organization as a BDC.

Investment Income

The following table sets forth the components of investment income (in thousands):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Stated interest income $ 12,429 $ 9,491 $ 24,179 $ 18,200
Amortization of original issue discount 3,709 3,015 7,156 4,691
Acceleration of amortization of original issue discount 1,976 934 3,123 1,363
Prepayment penalty and related fees 1,239 100 1,946 1,057
Other fee income 123 307 391 784
Total investment income $ 19,476 $ 13,847 $ 36,795 $ 26,095

We generate revenues primarily in the form of investment income from the investments we hold, generally in the form of interest income from our debt securities. Investment income represents interest income recognized as earned in accordance with the contractual terms of the loan agreement. Interest income from original issue discount (“OID”) represents the estimated fair value of detachable warrants obtained in conjunction with the origination of debt securities, including loans and equipment financings and is accreted into interest income over the term of the loan as a yield enhancement. Interest income from payment-in-kind (“PIK”) represents contractually deferred interest added to the loan balance recorded on an accrual basis to the extent such amounts are expected to be collected.

Loan and commitment fees in excess of related expenses are amortized into interest income over the contractual life of the loan. The Company also recognizes certain fees as one-time fee income, including, but not limited to, prepayment penalties, fees related to select covenant default, late-payment fees, structuring fees and exit fees related to a change in ownership of the portfolio company.

For the three months ended June 30, 2021, total investment income was approximately $19.5 million, which represents an approximate effective yield of 15.9% on the average investments during such period. For the three months ended June 30, 2020, total investment income was approximately $13.8 million, which represents an approximate yield of 14.6% on the investments during the period. The increase in investment income for the six months ended June 30, 2021 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which fluctuates based on investment activity and early repayment activity.

For the six months ended June 30, 2021, total investment income was approximately $36.8 million, which represents an approximate effective yield of 15.8% on the average investments during such period. For the six months ended June 30, 2020, total investment income was approximately $26.1 million, which represents an approximate effective yield of 14.8% on the investments during the period. The increase in investment income for the three months ended June 30, 2021 is due to higher stated interest income and amortization of OID and EOT based on an increased principal value of income producing debt investments and increased non-recurring fee income, which can fluctuate based on investment activity and early repayment activity.

Operating Expenses

Our operating expenses are comprised of interest and fees on our borrowings, employee compensation, professional fees and general and administrative expenses. Our operating expenses totaled approximately $9.4 million and $7.1

79

Table of Contents

million for the three months ended June 30, 2021 and 2020, respectively, and $19.5 million and $13.6 million for the six months ended June 30, 2021 and 2020, respectively.

Interest Expense and Other Debt Financing Costs

Interest expense and other debt financing costs on our borrowings totaled approximately $4.4 million and $4.3 million for the three months ended June 30, 2021 and 2020, respectively, and approximately $9.0 million and $8.5 million for the six months then ended. These costs are primarily comprised of interest and fees related to the Credit Facility, the 2025 Notes and the Convertible Notes. Our weighted effective interest rate, comprised of interest and amortization of fees and discount was approximately 7.6% and 6.6% for the three months ended June 30, 2021 and 2020, respectively, and 7.4% and 6.6% for the six months then ended. The increase in interest expense for the three and six months ended June 30, 2021 was primarily due to the issuance of the Convertible Notes in December 2020 and the six month increase partially offset by paydowns in the Credit Facility.

Employee Compensation and Benefits

Employee compensation and benefits totaled approximately $3.4 million and $1.7 million for the three months ended June 30, 2021 and 2020, respectively. The increase in employee compensation related expenses during the three months ended June 30, 2021 relates primarily to the accrual of bonuses expected to be paid at the discretion of management or upon approval of the Board, as applicable, as well as an increased headcount. Employee compensation and benefits totaled approximately $7.4 million and $3.1 million for the six months ended June 30, 2021 and 2020, respectively. The increase in employee compensation related expenses during the six months ended June 30, 2021 also relates primarily to the accrual of bonuses expected to be paid at the discretion of management or upon approval of the Board, as applicable, as well as an increased headcount. As of June 30, 2021 and 2020, the Company had 39 and 29 employees, respectively.

The Board and the Company’s stockholders have adopted and approved the (i) 2019 Trinity Capital Inc., Long-Term Incentive Plan; and (ii) Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan, with each plan becoming effective on June 17, 2021. See “Note 7 – Stockholder’s Equity” in the Notes to Consolidated Financial Statements.

Professional Fees Expenses

Professional fees expenses, consisting of legal fees, accounting fees, third-party valuation fees, and talent acquisition fees were approximately $0.6 million and $0.7 million for the three months ended June 30, 2021, and 2020, respectively. Professional fees expenses were approximately $1.2 million for the six months ended June 30, 2021, which is approximately equal to the amount for the six months ended June 30, 2020.

General and Administrative Expenses

General and administrative expenses include insurance premiums, rent, taxes and other various expenses related to our ongoing operations. Our general and administrative expenses totaled approximately $1.0 million and $0.4 million for the three months ended June 30, 2021 and 2020, respectively. General and administrative expenses totaled approximately $1.8 million and $0.8 million for the six months ended June 30, 2021 and 2020, respectively. The increase in general and administrative expenses for the three and six months ended June 30, 2021 is primarily due to a higher D&O insurance premiums.

Net Investment Income

As a result of approximately $19.5 million in total investment income as compared to approximately $9.4 million in total expenses, net investment income for the three months ended June, 2021 was approximately $10.1 million. As a result of approximately $13.9 million in total investment income as compared to approximately $7.1 million in total expenses, net investment income for the three months ended June 30, 2020 was approximately $6.8 million.

80

Table of Contents

As a result of approximately $36.8 million in total investment income as compared to approximately $19.5 million in total expenses, net investment income for the six months ended June 30, 2021 was approximately $17.3 million. As a result of approximately $26.1 million in total investment income as compared to approximately $13.6 million in total expenses, net investment income for the six months ended June 30, 2020 was approximately $12.5 million.

Net Realized Gains and Losses

Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of an investment or a financial instrument and the cost basis of the investment or financial instrument, without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period.

The net realized gains (losses) from the sales, repayments, or exits of investments were comprised of the following (in thousands):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Net realized gain (loss) on investments:
Gross realized gains $ 2,502 $ 41 $ 5,469 $ 835
Gross realized losses (507) (2,043) (879) (3,719)
Total net realized gains/(losses) on investments $ 1,995 $ (2,002) $ 4,590 $ (2,884)

Net Change in Unrealized Appreciation / (Depreciation) from Investments

Net change in unrealized appreciation/(depreciation) from investments primarily reflects the net change in the fair value of the investment portfolio and financial instruments and the reclassification of any prior period unrealized appreciation or depreciation on exited investments and financial instruments to realized gains or losses.

Net unrealized appreciation and depreciation on investments for the three and six months ended June 30, 2021 and 2020 is comprised of the following (in thousands):

Three Months Ended Six Months Ended
June 30, 2021 June 30, 2020 June 30, 2021 June 30, 2020
Gross unrealized appreciation $ 28,342 $ 11,820 $ 57,110 $ 3,996
Gross unrealized depreciation (12,543) (9,657) (21,969) (26,112)
Third party participation (1) (40) 283 (53)
Net unrealized appreciation/depreciation reclassified related to net realized gains or losses (2) (3,169) (7,318)
Total net unrealized gains (losses) on investments $ 12,630 $ 2,123 $ 28,106 $ (22,169)

(1) Certain third parties had rights to 17,485 shares of Ology Bioservices common stock at a fair value of approximately $0.6 million as of December 31, 2020. During March 2021, these shares were reissued by Ology Bioservices directly to the third parties and the corresponding liability was removed from the Consolidated Statement of Assets and Liabilities. The activity related to these shares and the related liability is recorded against unrealized appreciation/(depreciation).

(2) Investments were recorded at their fair values in the Formation Transactions on January 16, 2020, therefore no reclassification of unrealized appreciation (depreciation) was recorded during the three or six months ended June 30, 2020.

81

Table of Contents

The significant changes in net unrealized appreciation (depreciation) from investments during the three months ended June 30, 2021 consisted of the following (in thousands):

Net Unrealized
Appreciation
Portfolio Company (Depreciation)
Atieva, Inc. $ 11,418
Bowery Farming, Inc. 2,773
Matterport, Inc. 2,692
The Fynder Group, Inc. 954
UnTuckIt, Inc. 924
Convercent, Inc. (713)
Madison Reed, Inc. (953)
Vertical Communications, Inc. (1,302)
Ology Bioservices, Inc. (1,511)
Birchbox, Inc. (2,654)
Other, net 1,002
Total $ 12,630

The significant changes in net unrealized appreciation (depreciation) from investments during the three months ended June 30, 2020 consisted of the following (in thousands):

Net Unrealized
Appreciation
Portfolio Company (Depreciation)
Altierre Corporation $ 2,110
Vertical Communications, Inc. 956
Nanotherapeutics, Inc. 830
Birchbox, Inc. 857
Petal Card, Inc. 544
Project Frog, Inc. (602)
Atieva, Inc. (2,107)
Vidsys, Inc. (2,280)
Other, net 1,815
Total $ 2,123

The significant changes in net unrealized appreciation (depreciation) from investments during the six months ended June 30, 2021 consisted of the following (in thousands):

Net Unrealized
Appreciation
Portfolio Company (Depreciation)
Atieva, Inc. $ 33,611
Matterport, Inc 6,096
Bowery Farming, Inc. 2,976
UnTuckIt, Inc. 1,144
The Fynder Group, Inc. 897
Instart Logic, Inc. (978)
Vertical Communications, Inc. (1,035)
Incontext Solutions, Inc. (1,044)
Ology Bioservices, Inc. (7,259)
Birchbox, Inc. (10,624)
Other, net 4,322
Total $ 28,106

82

Table of Contents

The significant changes in net unrealized appreciation (depreciation) from investments during the six months ended June 30, 2020 consisted of the following (in thousands):

Net Unrealized
Appreciation
Portfolio Company (Depreciation)
Nanotherapeutics, Inc. $ 1,101
Hytrust, Inc. (538)
STS Media, Inc. (637)
BaubleBar, Inc. (1,011)
Edeniq, Inc. (1,013)
UnTuckIt, Inc. (1,562)
Project Frog, Inc. (2,109)
WorkWell Prevention & Care (2,116)
Vertical Communications, Inc. (2,912)
Atieva, Inc. (2,955)
Vidsys, Inc. (3,782)
Other, net (4,635)
Total $ (22,169)

During the three and six months ended June 30, 2021, we recorded net unrealized appreciation of $12.6 million and $28.1 million, respectively, which was primarily from net unrealized appreciation of approximately $8.2 million and $20.2 million, respectively, from our equity investments and $6.3 million and $10.5 million, respectively, from our warrant investments, offset by the reversal of unrealized appreciation upon pay-off of our portfolio companies during the period.

During the three and six months ended June 30, 2020, we recorded net unrealized appreciation of $2.1 million and net unrealized depreciation of $22.2 million, respectively. The unrealized appreciation for the three months ended June 30, 2021, was primarily from unrealized appreciation of $1.9 million from our debt investments, and $1.6 million from equity investments offset by unrealized depreciation of $1.4 million from our warrant investments. The $22.2 million of unrealized depreciation was a result of $11.4 million of unrealized depreciation from our debt investments, $5.3 million of unrealized depreciation from our warrant investments, and $5.5 million of unrealized depreciation from our equity investments.

Net Increase (Decrease) in Net Assets Resulting from Operations

Net increase in net assets resulting from operations during the three months ended June 30, 2021, was approximately $24.7 million. Net increase in net assets resulting from operations before formation costs during the three months ended June 30, 2020, was approximately $6.9 million. Net increase in net assets resulting from operations during the six months ended June 30, 2021, was approximately $50.0 million. Net decrease in net assets resulting from operations before formation costs during the six months ended June 30, 2020, was approximately $12.6 million.

Net Increase (Decrease) in Net Assets Resulting from Operations and Earnings Per Share

For the three months ended June 30, 2021, and 2020, basic and fully diluted net increase in net assets per common share were $0.93 and $0.38, respectively. The increase in 2021 is result of overall increased net operating results. For the six months ended June 30, 2021, basic and fully diluted net increase in net assets per common share were $2.00 . For the six months ended June 30, 2020, basic and diluted net decrease in net assets per common share were $1.57. Costs related to the acquisition of Trinity Capital Holdings was approximately $13.5 million, and the cost related to the acquisition of the Legacy Funds was approximately $2.1 million. The total cost of $15.6 million, when added to the net decrease in net assets resulting from operations before formation costs, resulted in a net decrease in net assets resulting from operations during the six months ended June 30, 2020, of approximately $(28.2) million.

83

Table of Contents

Financial Condition, Liquidity and Capital Resources

Our liquidity and capital resources are generated primarily from the net proceeds of offerings of our securities, including our initial public offering, the Private Offerings and the Convertible Notes offering, borrowings under the Credit Facility and cash flows from our operations, including investment sales and repayments, as well as income earned on investments and cash equivalents. Our primary use of our funds includes investments in portfolio companies, payments of interest on our outstanding debt, and payments of fees and other operating expenses we incur. We also expect to use our funds to pay distributions to our stockholders. We have used, and expect to continue to use, our borrowings, including under the Credit Facility or any future credit facility, and proceeds from the turnover of our portfolio to finance our investment objectives and activities.

We may, from time to time, enter into additional credit facilities, increase the size of our existing Credit Facility, or issue additional securities in private or public offerings. Any such incurrence or issuance would be subject to prevailing market conditions, our liquidity requirements, contractual and regulatory restrictions, and other factors.

For the six months ended June 30, 2021, we experienced a net decrease in cash and cash equivalents in the amount of $26.6 million, which is the net result of $54.9 million of cash used in operating activities and $0.8 million of cash used in investing activities partially offset by $29.1 million of cash provided by financing activities. During the six months ended June 30, 2020, we experienced a net increase in cash and cash equivalents in the amount of $38.4 million, which is the net result of $142.3 million of cash provided by financing activities partially offset by $91.8 million of cash used in investing activities and $12.1 million of cash from operating activities.

As of June 30, 2021 and December 31, 2020, we had cash, cash equivalents and restricted cash of $34.5 million and $61.1 million, respectively, of which $34.1 and $60.3 million, respectively, is held in the Goldman Sachs Financial Square Government Institutional Fund. Cash held in demand deposit accounts may exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limit and therefore is subject to credit risk. All of the Company’s cash deposits are held at large established high credit quality financial institutions, and management believes that the risk of loss associated with any uninsured balances is remote. As of June 30, 2021 and December 31, 2020, restricted cash consisted of approximately $15.3 million and $15.7 million, respectively, related to the Credit Facility covenants (See “Note 5 – Borrowings”), and an additional amount of approximately $0.7 million at December 31, 2020 was held in escrow related to the payout of a severance related liability assumed as part of the Formation Transactions with respect to a former member of certain general partners of certain Legacy Funds. As of June 30, 2021 and December 31, 2020, we had approximately $88.6 million and $42.0 million, respectively, of available borrowings under the Credit Facility, subject to its terms and regulatory requirements. Cash, cash equivalents and restricted cash, taken together with available borrowings under the Credit Facility, as of June 30, 2021, are expected to be sufficient for our investing activities and to conduct our operations in the near term.

On January 16, 2020, in connection with the Formation Transactions, we became a party to, and assumed, the Credit Facility through our wholly owned subsidiary, Trinity Funding 1, LLC. The Credit Facility matures on January 8, 2022, unless extended, and we have the ability to borrow up to an aggregate of $300.0 million. In addition, borrowings under the Credit Facility are subject to floating interest rates based on LIBOR, generally bearing interest at a rate of the three-month LIBOR plus 3.25%. We may utilize the leverage available under the Credit Facility to finance future investments. We used a portion of the proceeds from the Private Offerings to repay a portion of the aggregate amount outstanding under the Credit Facility in amount of approximately $60 million. As of June 30, 2021 and December 31, 2020, approximately $70.0 million and $135.0 million, respectively, was outstanding under the Credit Facility. During the three months ended June 30, 2021 we borrowed $25.0 million under the Credit Facility and made no repayments. During the six months ended June 30, 2021, the Company borrowed an additional $25.0 million and made repayments of $90.0 million to Credit Suisse. During the three and six months ended June 30, 2020, we made repayments of approximately $25.0 million and $85.0 million, respectively, to Credit Suisse with no additional borrowings.

In January 2020, we completed the Private Common Stock Offering in reliance upon the available exemptions from the registration requirements of the Securities Act, pursuant to which we issued and sold 8,333,333 shares of our common stock for aggregate gross proceeds of approximately $125.0 million. A portion of the proceeds of the Private

84

Table of Contents

Common Stock Offering were used to complete the Formation Transactions and repay a portion of the outstanding borrowings under the Credit Facility.

In January 2020, concurrent with the completion of the Private Common Stock Offering, we completed the 144A Note Offering in reliance upon the available exemptions from the registration requirements of the Securities Act, pursuant to which we issued and sold $125.0 million in aggregate principal amount of the unsecured 2025 Notes that mature on January 16, 2025, unless repurchased or redeemed in accordance with their terms prior to such date and bear interest at a fixed rate of 7.00% per year payable quarterly on March 15, June 15, September 15 and December 15 of each year. A portion of the proceeds of the 144A Note Offering were used to complete the Formation Transactions and repay a portion of the outstanding borrowings under the Credit Facility. Aggregate estimated offering expenses in connection with the transaction, including the fees and commissions, were approximately $4.8 million. As of June 30, 2021 and December 31, 2020, we had $125 million in aggregate principal amount of 2025 Notes outstanding.

In December 2020, we issued $50.0 million in aggregate principal amount of the Convertible Notes. The sale generated net proceeds of $47.0 million, including $1.7 million of debt issuance costs and $1.3 million of original issue discount. The Convertible Notes bear interest at a rate of 6.00% per year, payable semiannually in arrears on May 1 and November 1, of each year. The Convertible Notes mature on December 11, 2025, unless earlier converted by noteholders or purchased by the Company at the noteholders option upon the occurrence of a fundamental change, as defined in the indenture governing the Convertible Notes. As of June 30, 2021 and December 31, 2020, we had $50.0 million in aggregate principal amount of Convertible Notes outstanding.

On January 29, 2021, our common stock began trading on the Nasdaq Global Select Market under the symbol “TRIN.” On February 2, 2021, we completed our initial public offering of 8,006,291 shares of common stock at a price of $14.00 per share, inclusive of the underwriters’ option to purchase additional shares, which was exercised in full. Proceeds from this offering were primarily used to pay down a portion of our existing indebtedness outstanding under the Credit Facility.

Refer to “Item 2. Financial Statements and Supplementary Data – Note 5 – Borrowings” included in the notes to our consolidated financial statements appearing elsewhere in this report for a discussion of our borrowings.

Reduced Asset Coverage Requirements

In accordance with the 1940 Act, with certain limited exceptions, we are only allowed to incur borrowings, issue debt securities or issue preferred stock, if immediately after the borrowing or issuance, the ratio of total assets (less total liabilities other than indebtedness) to total indebtedness plus preferred stock, is at least 150%. On September 27, 2019, the Board, including a “required majority” (as such term is defined in Section 57(o) of the 1940 Act) and our initial stockholder approved the application to us of the 150% minimum asset coverage ratio set forth in Section 61(a)(2) of the 1940 Act. As a result, effective September 28, 2019, the asset coverage ratio under the 1940 Act applicable to us decreased from 200% to 150%, permitting us to potentially borrow $2 for investment purposes of every $1 of investor equity. As of June 30, 2021, our asset coverage ratio was approximately 255.0% and our asset coverage ratio per unit was approximately $2,550. As of December 31, 2020, our asset coverage ratio was approximately 177.0% and our asset coverage ratio per unit was approximately $1,770. We target a leverage range of between 1.15x and 1.35x.

Commitments and Off-Balance Sheet Arrangements

Other than contractual commitments with respect to our portfolio companies and other legal contingencies incurred in the normal course of our business, we do not have any off-balance sheet financings or liabilities as of June 30, 2021 or December 31, 2020.

The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. A portion of these unfunded contractual commitments as of June 30, 2021 and December 31, 2020 are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions that allow the Company relief from funding obligations for previously made

85

Table of Contents

commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the company. Since a portion of these commitments may expire without being withdrawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by milestones. As of June 30, 2021, the Company had outstanding unfunded commitments of approximately $4.0 million to two portfolio companies, Dandelion, Inc. and Greenlight Biosciences, Inc. As of December 31, 2020, the Company had outstanding unfunded commitments of approximately $0.1 million to one portfolio company, Dandelion, Inc. The Company will fund its future unfunded commitments from the same sources it uses to fund its investment commitments that are funded at the time they are made (which are typically through existing cash and cash equivalents and borrowings under the Credit Facility).

In the normal course of business, the Company enters into contracts that provide a variety of representations and warranties, and general indemnifications. Such contracts include those with certain service providers, brokers and trading counterparties. Any exposure to the Company under these arrangements is unknown as it would involve future claims that may be made against the Company; however, based on the Company’s experience, the risk of loss is remote and no such claims are expected to occur. As such, the Company has not accrued any liability in connection with such indemnifications.

Contractual Obligations

A summary of our contractual payment obligations as of June 30, 2021, is as follows:

Payments Due by Period
Less than 1
year 1 - 3 years 4 - 5 years After 5 years Total
Credit Facility $ $ 70,000 $ $ $ 70,000
7.00% Notes 125,000 125,000
Convertible Notes 50,000 50,000
Operating Leases (1) 112 845 751 1,619 3,327
Total Contractual Obligations $ 112 $ 70,845 $ 175,751 $ 1,619 $ 248,327

(1) Relates to lease for the Chandler office, which expires on July 31, 2022 and is subject to a five-year extension option that will not be exercised. Also includes the lease for our new headquarters in downtown Phoenix, Arizona which commenced on June 4, 2021. We are in the process of securing a subtenant to sublease the Chandler office for the remainder of the lease term.

Distributions

We intend to pay quarterly distributions to our stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board and will depend on our earnings, financial condition, maintenance of our tax treatment as a RIC, compliance with applicable BDC regulations and such other factors as the Board may deem relevant from time to time.

During the six months ended June 30, 2021, we declared a distribution on March 23, 2021 of $0.28 per share, which was paid on April 16, 2021 to stockholders of record as of March 31, 2021 and declared a distribution on June 15, 2021 of $0.29 per share, which was paid on July 15, 2021 to stockholders of record as of June 30, 2021. During the six months ended June 30, 2020, we declared a distribution on May 14, 2020 of $0.22 per share that was paid on June 5, 2020 to shareholders of record as of May 29, 2020.

Related Party Transactions

As discussed herein, the Legacy Funds were merged with and into the Company and we issued 9,183,185 shares of our common stock at $15.00 per share for a total value of approximately $137.7 million and paid approximately $108.7 million in cash to the Legacy Investors, which include the general partners/managers of the Legacy Funds. In addition,

86

Table of Contents

as part of the Formation Transactions, we acquired 100% of the equity interests of Trinity Capital Holdings for shares of our common stock and cash. Members of our management, including Steven L. Brown, Kyle Brown, Gerald Harder and Ron Kundich, owned 100% of the equity interests in Trinity Capital Holdings and controlling interests in the general partners/managers of the Legacy Funds.

As a result of the Formation Transactions, Messrs. S. Brown, K. Brown, Harder and Kundich collectively received (i) 533,332 shares of the Company’s common stock valued at approximately $8.0 million and approximately $2.0 million in cash in exchange for their equity interests in Trinity Capital Holdings, and (ii) 377,441 shares of the Company’s common stock valued at approximately $5.7 million for their limited partner and general partner interests in the Legacy Funds.

We have entered into indemnification agreements with our directors and executive officers. The indemnification agreements are intended to provide our directors and executive officers with the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that we shall indemnify the director or executive officer who is a party to the agreement, or an “Indemnitee,” including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.

Recent Developments

Departure of Certain Officers

On August 2, 2021, Scott Harvey, the Company’s Chief Legal Officer and Chief Compliance Officer, resigned from such positions and from his employment with the Company in connection with his retirement. The Board accepted Mr. Harvey’s resignation, and there was no disagreement between Mr. Harvey and the Company on any matter relating to the Company’s operations, policies or practices. Also on August 2, 2021, the Board appointed Sarah Stanton as the Chief Compliance Officer of the Company. Ms. Stanton also serves, and will continue to serve, as the General Counsel and Secretary of the Company.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, including valuation risk and interest rate risk. Uncertainty with respect to the economic effects of the COVID-19 pandemic has introduced significant volatility in the financial markets, and the effect of the volatility could materially impact our market risks, including those listed below.

Valuation Risk

Our investments may not have a readily available market price, and we value these investments at fair value as determined in good faith by the Board of Directors in accordance with our valuation policy. There is no single standard for determining fair value in good faith. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period, including as a result of the impact of the COVID-19 pandemic on the economy and financial and capital markets. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and it is possible that the difference could be material.

87

Table of Contents

Interest Rate Risk

Interest rate sensitivity and risk refer to the change in earnings that may result from changes in the level of interest rates. To the extent that we borrow money to make investments, including under the Credit Facility or any future financing arrangement, our net investment income will be affected by the difference between the rate at which we borrow funds and the rate at which we invest these funds. In periods of rising interest rates, our cost of borrowing funds would increase, which may reduce our net investment income. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

As of June 30, 2021, approximately 49.3% of our debt investments based on outstanding principal balance represented floating-rate investments based on Prime, and approximately 50.7% of our debt investments based on outstanding principal balance represented fixed-rate investments. In addition, borrowings under the Credit Facility are subject to floating interest rates based on LIBOR, generally bearing interest at a rate of the three-month LIBOR plus 3.25%.

Based on our Consolidated Statements of Operations as of June 30, 2021, the following table shows the annualized impact on net income of hypothetical base rate changes in the Prime rate on our debt investments (considering interest rate floors for floating rate instruments) and the hypothetical base rate changes in the three-month LIBOR on our Credit Facility and there are no changes in our investment and borrowing structure (in thousands):

Interest Interest Net
Income Expense Income/(Loss)
Up 300 basis points $ 6,800 $ 2,100 $ 4,700
Up 200 basis points $ 4,276 $ 1,400 $ 2,876
Up 100 basis points $ 1,989 $ 700 $ 1,289
Down 100 basis points $ — $ (83) $ 83
Down 200 basis points $ — $ (83) $ 83
Down 300 basis points $ — $ (83) $ 83

Currency Risk

In addition, any investments we make that are denominated in a foreign currency will be subject to risks associated with changes in currency exchange rates. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved. As of June 30, 2021, we had two foreign domiciled portfolio companies. Our exposure to currency risk related to the debt investments is minimal as payments from such portfolio companies are received in U.S. dollars. Our equity investments in such portfolio companies are also settled using U.S. dollars. No other investments at June 30, 2021 were subject to currency risk.

Hedging

We do not currently engage in any hedging activities. However, we may, in the future, hedge against interest rate and currency exchange rate fluctuations by using standard hedging instruments such as futures, options and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in benefits of lower interest rates with respect to our portfolio of investments with fixed interest rates. We may also borrow funds in local currency as a way to hedge our non-U.S. denominated investments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in

88

Table of Contents

Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q and determined that our disclosure controls and procedures are effective as of the end of the period covered by this Quarterly Report on Form 10-Q.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

89

Table of Contents

PART II OTHER INFORMATION

Item 1. Legal Proceedings

We are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Furthermore, third parties may seek to impose liability on us in connection with the activities of our portfolio companies. Our business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of these legal or regulatory proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.

Item 1A. Risk Factors

Investing in our securities involves a number of significant risks. In addition to the other information set forth in this quarterly report on Form 10-Q, including the risk factors set forth below, you should carefully consider the risk factors discussed in “Item 1A. Risk Factors” of Annual Report on Form 10 K filed with the SEC on March 4, 2021, all of which could materially affect our business, financial condition and/or results of operations. Although the risks described below and in our other SEC filings referenced above represent the principal risks associated with an investment in us, they are not the only risks we face. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, might materially and adversely affect our business, financial condition and/or results of operations.

Other than as described below, during the six months ended June 30, 2021, there have been no material changes to the risk factors discussed in our SEC filings referenced above.

We are exposed to risks associated with changes in interest rates.

Because we may borrow money to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. A reduction in the interest rates on new investments relative to interest rates on current investments could have an adverse impact on our net investment income. However, an increase in interest rates could decrease the value of any investments we hold which earn fixed interest rates and also could increase our interest expense, thereby decreasing our net income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock. Further, rising interest rates could also adversely affect our performance if such increases cause our borrowing costs to rise at a rate in excess of the rate that our investments yield.

In periods of rising interest rates, to the extent we borrow money subject to a floating interest rate, our cost of funds would increase, which could reduce our net investment income. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum interest rates (such as a LIBOR floor), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner as a result of such minimum interest rates.

If general interest rates rise, there is a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

90

Table of Contents

On July 27, 2017, the United Kingdom’s Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. On November 30, 2020, ICE Benchmark Administration (“IBA”), the administrator of LIBOR, with the support of the United States Federal Reserve and the FCA, announced plans to consult on ceasing publication of USD LIBOR on December 31, 2021 for only the one week and two month USD LIBOR tenors, and on June 30, 2023 for all other USD LIBOR tenors, which the FCA subsequently confirmed on March 5, 2021. The United States Federal Reserve concurrently issued a statement advising banks to stop new USD LIBOR issuances by the end of 2021. Such announcements indicate that the continuation of LIBOR on the current basis cannot and will not be guaranteed after 2021. It appears highly likely that LIBOR will be discontinued or modified by 2021.

The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions (the “ARRC”), is considering replacing U.S. dollar LIBOR with a new index calculated by short term repurchase agreements, backed by Treasury securities called the Secured Overnight Financing Rate (“SOFR”). The first publication of SOFR was released in April 2018. On July 29, 2021, the ARRC formally recommended SOFR as its preferred alternative replacement rate for LIBOR. Whether or not SOFR attains market traction as a LIBOR replacement remains a question and the future of LIBOR at this time is uncertain. Although SOFR appears to be the preferred replacement rate for U.S. dollar LIBOR, at this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or any other reforms to LIBOR that may be enacted. The elimination of LIBOR or any other changes or reforms to the determination or supervision of LIBOR could have an adverse impact on the market for or value of any LIBOR-linked securities, loans, and other financial obligations or extensions of credit held by or due to us or on our overall financial condition or results of operations. In addition, if LIBOR ceases to exist, we may need to renegotiate credit agreements extending beyond 2021 with our portfolio companies that utilize LIBOR as a factor in determining the interest rate, in order to replace LIBOR with the new standard that is established, which may have an adverse effect on our overall financial condition or results of operations. Following the replacement of LIBOR, some or all of these credit agreements may bear interest a lower interest rate, which could have an adverse impact on our results of operations. Furthermore, under the Credit Facility with Credit Suisse, borrowings generally will bear interest at a rate of the three-month LIBOR plus 3.25%. If LIBOR ceases to exist, we will need to renegotiate certain terms of the Credit Facility. If we are unable to do so, amounts drawn under the Credit Facility may bear interest at a higher rate, which would increase the cost of our borrowings and, in turn, affect our results of operations.

We cannot predict how new tax legislation will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.

Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our investors of such qualification or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On April 16, 2021, pursuant to its amended and restated distribution reinvestment plan, the Company issued 75,999 shares of its common stock, at a price of $14.92 per share, to stockholders of record as of March 31, 2021 that did not opt out of the Company’s amended and restated distribution reinvestment plan in order to satisfy the reinvestment portion of the Company’s distribution. This issuance was not subject to the registration requirements of the Securities Act.

91

Table of Contents

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

92

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of this Quarterly Report on Form 10-Q or hereby incorporated by reference to exhibits previously filed with the SEC:

Exhibit Number Description of Exhibits
3.1 Articles of Amendment and Restatement (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
3.2 Bylaws (incorporated by reference to Exhibit 3.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.1 Amended and Restated Registration Rights Agreement dated December 15, 2020 (Common Stock) (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed December 16, 2020).
4.2 Registration Rights Agreement, dated January 16, 2020 (Notes) (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.3 Registration Rights Agreement, dated December 11, 2020 (Convertible Notes) (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on December 14, 2020).
4.4 Indenture, dated as of January 16, 2020, by and between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.5 First Supplemental Indenture, dated as of January 16, 2020, relating to the 7.00% Notes due 2025, by and between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 10 filed on January 16, 2020).
4.6 Form of 7.00% Note due 2025 (included as part of and incorporated by reference to Exhibit 4.5 hereto) .
4.7 Second Supplemental Indenture, dated January 16, 2020, relating to the 6.00% Convertible Notes due 2025, between Trinity Capital Inc. and U.S. Bank National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on December 14, 2020).
4.8 Form of 6.00% Convertible Notes due 2025 (included as part of and incorporated by reference to Exhibit 4.7 hereto).
10.1 2019 Trinity Capital Inc. Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 23, 2021).
10.2 Trinity Capital Inc. 2019 Non-Employee Director Restricted Stock Plan (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on June 23, 2021).
31.1* Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2* Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1* Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2* Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  • Filed herewith

93

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TRINITY CAPITAL INC.
Dated: August 5, 2021 By: /s/ Steven L. Brown
Steven L. Brown
Chairman and Chief Executive Officer
(Principal Executive Officer)
Dated: August 5, 2021 By: /s/ David Lund
David Lund
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)

94